<SEC-DOCUMENT>0001104659-20-132297.txt : 20201204
<SEC-HEADER>0001104659-20-132297.hdr.sgml : 20201204
<ACCEPTANCE-DATETIME>20201204121630
ACCESSION NUMBER:		0001104659-20-132297
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201204
DATE AS OF CHANGE:		20201204
EFFECTIVENESS DATE:		20201204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		201369298

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	19920929
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>tm2030671d1_ncsr.htm
<DESCRIPTION>N-CSR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB APPROVAL</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 52%; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB Number:</FONT></TD>
    <TD STYLE="width: 12%; border-right: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3235-0570</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires:</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2022</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED STATES</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated average burden hours per response. . . . . . . . . . . . . . .20.6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES AND EXCHANGE COMMISSION</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington, D.C. 20549</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-top: 2pt; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM N-CSR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFIED SHAREHOLDER REPORT OF REGISTERED<BR>
MANAGEMENT INVESTMENT COMPANIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Company Act file number</FONT></TD>
    <TD COLSPAN="7" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">811-06565</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font: 14pt Times New Roman, Times, Serif">Tekla Life Sciences Investors</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of registrant as specified in charter)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="8" STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    Federal Street, 19</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>&nbsp;Floor, Boston, MA</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02110</FONT></TD></TR>
<TR>
    <TD COLSPAN="8" STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip code)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Laura Woodward, Chief Compliance Officer
        and Vice President of Fund Administration</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
        Federal Street, 19</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> Floor, Boston, MA 02110</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name and address of agent for service)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="5"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s telephone number, including area code:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">617-772-8500</FONT></TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of fiscal year end:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30</FONT></TD>
    <TD COLSPAN="6">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="10">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of reporting period:</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 1, 2019 to September 30, 2020</FONT></TD>
    <TD COLSPAN="4">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 1. REPORTS TO STOCKHOLDERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Document name: 20-30671-2.aa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j20306712_aa001.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j20306712_aa002.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j20306712_aa003.jpg"></p>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:30pt;"><b><i>Annual Report</i></b></font></p>
<p style="margin:11pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:13pt;">&nbsp;&nbsp;2&nbsp;&nbsp;0&nbsp;&nbsp;2&nbsp;&nbsp;0</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of the Fund's annual and semi-annual shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports. Instead, the reports will be made available on the Fund's website, teklacap.com., and you will be notified by mail each time a report is posted and provided with a website link to access the report.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Beginning on January 1, 2019, you may elect to receive all future reports in paper free of charge. If you invest through a financial intermediary, you can contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. If you invest directly with the Fund, you can call Computershare at 1-800-426-5523 to inform the Fund that you wish to continue receiving paper copies of your shareholder reports. Your election to receive reports in paper will apply to all funds held in your account if you invest through your financial intermediary or all funds held with the fund complex if you invest directly with the Fund.</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='20-30671-2.aa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Distribution policy:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has implemented a managed distribution policy (the Policy) that provides for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Policy would result in a return of capital to shareholders, if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The amounts and sources of distributions reported in the Fund's notices pursuant to Section 19(a) of the Investment Company Act of 1940 are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that tells you how to report distributions for federal income tax purposes.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You should not draw any conclusions about the Fund's investment performance from the amount of distributions pursuant to the Policy or from the terms of the Policy. The Policy has been established by the Trustees and may be changed or terminated by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distributions considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions. The suspension or termination of the Policy could have the effect of creating a trading discount or widening an existing trading discount. At this time there are no reasonably foreseeable circumstances that might cause the Trustees to terminate the Policy.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Consider these risks before investing:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> As with any investment company that invests in equity securities, the Fund is subject to market risk&#151;the possibility that the prices of equity securities will decline over short or extended periods of time. As a result, the value of an investment in the Fund's shares will fluctuate with the market generally and market sectors in particular. You could lose money over short or long periods of time. Political and economic news can influence market-wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares. Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of healthcare companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=2,FOLIO='',FILE='20-30671-2.aa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.ba-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dear Shareholders,</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We are definitely living in interesting times. In fact, I don't know how much more "interesting" things can get. We are in the middle of a global pandemic the likes of which we have not seen in a hundred years. Globally, more than one hundred and sixty million people are estimated to have been infected by the Covid-causing coronavirus. More than 1,295,185 people have succumbed to this epidemic, including more than 242,435 Americans. From April through June 2020, U.S. GDP had decreased by an annualized 32.9% while record unemployment claims were recorded. It is doubtful that these occurrences could have been imagined just a handful of months beforehand. Nor could the associated lockdowns and work from home activities be contemplated, at least by us. The personal, professional and commercial toll of this pandemic across many sectors has had a great impact on the U.S. economy and will be felt for a long, long time. Among others, the entertainment, accommodation, food service and travel sectors have been particularly hard hit and may never be the same again. It has been suggested by McKinsey and others that the most hard-hit sectors could take more than five years to fully recover.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Real GDP: Percent change from preceding quarter</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j20306712_ba004.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amidst this broadly distressing situation, there are some sectors and parts of the economy that are doing well. The stock market has rebounded nicely in general, and the sectors described above notwithstanding, the economy is making a comeback. GDP was up an annualized 30% by the third quarter of 2020. The healthcare sector, in particular, has retraced its losses nicely. This sector's prospects appear promising to us and others. McKinsey, for example, predicts that healthcare will be among the fastest to return to pre-Covid levels. Separately, we are encouraged by the third quarter public company reports we have seen to date.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Real GDP: Percent change from preceding quarter</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j20306712_ba005.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Our optimism is not without some caution. We recognize that healthcare faces headwinds but feel that there are more factors favoring the sector than opposing it. The challenges have been well chronicled: a key issue is that drug prices at the individual and system level are perceived to be too high and both political parties have expressed strong interest in decreasing drug costs. We quarrel with this characterization and have cited studies that demonstrate the opposite view, but we accept that it is the prevailing lay opinion.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We counter this view with several encouraging points. As a practical matter, we do not think that the near-term legislative emphasis will be on reducing drug prices. Irrespective of which party ultimately succeeds in the elections, we believe that the focus for some time to come will be on stimulus and on helping the individuals, industries and sectors that have been damaged by the pandemic, not on decreasing drug prices. In the meantime, we think the drug and biotech sectors will be able to show that their products are well worth what they cost in terms of sparing productivity losses, morbidity and mortality.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">More importantly, we are encouraged by the continued financial, scientific, clinical, regulatory and commercial progress the healthcare sector has demonstrated in 2020. According to CBInsights, the third quarter of 2020 set a record for global healthcare investment, in terms of both deals completed and dollars raised. There have been numerous scientific and clinical accomplishment in 2020. As an example, note that since the Covid epidemic began earlier this year, a host of healthcare/biotech companies have initiated the development of testing, vaccine and therapeutic products aimed at the Covid virus. At least four companies are nearing completion of pivotal clinical trials to evaluate Covid vaccines. One company has reported encouraging early results. The industry seems poised to have multiple tests, vaccines and therapeutic modalities approved for assessing, treating and preventing or lessening </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">the severity of the Covid virus within a year of the initially reported U.S. coronavirus cases. More generally, despite the challenges presented by the Covid epidemic, the industry has submitted, and FDA has approved more than 40 new drug entities/uses in 2020. These developments are the basis for optimism about the sector.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Furthermore, we think a substantial case can be made for optimism about the future of investing in healthcare. Some subsectors such as medtech are already back to or near pre-Covid sales levels and others are heading in a similar direction. The IPO and secondary markets, drivers for both future growth and sentiment, have been strong. And the healthcare stock market itself, particularly the biotech sector, has been competitive. In aggregate, these positives make us optimistic.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Given the proximity to the U.S. election and its potential impact on and importance to the healthcare sector, we think some commentary is appropriate. At the moment (mid November 2020), it seems most likely that Mr. Biden will be elected as U.S. President and the Republican party will maintain a majority in the the U.S Senate. These results would produce a "split" government. In our view, while the outcome is hypercritical to many individuals for many reasons, we think that healthcare will be all right irrespective of the actual election outcome be it a split government or even a (Democratic) sweep. The healthcare industry is a key to addressing the Covid pandemic and to our "return to normal," and, as such, is more a part of the solution to what ails us rather than part of the problem. The sector is innovation focused and few are opposed to innovation. And, of course, the sector's main goal is to produce products that improve quality of life and reduce morbidity and mortality. And for what it is worth, many of the largest and most well-known pharma and biotech companies are cheap, trading at a discount to the broad market.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As always, we thank you for your consideration of the Tekla Funds. Please call our distribution partner Destra Capital Advisors LLC or us if you have any questions.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Be well,</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="8" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<img src="j20306712_ba006.jpg">
<img src="j20306712_ba007.jpg">
</td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead<BR>President and Portfolio Manager</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Essentials</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Objective of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies.</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Description of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Life Sciences Investors ("HQL") is a non-diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in the life sciences industries and will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Philosophy</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Capital Management LLC, the Investment Adviser to the Fund, believes that:</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Aging demographics and adoption of new medical products and services can provide long-term tailwinds for healthcare companies</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Late stage biotechnology product pipeline could lead to significant increases in biotechnology sales</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Robust M&amp;A activity in healthcare may create additional investment opportunities</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Overview and Characteristics </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">as of 9/30/20</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Market Price<sup>1</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>17.58</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV<sup>2</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>20.25</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Premium/(Discount)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>-13.19</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Average 30 Day Volume</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>73,012</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Net Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>483,570,376</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Ticker</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="104" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV Ticker</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="104" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>XHQLX</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Commencement of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Operations Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="104" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>5/8/92</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="101" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Fiscal Year to Date <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Per Share</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>1.47</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>1</sup></i><i> The closing price at which the Fund's shares were traded on the exchange.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>2</sup></i><i> Per-share dollar value of the Fund, calculated by dividing the total value of all the securities in its portfolio, plus any other assets and less liabilities, by the number of Fund shares outstanding.</i></font></p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Holdings of the Fund</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Data is based on net assets)</i></font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Asset Allocation as of 9/30/20</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j20306712_ba008.jpg">
</p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Sector Diversification as of 9/30/20</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j20306712_ba009.jpg">
</p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><i>This data is subject to change on a daily basis.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Largest Holdings by Issuer</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Excludes Short-Term Investments)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>As of September 30, 2020</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Issuer</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i> &#150; Sector</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>% of Net <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Amgen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8.8</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Vertex Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">7.5</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Regeneron Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6.8</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Gilead Sciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.8</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Seagen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.6</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Illumina, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.6</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Biogen, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.9</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Horizon Therapeutics plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.7</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Moderna, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.4</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Immunomedics, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Pharmaceuticals</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.3</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>BioMarin Pharmaceutical, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.1</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alnylam Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.1</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alexion Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.0</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Sarepta Therapeutics, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.9</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Exelixis, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.5</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Argenx SE</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.5</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Ascendis Pharma A/S</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Arena Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.1</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Blueprint Medicines Corp.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.1</font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="218" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NovoCure Ltd.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i> &#150; Health Care Equipment &amp; Supplies</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.0</font></p></td>
<td colspan="1" width="22" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Portfolio Highlights as of September 30, 2020</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other investments, Tekla Life Sciences Investors' performance benefitted in the past year by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Immunomedics, Inc. (IMMU)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> was an oncology-focused company recently acquired by Gilead Sciences, Inc. for $21 billion. The company successfully advanced their drug Trodelvy through the clinic and onto the market, with launch revenues exceeding expectations. The Fund was overweight the stock into the acquisition.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Horizon Therapeutics plc (HZNP)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a specialty pharmaceuticals company transitioning to a focused orphan disease business model centered around two key products, one for gout and the other for thyroid disease. As the Company has executed well from pipeline development to commercial sales, the stock has performed strongly as we have been overweight the stock.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Novavax, Inc. (NVAX)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a vaccine developer with a novel recombinant platform. Based on strong immune stimulation activity with early clinical data, the company's stock has performed strongly while we were overweight in the Fund.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other examples, Tekla Life Sciences Investors' performance was negatively impacted by the following investments:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Moderna, Inc. (MRNA)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a vaccine company based on a new therapeutic modality, messenger RNA. The company has multiple programs in the clinic, most notably a recent vaccine candidate targeting the COVID-19 virus. The Fund owned Moderna but was underweight during its recent runup.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Forty Seven, Inc. (FTSV)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> was an immune-oncology company recently acquired by Gilead for $4.9 billion based on stronger than expected data in certain subtypes of leukemias. The Fund was underweight FTSV during this reporting period.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Momenta Pharmaceuticals, Inc. (MNTA)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> was a immunology company recently acquired by Johnson &amp; Johnson for $6.5 billion. The company's lead asset, nipocalimab, is an anti-FcRn antibody being developed for various autoimmune indications. The Fund was underweight Momenta during this reporting period.</font></p>
<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Performance</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL is a closed-end fund which invests predominantly in life science companies. Subject to regular consideration, the Trustees of HQL have instituted a policy of making quarterly distributions to shareholders. The Fund seeks to make such distributions in the form of long-term capital gains.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund considers investments in companies of all sizes and in all life science subsectors, including but not limited to, biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. The Fund emphasizes innovation, investing both in public and pre-public venture companies. The Fund considers its venture investments to be a differentiating characteristic. Among the various healthcare subsectors, HQL has considered the biotechnology subsector, including both pre-public and public companies, to be a key contributor to the healthcare sector. The Fund holds biotech </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets, including both public and pre-public, often representing 65-80% of net assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">There is no commonly published index which matches the investment strategy of HQL. The S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index* ("S15HLTH") consists of more than 170 companies representing most or all of the healthcare subsectors in which HQL typically invests; biotechnology often represents 15-20% of this index. By contrast, the NASDAQ Biotechnology Index<sup>&reg;</sup>* ("NBI"), which contains approximately 200 constituents, is much more narrowly constructed. The vast majority of this index is comprised of biotechnology, pharmaceutical and life science tools companies. In recent years, biotechnology has often represented 72-82% of the NBI. Neither the S15HLTH nor NBI indices contain any material amount of pre-public company assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Given the circumstances, we present both NAV and stock returns for the Fund in comparison to several commonly published indices. One index, the S&amp;P 500<sup>&reg;</sup> Index* ("SPX"), is a commonly considered broad based index; this index is comprised of companies in many areas of the economy, including, but not limited to healthcare. As described above, the NBI is a healthcare index mostly focused in three healthcare sectors with a uniquely high level of biotechnology comparison. The S15HLTH contains a wider representation of healthcare subsectors, but typically contains a much lower biotechnology composition.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL generally invests in a combination of large-cap growth-oriented and earlier stage innovative healthcare companies with a focus on the biotechnology sector. Generally, HQL targets biotechnology exposure below that of the NBI and a higher biotechnology exposure than that of the S15HLTH. We note that in recent periods, biotechnology has been a significant contributor to returns (both positive and negative) associated with those indices. We believe this sector continues to have significant potential for growth in the future.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>10 Year Performance Ending September 30, 2020</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j20306712_ba010.jpg">
</p>
<p style="margin:12pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Performance for the Period Ending September 30, 2020</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Period</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL NAV</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="70" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL MKT</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="52" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>NBI</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>S15HLTH</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="52" align="center" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>SPX</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">month</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">23.54</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">22.36</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">25.86</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">20.75</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">31.31</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">34.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">27.50</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">36.90</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">20.12</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15.14</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6.91</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.83</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">6.62</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">12.15</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">14.14</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="48" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">10 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15.95</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="54" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">16.43</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">17.36</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">15.68</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="36" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">13.73</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:9pt 0pt 0pt 0pt;" align="center"><img src="j20306712_ba011.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>All performance over one-year has been annualized.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund's total annual expenses and does not reflect transaction charges. If transaction charges were reflected, NAV total return would be reduced. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. Until the DRIP price is available from the Plan Agent, the market price returns reflect the reinvestment at the closing market price on the last business day of the month. Once the DRIP is available around mid-month, the market price returns are updated to reflect reinvestment at the DRIP price.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">*The trademarks NASDAQ Biotechnology Index<sup>&reg;</sup>, S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index and S&amp;P 500<sup>&reg;</sup> Index referenced in this report are the property of their respective owners. These trademarks are not owned by or associated with the Fund or its service providers, including Tekla Capital Management LLC.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='20-30671-2.ba.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.ca-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE PREFERRED AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Restricted) </b><b><sup>(a) (b)</sup></b><b> - 4.2% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 3.3%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">140,000</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amphivena Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,100,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">225,416</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amphivena Therapeutics, Inc. Series C, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">808,848</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">848,333</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Arkuda Therapeutics, Inc. Series A, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,018,184</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">398,616</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Decipher Biosciences, Inc. Series II, 8.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">865,395</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">396,284</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Decipher Biosciences, Inc. Series III, 8.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">860,333</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">30,646</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Decipher Biosciences, Inc. Series IV, 8.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">66,532</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">62,205</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dynacure Series C <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,547,622</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">41,470</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dynacure Series C Warrants (expiration <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">04/21/25 exercise price $24.88) <sup>(c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">645,834</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Hotspot Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,550,002</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,229,167</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Invetx, Inc. Series A</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,550,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">117,704</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Oculis SA, Series B2, 6.00% <sup>(c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,064,007</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,153,847</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rainier Therapeutics, Inc. Series A, 6.00%</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">115</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">668,449</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rainier Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">67</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,229,766</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rallybio Holdings, LLC Series B</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,100,044</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">345,010</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Vectivbio Holding AG Series A2, 6.00%</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">397,106</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">15,928,255</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="349" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.3%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">362,887</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IO Light Holdings, Inc. Series A2</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,397,369</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 0.6%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,719,854</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Curasen Therapeutics, Inc. Series A</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,999,999</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE PREFERRED AND <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $21,932,281)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,325,623</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE NOTES (Restricted) </b><b><sup>(a) (b)</sup></b><b> - 0.1% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 0.1%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">652,728</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rainier Therapeutics, Inc. Promissory Notes, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.00% due 12/31/20</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">295,378</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE NOTES<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $652,736)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">295,378</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>COMMON STOCKS AND WARRANTS - 92.9% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 70.6%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">52,739</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AC Immune SA<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">257,366</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">86,352</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ACADIA Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,562,020</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">85,352</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alexion Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,766,829</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">60,092</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alkermes plc<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">995,724</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,188</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Allakos, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,807,213</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,432</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alnylam Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,963,699</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">291,970</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amarin Corp. plc<sup> (a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,229,194</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">167,890</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amgen, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">42,670,922</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">149,195</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amicus Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,106,633</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">102,111</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Apellis Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,080,689</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">32,461</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ARCA biopharma, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">143,478</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,027</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ARCA biopharma, Inc. Warrants (expiration <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">06/11/22, exercise price $1.10)<sup> (a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,993</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">289,336</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ardelyx, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,519,014</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">70,634</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Arena Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,282,717</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,928</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Argenx SE<sup> (a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,331,659</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,666</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Arrowhead Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,449,658</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">44,892</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ascendis Pharma A/S<sup> (a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,927,733</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,919</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Atreca, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">683,398</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,000</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Bellicum Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">39,420</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">49,374</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Biogen, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">14,006,416</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,482</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Biohaven Pharmaceutical Holding Co., Ltd.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">681,435</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">131,095</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioMarin Pharmaceutical, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,973,708</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,679</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioNTech SE<sup> (a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">946,997</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,924</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">bluebird bio, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,830,200</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">56,543</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Blueprint Medicines Corp.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,241,536</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">47,437</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cellectis S.A.<sup> (a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">877,585</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">53,779</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ChemoCentryx, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,947,089</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">345,879</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cogent Biosciences, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">809,357</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">76,742</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Coherus BioSciences, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,407,448</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">154,310</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Corbus Pharmaceuticals Holdings, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">277,758</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,648</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CRISPR Therapeutics AG<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,977,919</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">32,636</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CymaBay Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">236,285</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">19,036</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Deciphera Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">976,547</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,531</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dicerna Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">387,343</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,118</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eidos Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">309,143</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">14,732</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Esperion Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">547,588</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">300,480</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Exelixis, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,346,736</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">97,218</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Fate Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,885,803</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">67,921</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">FibroGen, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,792,912</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">145,858</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Galera Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,318,556</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,963</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Genmab A/S<sup> (a) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,096,945</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">444,023</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Gilead Sciences, Inc.<sup> (e)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">28,057,813</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,069</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Global Blood Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,492,585</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,366</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Harpoon Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">566,888</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,056</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Incyte Corp.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">992,165</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">37,238</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Insmed, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,196,829</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,630</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Intercept Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">772,400</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">75,143</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ionis Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,565,535</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">101,017</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Iovance Biotherapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,325,480</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">223,863</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Kadmon Holdings, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">877,543</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,409</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Karuna Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,655,344</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">59,339</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Kura Oncology, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,818,147</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">114,141</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Magenta Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">776,159</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">165,838</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Moderna, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,733,039</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">116,213</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Molecular Templates, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,269,046</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">80,164</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Nektar Therapeutics<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,329,921</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,213</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurocrine Biosciences, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,328,322</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">44,550</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NexGel, Inc.<sup> (a) (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">138</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,523</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Novavax, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,248,517</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">144,434</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NuCana plc<sup> (a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">746,724</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">111,820</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ovid Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">641,847</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">374,819</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">775,875</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,821</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., Series A Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 06/08/21, exercise price $3.00)<sup> (a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,479</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,911</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., Series B Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 06/08/21, exercise price $2.00)<sup> (a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,360</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">59,160</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Regeneron Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,116,585</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">33,741</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sage Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,062,250</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">64,886</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sarepta Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,111,941</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">114,677</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Seagen Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,441,142</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">193,471</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sutro Biopharma, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,944,384</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">131,785</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trillium Therapeutics, Inc.<sup> (a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,872,665</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,770</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ultragenyx Pharmaceutical, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,446,796</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,142</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">uniQure N.V.<sup> (a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">852,320</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,511</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">United Therapeutics Corp.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,071,611</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">375,000</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Vectivbio Holding AG (Restricted)<sup> (a) (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">296,250</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">133,745</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Vertex Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">36,394,689</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">46,595</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Xencor, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,807,420</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,842</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Y-mAbs Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">915,294</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,502</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Zai Lab Ltd.<sup> (a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">956,621</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">28,012</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Zymeworks, Inc.<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,304,799</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">341,490,588</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="349" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Drug Discovery Technologies </i><i><sup>(a)</sup></i><i> - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">51,160</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ImmunoGen, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">184,176</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies </i><i><sup>(a)</sup></i><i> - 2.8%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">130,000</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cercacor Laboratories, Inc. (Restricted)<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,331,737</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">36,049</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Guardant Health, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,029,557</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,329</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IDEXX Laboratories, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,274,213</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,042</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Inogen, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">146,218</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">42,858</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NovoCure Ltd.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,770,524</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,552,249</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Providers &amp; Services </i><i><sup>(a)</sup></i><i> - 0.2%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">148,148</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">InnovaCare, Inc. Escrow Shares (Restricted)<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">105,467</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,822</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Medpace Holdings, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">650,609</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">756,076</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Healthcare Services </i><i><sup>(a)</sup></i><i> - 0.3%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,811</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Syneos Health, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,318,953</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Life Sciences Tools &amp; Services - 6.4%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,715</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Adaptive Biotechnologies Corp.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,201,890</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">16,541</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Bio-Techne Corp.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,097,702</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">71,882</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Illumina, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,217,289</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">31,134</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">PRA Health Sciences, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,158,233</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">30,675,114</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="349" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 12.6%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,403</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Aerie Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">240,143</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">63,808</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Agios Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,233,280</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">96,486</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Aurinia Pharmaceuticals, Inc.<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,421,239</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">95,101</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Avadel Pharmaceuticals plc<sup> (a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">479,309</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,784</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Axsome Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">697,110</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,008</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Bristol-Myers Squibb Co.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,085,702</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">399,550</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Bristol-Myers Squibb Co., CVR 03/31/21<sup> (a) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">898,989</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">165,330</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Clearside Biomedical, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">254,608</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,100</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Endo International plc<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">96,030</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">40,585</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Heron Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">601,470</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">171,156</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Horizon Therapeutics plc<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,295,398</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">130,016</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Immunomedics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,055,260</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">34,082</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Intra-Cellular Therapies, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">874,544</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,203</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Jazz Pharmaceuticals plc<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,593,696</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,060</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Madrigal Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">482,044</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">63,994</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone Pharmaceuticals, Inc.<sup> (a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">468,436</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,127</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Mirati Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,504,438</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">294,349</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Mylan N.V.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,365,196</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,870</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">MyoKardia, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">800,257</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,881</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Reata Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,423,907</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">26,600</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Revance Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">668,724</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">58,272</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sanofi<sup> (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,923,506</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">34,880</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Spectrum Pharmaceuticals, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">142,310</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">14,218</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tetraphase Pharmaceuticals, Inc. CVR<sup> (a) (b) (f)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,844</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">92,276</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Theravance Biopharma, Inc.<sup> (a) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,364,301</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">15,943</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tricida, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">144,444</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,766</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Turning Point Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">154,278</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">929,053</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc<sup> (a) (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">779,222</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">199,669</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc<sup> (a) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,245,935</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">371,622</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc Warrants (expiration <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">04/27/22, exercise price $2.67)<sup> (a) (b) (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">49,631</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">162,481</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">VYNE Therapeutics, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">269,718</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">189,946</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Zogenix, Inc.<sup> (a)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,405,732</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">61,021,701</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL COMMON STOCKS AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $328,582,206)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">448,998,857</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHORT-TERM INVESTMENT - 1.0% of Net Assets</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,966,000</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Repurchase Agreement, Fixed Income Clearing <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Corp., repurchase value $4,966,000, 0.00%, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">dated 09/30/20, due 10/01/20 (collateralized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">by U.S. Treasury Note 2.75%, due 02/15/28, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">market value $5,065,405)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,966,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL SHORT-TERM INVESTMENT<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $4,966,000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,966,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS BEFORE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>MILESTONE INTERESTS - 98.2%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $356,133,223)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">474,585,858</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTERESTS</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>MILESTONE INTERESTS (Restricted) </b><b><sup>(a) (b)</sup></b><b> - 1.9% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="349" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 0.3%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Therachon Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,515,794</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="349" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Therox Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,407</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="349" align="left" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 1.6%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">280,351</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,459,547</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="63" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,971,493</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="403" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,711,391</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="63" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL MILESTONE INTERESTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $4,994,233)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,230,592</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:1pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="160" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NUMBER OF<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONTRACTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(100 SHARES<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>EACH)/<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NOTIONAL <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT ($)</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CALL OPTION CONTRACTS PURCHASED - 0.0% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">&nbsp;</font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">87/3,045,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Biogen, Inc. Mar21 350 Call</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">156,600</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CALL OPTION CONTRACTS <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PURCHASED<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Premiums paid $173,308)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">156,600</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CALL OPTION CONTRACTS WRITTEN - 0.0% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">711/</font></p></td>
<td colspan="1" width="63" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(4,799,250)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Gilead Sciences, Inc. Oct20 67.5 Call</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(12,087</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CALL OPTION CONTRACTS <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>WRITTEN<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Premiums received $(68,127))</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(12,087</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS - 100.1%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $361,232,637)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,960,963</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="235" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OTHER LIABILITIES IN EXCESS OF <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>AS</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>SETS - (0.1)%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(390,587</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="160" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="235" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NET ASSETS - 100%</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(a)&nbsp;&nbsp;Non-income producing security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(b)&nbsp;&nbsp;Security fair valued using significant unobservable inputs. See Investment Valuation and Fair Value Measurements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(c)&nbsp;&nbsp;Foreign security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(d)&nbsp;&nbsp;American Depository Receipt</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(e)&nbsp;&nbsp;A portion of security is pledged as collateral for call option written.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(f)&nbsp;&nbsp;Contingent Value Right</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='20-30671-2.ca.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.da-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments, at value (cost $356,306,531)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">474,742,458</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests, at value (cost $4,994,233)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,230,592</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,973,050</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividends and interest receivable</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">73,897</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Prepaid expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">26,952</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other assets (see Note 1)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">91,662</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">484,165,561</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">LIABILITIES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Due to custodian</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,943</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued advisory fee</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">396,860</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued investor support service fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,420</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued shareholder reporting fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,111</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Options written, at value (premium received $68,127)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,087</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued other</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">122,764</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total liabilities</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">595,185</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Commitments and Contingencies (see Notes 1 and 4)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SOURCES OF NET ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shares of beneficial interest, par value $.01 per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">unlimited number of shares authorized, amount <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">paid in on 23,883,152 shares issued and outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">238,832</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Additional paid-in-capital</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">356,301,677</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total distributable earnings (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">127,029,867</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total net assets (equivalent to $20.25 per share <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">based on 23,883,152 shares outstanding)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='20-30671-2.da.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF OPERATIONS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>YEAR ENDED SEPTEMBER 30, 2020</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">INVESTMENT INCOME:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividend income (net of foreign tax of $14,258)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,226,831</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Interest and other income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">164,800</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investment income</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,391,631</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EXPENSES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Advisory fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,476,344</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investor support service fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">225,317</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trustees' fees and expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">129,119</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Custodian fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">121,119</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Administration fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">111,347</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auditing fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">108,860</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholder reporting</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">89,427</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Legal fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">54,296</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Transfer agent fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">53,345</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other (see Note 2)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">137,149</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,506,323</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2,114,692</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">REALIZED AND UNREALIZED GAIN (LOSS):</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain (loss) on:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,254,149</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Closed or expired option contracts written</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">425,868</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Foreign currency transactions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(11,177</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,668,840</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net change in unrealized appreciation (depreciation) on:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">87,203,515</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,239,297</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Option contracts written</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">56,040</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">89,498,852</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">125,167,692</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="249" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets resulting from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">operations</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">123,053,000</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='20-30671-2.da.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="184" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="122" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2020</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="122" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2019</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="436" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET INCREASE (DECREASE) IN NET <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS RESULTING FROM OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,114,692</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,879,038</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,668,840</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,802,005</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in net unrealized appreciation <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">89,498,852</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(103,401,585</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in net <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">123,053,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(70,478,618</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DISTRIBUTIONS TO SHAREHOLDERS <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(See Note 1):</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(34,380,780</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(33,775,050</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="436" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CAPITAL SHARE TRANSACTIONS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Reinvestment of distributions <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(839,942 and 880,878 shares, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">respectively)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,438,152</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,969,734</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Fund shares repurchased <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(136,700 and 107,109 shares, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">respectively) (see Note 1)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2,191,362</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1,556,624</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total capital share transactions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,246,790</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,413,110</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">net assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">99,919,010</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(91,840,558</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="436" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Beginning of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">383,651,366</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="79" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">475,491,924</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="184" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">End of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">483,570,376</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="24" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="79" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">383,651,366</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='20-30671-2.da.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.ea-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>FINANCIAL HIGHLIGHTS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="155" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="406" align="center" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">For the years ended September 30,</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2019</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2018</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="561" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>OPERATING PERFORMANCE FOR A <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SHARE OUTSTANDING THROUGHOUT <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>EACH YEAR</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, beginning of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16.55</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.22</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.62</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.51</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.09</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.13</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.16</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.18</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.19</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.25</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.06</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.39</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.39</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.47</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total increase (decrease) from investment <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.16</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.19</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.23</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.21</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.66</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="561" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions to shareholders from:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.13</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.38</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.05</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized capital gains</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.47</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.36</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.25</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.54</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(2)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total distributions</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.47</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.49</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.63</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.59</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Increase resulting from shares repurchased <sup>(1)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><sup>(3)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, end of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.25</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">16.55</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.22</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.62</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Per share market value, end of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.58</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.10</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.42</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.48</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18.73</font></p></td>
<td colspan="1" width="23" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at market value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27.50</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(18.86</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.31</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.26</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4.66</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at net asset value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">34.00</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(14.38</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6.61</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.12</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.52</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="561" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>RATIOS</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.22</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.29</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.25</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.32</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.27</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss to average net assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.47</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.70</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.81</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="561" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SUPPLEMENTAL DATA</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net assets at end of year (in millions)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">484</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">384</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">475</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">466</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="31" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">415</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="155" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Portfolio turnover rate</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">51.27</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">43.78</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">37.49</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">43.08</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="31" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30.99</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:9pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1)&nbsp;&nbsp;Computed using average shares outstanding.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2)&nbsp;&nbsp;Amount previously presented incorrectly as solely distributions from net realized capital gains has been revised to reflect the proper classification.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3)&nbsp;&nbsp;Amount represents less than $0.005 per share.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='20-30671-2.ea.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.fa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(1)&nbsp;&nbsp;Organization and Significant Accounting Policies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Life Sciences Investors (the Fund) is a Massachusetts business trust formed on February 20, 1992, and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on May 8, 1992. The Fund's investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser), to have significant potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers that are traded primarily in foreign markets.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates and such differences could be material. The following is a summary of significant accounting policies followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America (GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board Accounting Standards Codification 946. Events or transactions occurring after September 30, 2020, through the date that the financial statements were issued, have been evaluated in the preparation of these financial statements.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The impact of the COVID-19 outbreak on the financial performance of the Fund's investments will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of COVID-19 on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Fund's future investment results may be materially adversely affected.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investment Valuation</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price, as of the close of trading, generally 4 p.m., Eastern Time. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible, corporate and government bonds are valued using a third-party pricing service. Convertible bonds are valued using this pricing service only on days when there is no sale reported. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by the Adviser also using fair valuation policies and procedures approved by the Trustees described below. Non-exchange traded warrants of publicly traded companies are generally valued using the Black-Scholes model, which incorporates both observable and unobservable inputs. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs the Adviser considers may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the company, which may include an analysis of the company's financial statements, products, intended markets or technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Due to the uncertainty inherent in the valuation process, such estimates of fair value may differ significantly from the values that would have been used had a ready market for the investments existed, and differences could be material. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Milestone Interests</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund holds financial instruments which reflect the current value of future milestone payments the Fund may receive as a result of contractual obligations from other parties. The value of such payments are adjusted to reflect the estimated risk based on the relative uncertainty of both the timing and the achievement of individual milestones. A risk to the Fund is that the milestones will not be achieved and no payment will be received by the Fund. The milestone interests were received as part of the proceeds from the sale of six private companies. Any payments received are treated as a reduction of the cost basis of the milestone interests with payments received in excess of the cost basis treated as a realized gain. The contractual obligations with respect to the milestone interests provide for payments at various stages of the development of Afferent, Ethismos Research, Neurovance, Impact Biomedicines, Therachon and Therox's principal product candidate as of the date of the sale.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the impact of the milestone interests on the financial statements as of and for the year ended September 30, 2020:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="276" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Milestone interests, at value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">9,230,592</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="276" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Total distributable earnings</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4,236,359</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="276" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations, Change in unrealized appreciation (depreciation) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">on milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">2,239,297</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Options on Securities</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">An option contract is a contract in which the writer (seller) of the option grants the buyer of the option, upon payment of a premium, the right to purchase from (call option) or sell to (put option) the writer a designated instrument at a specified price within a specified period of time. Certain options, including options on indices, will require cash settlement by the Fund if the option is exercised. The Fund enters into option contracts in order to hedge against potential adverse price movements in the value of portfolio assets, as a temporary substitute for selling selected investments, to lock in the purchase price of a security or currency which it expects to purchase in the near future, as a temporary substitute for purchasing selected investments, or to enhance potential gain or to gain or hedge exposure to financial market risk.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's obligation under an exchange traded written option or investment in an exchange traded purchased option is valued at the last sale price or in the absence of a sale, the mean between the closing bid and asked prices. Gain or loss is recognized when the option contract expires, is exercised or is closed.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">If the Fund writes a covered call option, the Fund foregoes, in exchange for the premium, the opportunity to profit during the option period from an increase in the market value of the underlying security above the exercise price. If the Fund writes a put option it accepts the risk of a decline in the market value of the underlying security below the exercise price. Over-the-counter options have the risk of the potential inability of counterparties to meet the terms of their contracts. The Fund's maximum exposure to purchased options is limited to the premium initially paid. In addition, certain risks may arise upon entering into option contracts including the risk that an illiquid secondary market will limit the Fund's ability to close out an option contract prior to the expiration date and that a change in the value of the option contract may not correlate exactly with changes in the value of the securities or currencies hedged.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">All options on securities and securities indices written by the Fund are required to be covered. When the Fund writes a call option, this means that during the life of the option the Fund may own or have the contractual right to acquire the securities subject to the option or may maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the market value of the securities underlying the option. When the Fund writes a put option, this means that the Fund will maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the exercise price of the option.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The average number of outstanding call options written and options purchased for the year ended September 30, 2020 were 187 and 47, respectively.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="111" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Derivatives not accounted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">for as hedging instruments <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">under ASC 815</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="148" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Liabilities Location</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="179" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations Location</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equity Contracts<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="86" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets: Investments, </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">at <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="46" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$156,600</font></td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="109" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Net realized gain (loss) on <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">investments </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="54" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">($247,467) </font></td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="86" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="109" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation (depreciation) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on investments </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="54" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$217,799 </font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="86" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Liabilities: Options <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">written, at value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="46" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$12,087<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="109" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized gain (loss) on<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">closed or expired option<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">contracts written</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="54" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$425,868 </font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="18" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="86" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="62" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="109" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation (depreciation) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on option contracts written</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="54" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$56,040</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Other Assets</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Other assets in the Statement of Assets and Liabilities consists of amounts due to the Fund at various times in the future in connection with the sale of investments in four private companies.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investment Transactions and Income</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date, less any foreign taxes withheld. Upon notification from issuers, some of the dividend income received may be redesignated as a reduction of cost of the related investment if it represents a return of capital.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The aggregate cost of purchases and proceeds from sales of investment securities (other than short-term investments) for the year ended September 30, 2020 totaled $229,762,577 and $224,130,893, respectively.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Repurchase Agreements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities from the counterparty, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed. The Fund may enter into repurchase transactions with any broker, dealer, registered clearing agency or bank. Repurchase agreement transactions are not counted for purposes of the limitations imposed on the Fund's investment in debt securities.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Distribution Policy</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Pursuant to a Securities and Exchange Commission exemptive order, the Fund may make periodic distributions that include capital gains as frequently as 12 times in any one taxable year </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">in respect of its common shares, and the Fund has implemented a managed distribution policy (the Policy) providing for quarterly distributions at a rate set by the Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but the Policy would result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. If taxable income and net long-term realized gains exceed the amount required to be distributed under the Policy, the Fund will at a minimum make distributions necessary to comply with the requirements of the Internal Revenue Code. The Policy has been established by the Trustees and may be changed by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distribution considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's policy is to declare quarterly distributions in stock. The distributions are automatically paid in newly-issued full shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts of the Fund's transfer agent who will have whole and fractional shares added to their accounts. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date. If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares reinvested will be valued at the lower of the net asset value or market price on the pricing date. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. Additional distributions, if any, made to satisfy requirements of the Internal Revenue Code may be paid in stock, as described above, or in cash.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Share Repurchase Program</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In March 2020, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July 14, 2021. Prior to this renewal, in March 2019, the Trustees approved the renewal of the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one-year period ending July 14, 2020. The share repurchase program is intended to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the Fund's net asset value.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">During the year ended September 30, 2020, the Fund repurchased 136,700 shares at a total cost of $2,191,362. The weighted average discount per share between the cost of repurchase and the net asset value applicable to such shares at the date of repurchase was 11.70%.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">During the year ended September 30, 2019, the Fund repurchased 107,109 shares at a total cost of $1,556,624. The weighted average discount per share between the cost of repurchase and the net asset value applicable to such shares at the date of repurchase was 9.94%.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Federal Taxes</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">As of September 30, 2020, the Fund had no uncertain tax positions that would require financial statement recognition or disclosure. The Fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Distributions</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund records all distributions to shareholders on the ex-dividend date. Such distributions are determined in conformity with income tax regulations, which may differ from GAAP. These differences include temporary and permanent differences from losses on wash sale transactions, passive foreign investment companies transactions, installment sale adjustments, premium amortization accruals, foreign currency gains and losses, book to tax difference due to merger and ordinary loss netting to reduce short term capital gains. Reclassifications are made to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations. At September 30, 2020, the Fund reclassified $626,143 from accumulated net realized gain on investment and $626,143 to undistributed net investment income for current period book/tax differences.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The tax basis components of distributable earnings and the tax cost as of September 30, 2020 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of Investments for tax purposes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">367,547,664</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="157" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized appreciation</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">164,309,584</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized depreciation</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">47,896,285</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="157" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net tax unrealized appreciation on investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">116,413,299</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Undistributed ordinary income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,378,400</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="157" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Undistributed long-term capital gains</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">238,169</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has designated the distributions for its taxable years ended September 30, 2020 and 2019 as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="169" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions paid from:</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2019</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="169" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ordinary income (includes short-term capital gain)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,015,898</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="169" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Long-term capital gain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">34,380,780</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30,759,152</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Commitments and Contingencies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investor Support Services</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has retained Destra Capital Advisors LLC (Destra) to provide investor support services in connection with the ongoing operation of the Fund. The Fund pays Destra a fee in an annual amount equal to 0.05% of the average aggregate daily value of the Fund's Managed Assets pursuant to the investor support services agreement.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(2)&nbsp;&nbsp;Investment Advisory and Other Affiliated Fees</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with the Adviser. Pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.50% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for all other net assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.80% of the average net assets for the next $500 million and 0.70% of the average net assets thereafter. The aggregate fee would not exceed a rate when annualized of 1.36%.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2020, these payments amounted to $51,906 and are included in the Other category of expenses in the Statement of Operations, together with insurance and other expenses incurred to unaffiliated entities. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated to the Fund in an equitable fashion as approved by the Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund pays compensation to Independent Trustees in the form of a retainer, attendance fees, and additional compensation to Board and Committee chairpersons. The Fund does not pay compensation directly to Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(3)&nbsp;&nbsp;Fair Value Measurements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For the year ended September 30, 2020, the total amount of transfers between Level 3 and Level 1 was $979,998. The investment was transferred due to an initial public offering and the value is being supported by the market price. There were no other transfers between levels.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the levels used as of September 30, 2020 to value the Fund's net assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets at Value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 1</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 2</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15,928,255</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15,928,255</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Notes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">295,378</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">295,378</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">341,161,368</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">329,220</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">341,490,588</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Drug Discovery Technologies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">184,176</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">184,176</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,220,512</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,331,737</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,552,249</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Providers &amp; Services</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">650,609</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">105,467</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">756,076</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Healthcare Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,318,953</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,318,953</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30,675,114</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30,675,114</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">60,969,226</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,844</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">49,631</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">61,021,701</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Short-term Investment</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,966,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,966,000</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,711,391</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,711,391</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">91,662</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">91,662</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">447,179,958</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,968,844</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">31,759,310</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">483,908,112</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Financial Instruments</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Call Options Contracts Purchased</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">156,600</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">156,600</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="464" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Liabilities</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Call Options Contracts Written</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(12,087</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="44" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(12,087</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">144,513</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="44" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">144,513</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Investment <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">in securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="86" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2019</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="91" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">sales and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">into<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:12pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 2020</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="643" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,100,496</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">595,222</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,403,043</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">980,062</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15,928,255</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">792,748</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(41,757</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,395,215</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(748,837</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,499,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,500,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="643" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Notes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">597,977</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(357,405</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">54,806</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">295,378</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Investment <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">in securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="86" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2019</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="100" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="91" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">sales and<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">into<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 2020</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,682,975</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,337,196</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">345,779</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="643" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">374,616</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(41,740</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3,656</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">329,220</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">678,730</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">653,008</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,331,738</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Providers <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&amp; Services</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,359,525</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(734,665</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">135,770</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(655,163</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">105,467</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">822</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">48,809</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">49,631</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="643" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,444,178</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">71,616</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,567</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1,158</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,543,707</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,167,683</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,711,390</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="59" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">391,097</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">220,518 </font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(519,953</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="41" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">91,662</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">22,471,437</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">166,871</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,709,352 </font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,274,546</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="41" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">980,062</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">31,759,310</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="551" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 3pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net change in unrealized appreciation (depreciation) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investments still held as of September 30, 2020</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,338,504</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 3pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a quantitative disclosure about significant unobservable inputs used in the determination of the fair value of Level 3 assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="80" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Fair Value at<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2020</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Valuation Technique</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unobservable Input</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="167" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Range<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(Weighted Average)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stock<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,414,200<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income approach, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Black-Scholes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">marketability</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00<BR></font></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%-50.00% (28.00%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="57" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">105,467<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.25-3.25 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.25) years</font></td>
<td colspan="1" width="76" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">% (20.00%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">296,388</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and Warrants</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="57" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">172,629<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.75 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.75) years</font></td>
<td colspan="1" width="76" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">% (20.00%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,973,036</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,179,958</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Recent transaction</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(b)</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="83" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" width="76" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Notes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">295,378<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.50-15.75 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.70) years</font></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%-99.00% (35.13%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestones</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="57" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,230,592<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10.00<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.50-16.50 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3.96) years</font></td>
<td colspan="1" width="76" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%-100.00% (61.54%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="93" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A</font></p></td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="57" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">91,662<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;</font></td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="93" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="83" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.50-7.00 </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.54) years</font></td>
<td colspan="1" width="76" align="left" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%-95.00% (20.47%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">31,759,310</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="83" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)&nbsp;&nbsp;There is no quantitative information to provide as this method of measure is investment specific.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(b)&nbsp;&nbsp;The valuation technique used as a basis to approximate fair value of these investments is based on subsequent financing rounds.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(4) Private Companies and Other Restricted Securities</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund may invest in private companies and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represented 7% of the Fund's net assets at September 30, 2020.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">At September 30, 2020, the Fund had a commitment of $5,417,702 relating to additional investments in five private companies.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at September 30, 2020. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/27/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">161,872</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">280,351.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">280,351</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,101,222</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,100,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/18</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">808,848</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.59</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">808,848</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Arkuda Therapeutics, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">05/16/19, 04/02/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,018,184</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.38</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,018,184</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cercacor Laboratories, Inc. Common</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/31/98&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10.24</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,331,737</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Curasen Therapeutics, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">09/18/18, 01/07/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.10</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,999,999</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Decipher Biosciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series II Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/29/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,846,969</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.17</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">865,395</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series III Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/29/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">417,862</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.17</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">860,333</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series IV Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">05/14/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">66,532</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.17</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">66,532</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Dynacure</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/21/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,433,840</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.88</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,547,622</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Warrants (expiration 04/21/25)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/21/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/31/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Hotspot Therapeutics, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/22/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,002</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.40</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,002</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/20/10</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,459,547.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,459,547</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">InnovaCare, Inc. Escrow Shares Common</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">95,673</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.71</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">105,467</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Invetx, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">08/06/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.48</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,550,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">IO Light Holdings, Inc. Series A2 Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">04/30/20&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,394,759</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.85</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,397,369</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/20/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,417,500</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,971,493.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,971,493</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Oculis SA, Series B2 Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">01/16/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">990,902</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9.04</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,064,007</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Rainier Therapeutics, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">01/19/16, 10/24/16</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">750,652</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&dagger;&dagger;</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">115</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/03/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">500,091</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&dagger;&dagger;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">67</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Notes</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">01/30/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">189,675</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Notes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/28/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">189,675</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Notes</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/16/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">218,635</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">108.05</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">236,223</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Notes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/07/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">54,751</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">108.05</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">59,155</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Rallybio Holdings, LLC Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">03/27/20</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,105,343</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.39</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,100,044</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therachon Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/01/19</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,409,779</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794.00</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,515,794</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Therox Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">06/18/19</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,082</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407.00</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,407</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="484" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Vectivbio Holding AG</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">07/01/19&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">292,594</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.79</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">296,250</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A2 Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="73" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">09/02/20</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">397,076</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.15</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">397,106</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="148" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="73" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">27,967,517</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="99" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">31,585,047</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2020</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(continued)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;(#)&nbsp;&nbsp;See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&nbsp;&nbsp;Interest received as part of a corporate action for a previously owned security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&dagger;&nbsp;&nbsp;Carrying value per unit is greater than $0.00 but less than $0.01.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>29</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='29',FILE='20-30671-2.fa.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.ga-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>To the shareholders and the Board of Trustees of Tekla Life Sciences Investors:</i></font></p>
<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><u>Opinion on the Financial Statements and Financial Highlights</u></font></p>
<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">We have audited the accompanying statement of assets and liabilities of Tekla Life Sciences Investors (the "Fund"), including the schedule of investments, as of September 30, 2020, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of September 30, 2020, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><u>Basis for Opinion</u></font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of September 30, 2020 by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">DELOITTE &amp; TOUCHE LLP<BR>Boston, Massachusetts<BR>November 20, 2020</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">We have served as the auditor of one or more Tekla investment companies since 2004.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>30</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='30',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="835" align="left" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1</sup></b><b>, Date of Birth,<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served, Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and Other Directorship Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="754" align="center" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with Fund, <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Term of Office</b><b><sup>2</sup></b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="746" align="center" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of Portfolios <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>in Fund Complex <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Overseen by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Jeffrey A. Bailey,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 4/1962</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2020</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">CEO, IlluminOss Inc. (2018-2020); Board Chairman, Aileron Therapeutics Inc. (since 2018); Director, Madison Vaccines, Inc. (since 2018); Director, BioDelivery Systems, Inc. (since 2020).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Rakesh K. Jain, Ph.D.,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 12/1950</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2007</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (2012-2018).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Thomas M. Kent, CPA,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 6/1953</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2017</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Director, Principal Global Investors Trust Co. (since 2014); Trustee, Thayer Academy (2009-2018); Director, New England Canada Business Council (since 2017).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Oleg M. Pohotsky, M.B.A., J.D.,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 3/1947<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2000<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chairman since 2012</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Consultant and Managing Partner, Right Bank Partners (since 2002); Adviser, Board Advisers, Kaufman &amp; Co. LLC (since 2008); Director, AvangardCo Investments Holdings (since 2011); Director, The New America High Income Fund, Inc. (since 2013).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>William S. Reardon, M.B.A.,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 6/1946</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2010</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Independent Consultant (since 2002); Director, Idera Pharmaceuticals, Inc (2002-2019); Director, Synta Pharmaceuticals, Inc. (2004-2016).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Lucinda H. Stebbins, M.B.A., CPA,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 11/1945</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2006</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Independent Consultant, Deutsche Bank (2004-2015); Director, Solstice Home Care, Inc. (since 2014); Director, The Pointe at Pelican Bay (since 2019).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:9pt 0pt 7pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INTERESTED TRUSTEE</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="835" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Daniel R. Omstead, Ph.D.</b><b><sup>3</sup></b><b>,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 7/1953<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> &nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="754" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President since 2001<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee since 2003</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="99" bgcolor="#cceeff" align="left" valign="top" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="2335" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund (since 2001), Tekla Healthcare Investors (HQH) (since 2001), Tekla Healthcare Opportunities Fund (THQ) (since 2014), Tekla World Healthcare Fund (THW) (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002); Director: Palyon Medical Corporation (2009-2015); IlluminOss Medical, Inc. (2011-2020); Magellan Diagnostics, Inc.(2006-2016); Dynex Corporation (2011-2017); Insightra Medical, Inc. (2015-2016); Neurovance, Inc. (2015-2017); EBI Life Sciences, Inc. (2015-2017); Euthymics Biosciences, Inc. (2015-2017); Veniti, Inc. (2015-2018); Joslin Diabetes Center (2016-2019) Decipher Biosciences Inc. (2016-2018).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each Trustee is: c/o Tekla Life Sciences Investors, 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each Trustee currently is serving a three year term.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>3</sup>&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>31</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=33,FOLIO='31',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>OFFICERS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="476" align="left" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1</sup></b><b>, Date of Birth,<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s) <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="432" align="center" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="476" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Daniel R. Omstead, Ph.D.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">, Born: 7/1953</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="432" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President since 2001</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="908" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund, HQH (since 2001), THQ (since 2014), THW (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="476" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Laura Woodward, CPA,</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Born: 11/1968<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> &nbsp;&nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="432" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Secretary and Treasurer<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">since 2009</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="908" align="left" valign="bottom" style="padding:0pt .7pt 5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, Secretary and Treasurer of the Fund, HQH (since 2009), THQ (since 2014), THW (since 2015); Chief Compliance Officer and Vice President of Fund Administration, Tekla Capital Management LLC (since 2009); Senior Manager, PricewaterhouseCoopers LLP (1990-2009).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each officer is: c/o Tekla Life Sciences Investors; 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">The Fund's Statement of Additional Information includes additional information about the Fund's Trustees and is available without charge, upon request by calling (617) 772-8500 or writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>32</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=34,FOLIO='32',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>ANNUAL MEETING REPORT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> An Annual Meeting of Shareholders was held on June 11, 2020. Shareholders voted to elect Trustees of the Fund to hold office for a term of three years or until their respective successors shall have been duly elected and qualified. The following votes were cast with respect to each of the nominees:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="137" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Withheld</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="137" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg M. Pohotsky, M.B.A., J.D.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">19,451,383</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">875,898</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="137" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">William S. Reardon, M.B.A.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">19,511,502</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">815,779</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg M. Pohotsky, M.B.A., J.D. and William S. Reardon, M.B.A. were elected to serve until the 2023 Annual Meeting.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2021 Annual Meeting are Daniel R. Omstead, Ph.D. and Lucinda H. Stebbins, M.B.A., CPA.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2022 Annual Meeting are Rakesh K. Jain, Ph.D., Thomas M. Kent, CPA.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shareholders ratified the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2020 by the following votes:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="137" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Against/<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Withhold</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="63" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Abstain</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="121" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">19,843,067</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">261,930</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">222,283</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
 &nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FOR MORE INFORMATION:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110; (iii) on the Fund's website at www.teklacap.com; and (iv) on the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed with the SEC on Form N-PORT. This Schedule of Investments will also be available on the Fund's website at www.teklacap.com, or the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You can find information regarding the Fund at the Fund's website, www.teklacap.com. The Fund regularly posts information to its website, including information regarding daily share pricing, distributions, press releases and links to the Fund's SEC filings. The Fund currently publishes and distributes quarterly fact cards, which include performance, portfolio holdings and sector information for each fiscal quarter. These fact cards will be available on the Fund's website and by request from the Fund's marketing and investor support services agent, Destra Capital Advisors LLC, at 1-877-855-3434.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FEDERAL TAX INFORMATION (unaudited):</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Certain information for the Fund is required to be provided to shareholders based on the Fund's income and distributions for the taxable year ended December 31, 2020. In February 2021, shareholders will receive Form 1099-DIV, which will include their share of qualified dividends and capital gains and return of capital distributed during the calendar year 2020. Shareholders are advised to check with their tax advisors for information on the treatment of these amounts on their individual tax returns.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under Section 854(b)(2) of the Code, the Fund designated $3,213,749 as qualified dividends for the year ended September 30, 2020.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>33</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=35,FOLIO='33',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>DISTRIBUTION POLICY:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>SHARE REPURCHASE PROGRAM:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> In March 2020, the Trustees reauthorized the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one year period ending July 14, 2021.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>PORTFOLIO MANAGEMENT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A., Ph.D., Christian M. Richard, M.B.A., M.S., Henry Skinner, Ph. D., Ashton L. Wilson, Christopher Abbott, Robert Benson, Richard Goss, Jack Liu, M.B.A., Ph.D., and Loretta Tse, Ph.D. are members of a team that analyzes investments on behalf of the Fund. Dr. Omstead exercises ultimate decision making authority with respect to investments.</font></p>
<p style="margin:11pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following information in this annual report is a summary of certain information about the Fund and changes since September 30, 2019. This information may not reflect all of the changes that have occurred since you purchased the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Investment Objective and Policies</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">There have been no changes in the Fund's investment objective and policies since September 30, 2019 that have not been approved by shareholders.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of equity and related securities (including securities subject to legal or contractual restrictions on resale) of U.S. and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in life sciences (including biotechnology, pharmaceuticals, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices, supplies and other healthcare-related subsectors), agriculture and environmental management ("Life Sciences Companies").</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In an effort to achieve its investment objective, the Fund will invest primarily in securities of U.S. and foreign companies that are generally believed by the Investment Adviser to have significant potential for above-average, long-term growth in revenues and earnings. The Investment Adviser expects that such companies generally will possess some or all of the following characteristics, in the Investment Adviser's judgment: current or anticipated strong market position for their services or products, experienced business management, recognized technological expertise and the ability either to generate funds internally to finance growth or to secure outside sources of capital. For companies with earnings, the Investment Adviser generally will attempt to invest in securities that sell at price-earnings ratios or at multiples of underlying asset or potential values which, have upside potential.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund may invest in securities of emerging growth Life Sciences Companies which may offer limited products or services or which are at the research and development stage with no marketable or approved products or technologies. The Fund also may invest in securities of large, well-known companies with existing products in the life sciences industries that are believed by the Investment Adviser to be undervalued in relation to their long-term growth potential or asset value.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>34</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=36,FOLIO='34',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund also may invest up to 40% of its net assets in venture capital and other securities that are subject to legal or contractual restrictions on resale ("Restricted Securities").</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund also may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers traded in foreign markets ("Foreign Securities"). The Fund may buy and sell currencies for the purpose of settlement of transactions in Foreign Securities.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under normal market conditions, the Fund expects to invest at least 80% of its net assets in securities of Life Sciences Companies. This policy may not be changed without 60 days' prior notice to the Fund's shareholders (the "Shareholders"). The Fund is required, except for temporary defensive purposes, to invest at least 25% of its net assets in such companies. For purposes of satisfying the foregoing requirements, a company will be deemed to be a Life Sciences Company if, at the time the Fund makes an investment therein, 50% or more of such company's sales, earnings efforts or assets arise from or are dedicated to, or are expected to arise from or be dedicated to, the application of scientific advances related to healthcare, agriculture or environmental management, as the case may be. Determinations as to whether a company is a Life Sciences Company will be made by the Investment Adviser in its discretion.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The equity and related securities in which the Fund may invest consist of common stock of Life Sciences Companies and, to a lesser extent, of preferred stock, convertible debt, limited partnership interests and warrants or other rights to acquire common or preferred stocks of such companies. The Fund's investments in venture capital opportunities, which are considered Restricted Securities, will be made primarily in convertible preferred stock. The Fund may also purchase non-convertible debt securities in connection with its venture capital investments, and otherwise when the Investment Adviser believes that such investments would be consistent with the Fund's investment objective. While these debt investments typically will not be rated, the Investment Adviser believes that, in light of the risk characteristics associated with investments in emerging growth companies (see "Risk Factors"), if such investments were to be compared with investments rated by S&amp;P or Moody's, they may be rated as low as "C" in the rating categories established by S&amp;P and Moody's. Such securities are commonly referred to as "junk bonds" and are considered, on balance, as predominantly speculative.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Changes to Risk Factors</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following information is a summary of certain changes to the Risk Factors since September 30, 2019 and may not reflect all of the changes that have occurred since you purchased this Fund: The Fund added the Risk Factor "Special Purpose Acquisition Company Risk" to address the risks associated with investments in Special Purpose Acquisition Companies ("SPAC").</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Risk Factors</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Investing in any investment company security involves risk, including the risk that you may receive little or no return on your investment or even that you may lose part or all of your investment. Investors should consider the following Risk Factors and special considerations associated with investing in the Fund's shares.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolio Market Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> As with any investment company that invests in equity securities, the Fund is subject to market risk&#151;the possibility that the prices of equity securities will decline over short or extended periods of time. The price of an equity security of an issuer may be </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>35</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=37,FOLIO='35',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">particularly sensitive to general movements in the stock market, or a drop in the stock market may depress the price of most or all of the equity securities held by the Fund. In addition, equity securities held by the Fund may decline in price if the issuer fails to make anticipated distributions or dividend payments because, among other reasons, the issuer experiences a decline in its financial condition. As a result, the value of an investment in the Fund's shares will fluctuate with the market. You could lose some or all of your investment over short or long periods of time.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Political and economic news can influence market-wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Instability in the financial markets has led the U.S. government and certain foreign governments to take a number of unprecedented actions designed to support certain financial institutions and segments of the financial markets that have experienced extreme volatility, and in some cases a lack of liquidity, including through direct purchases of equity and debt securities. Federal, state, and foreign governments, their regulatory agencies or self-regulatory organizations may take actions that affect the regulation of the issuers in which the Fund invests in ways that are unforeseeable. Legislation or regulation may also change the way in which the Fund is regulated. Such legislation or regulation could limit or preclude the Fund's ability to achieve its investment objective</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The value of your investment in the Fund is based on the market prices of the securities the Fund holds. The increasing interconnectivity between global economies and financial markets increases the likelihood that events or conditions in one region or financial market may adversely impact issuers in a different country, region or financial market. Securities in the Fund's portfolio may underperform due to inflation (or expectations for inflation), interest rates, global demand for particular products or resources, natural disasters, pandemics, epidemics, terrorism, regulatory events and governmental or quasi-governmental actions. The occurrence of global events similar to those in recent years, such as terrorist attacks around the world, natural disasters, social and political discord or debt crises and downgrades, among others, may result in market volatility and may have long term effects on both the U.S. and global financial markets. A disruption of financial markets or other terrorist attacks could adversely affect Fund service providers and/or the Fund's operations as well as interest rates, secondary trading, credit risk, inflation and other factors relating to the shares. The Fund cannot predict the effects or likelihood of similar events in the future on the U.S. and world economies, the value of the shares or the NAV of the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Social, political, economic and other conditions and events, such as natural disasters, health emergencies (e.g., epidemics and pandemics), terrorism, conflicts and social unrest, may occur and could significantly impact issuers, industries, governments and other systems, reduce consumer demand or economic output, result in market closures, travel restrictions or quarantines, and generally have a significant impact on the economies and financial markets and the Investment Adviser's investment advisory activities and services of other service providers, which in turn could adversely affect the Fund's investments and other operations. These types of events quickly and significantly impact markets in the U.S. and across the globe leading to extreme market volatility and disruption. The extent and nature of the impact on supply chains or economies and markets from these events is unknown, particularly if a health emergency or other similar event, such as the recent COVID-19 outbreak, </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>36</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=38,FOLIO='36',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">persists for an extended period of time. The value of the Fund's investment may decrease as a result of such events, particularly if these events adversely impact the operations and effectiveness of the Investment Adviser or key service providers or if these events disrupt systems and processes necessary or beneficial to the investment advisory or other activities on behalf the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Security Market Risk&#151;Discount to NAV.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Market price risk is a risk separate and distinct from the risk that the Fund's NAV will decrease. The Fund's shares have traded in the market below NAV per share (a discount), at NAV per share and above NAV per share (premium) since the commencement of the Fund's operations. There can be no assurance that the Fund's shares will trade at a premium in the future or that any such premium will be sustainable. The Fund cannot predict whether the shares will trade in the future at, above or below their NAV.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Non-Diversification Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund is non-diversified, meaning that the Fund is permitted to invest more of its assets in fewer issuers than "diversified" funds. Thus, the Fund may be more susceptible to adverse developments affecting any single issuer held in its portfolio, and may be more susceptible to greater losses because of these developments.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Selection Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of Life Sciences Companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Concentration in the Life Sciences Industries.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Under normal market conditions, the Fund expects to invest at least 80% of its net assets in securities of Life Sciences Companies. This policy may not be changed without 60 days' prior written notice to Shareholders. The Fund will not have less than 25% of its net assets invested in Life Sciences Companies. As a result, the Fund's portfolio may be more sensitive to, and possibly more adversely affected by, regulatory, economic or political factors or trends relating to the life sciences industries than a portfolio of companies representing a larger number of industries. As a result of its concentration policy, the Fund's investments may be subject to greater risk and market fluctuation than a fund that has securities representing a broader range of investments.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Life Sciences Companies have in the past been characterized by limited product focus, rapidly changing technology and extensive government regulation. In particular, technological advances can render an existing product, which may account for a disproportionate share of a company's revenue, obsolete. Obtaining governmental approval from agencies such as the Food and Drug Administration (the "FDA"), U.S. Department of Agriculture and other U.S. and non U.S. governmental agencies for new products can be lengthy, expensive and uncertain as to outcome. Such delays in product development may result in the need to seek additional capital, potentially diluting the interests of existing investors such as the Fund. In addition, governmental agencies may, for a variety of reasons, restrict the release of certain innovative technologies of commercial significance, such as genetically altered material. These various factors may result in abrupt advances and declines in the securities prices of particular companies and, in some cases, may have a broad effect on the prices of securities of companies in particular life sciences industries.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Intense competition exists within and among certain life sciences industries, including competition to obtain and sustain proprietary technology protection. Life Sciences Companies can be highly dependent on the strength of patents, trademarks and other intellectual prop-</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>37</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=39,FOLIO='37',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">erty rights for maintenance of profit margins and market share. The complex nature of the technologies involved can lead to patent disputes, including litigation that could result in a company losing an exclusive right to a patent. Competitors of Life Sciences Companies may have substantially greater financial resources, more extensive development, manufacturing, marketing and service capabilities, and a larger number of qualified managerial and technical personnel. Such competitors may succeed in developing technologies and products that are more effective or less costly than any that may be developed by Life Sciences Companies in which the Fund invests and may also prove to be more successful in production and marketing. Competition may increase further as a result of potential advances in health services and medical technology and greater availability of capital for investment in these fields.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">With respect to healthcare, cost containment measures already implemented by national governments, state or provincial governments, international organizations and the private sector have adversely affected certain sectors of these industries. Increased emphasis on managed care in the United States may put pressure on the price and usage of products sold by life sciences companies in which the Fund may invest and may adversely affect the sales and revenues of life sciences companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Product development efforts by Life Sciences Companies may not result in commercial products for many reasons, including, but not limited to, failure to achieve acceptable clinical trial results, limited effectiveness in treating the specified condition or illness, harmful side effects, failure to obtain regulatory approval, and high manufacturing costs. Even after a product is commercially released, governmental agencies may require additional clinical trials or change the labeling requirements for products if additional product side effects are identified, which could have a material adverse effect on the market price of the securities of those Life Sciences Companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Certain Life Sciences Companies in which the Fund may invest may be exposed to potential product liability risks that are inherent in the testing, manufacturing, marketing and sale of pharmaceuticals, medical devices or other products. There can be no assurance that a product liability claim would not have a material adverse effect on the business, financial condition or securities prices of a company in which the Fund has invested.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">All of these factors as well as others may cause the value of the Fund's shares to fluctuate significantly over relatively short periods of time.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Risks Associated with Regulatory and Policy Changes.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> In March 2010, the ACA was enacted, which helped extend healthcare coverage to millions of uninsured Americans. Many of the ACA's most significant reforms, such as the establishment of state-based and federally facilitated insurance exchanges that provide a marketplace for eligible individuals and small employers to purchase health care insurance, continue to evolve. Potential changes to the ACA or future changes to broader U.S. healthcare policy could affect the Fund and its investments over the next several years. The affordability of healthcare in the U.S. will remain a topic of debate, and proposals, laws and regulations to reduce the costs of healthcare products and services could adversely impact healthcare companies that the Fund invests in.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Investment in Emerging Growth Companies.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may invest in equity securities of emerging growth Life Sciences Companies. While these securities offer the opportunity for significant capital gains, such investments also involve a degree of risk that can result in substantial losses. There can be no assurance that securities of start-up or emerging growth companies will, in the future, yield returns commensurate with their associated risks.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>38</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=40,FOLIO='38',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Liquidity of Portfolio Investments.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may invest in securities that are traded in the over-the-counter markets or on regional stock exchanges where the low trading volume of a particular security may result in abrupt and erratic price movements or that are not traded in any market. An investment in such securities may have limited liquidity, and the Fund may find it necessary to sell at a discount from recent prices or to sell over extended periods of time when disposing of such securities. In addition, the Fund may invest up to 40% of its net assets in Restricted Securities, which by their terms are illiquid. In many cases, Restricted Securities in which the Fund may invest cannot be sold except in a public offering registered under the Securities Act of 1933, as amended, pursuant to an exemption from the Securities Act or in compliance with applicable Securities and Exchange Commission regulations.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Venture Capital Investments Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may occasionally invest in venture capital opportunities. While these securities offer the opportunity for significant capital gains, such investments also involve a degree of risk that can result in substantial losses. Some of the venture capital opportunities in which the Fund may invest are expected to be companies that are in a "start-up" stage of development, have little or no operating history, operate at a loss or with substantial variations in operating results from period to period, have limited products, markets, financial resources or management depth, or have the need for substantial additional "follow-on" capital to support expansion or to achieve or maintain a competitive position. Such additional investments may dilute the interests of prior investors, such as the Fund. Some of these companies may be emerging companies at the research and development stage with no marketable or approved products or technology. There can be no assurance that securities of start-up or emerging growth companies will, in the future, yield returns commensurate with their associated risks.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">These investments, which are considered Restricted Securities, will be made primarily in convertible preferred stock. The Fund may also purchase non-convertible debt securities in connection with its venture capital investments, and otherwise when the Investment Adviser believes that such investments would be consistent with the Fund's investment objective. While these debt investments typically will not be rated, the Investment Adviser believes that, in light of the risk characteristics associated with investments in emerging growth companies, if such investments were to be compared with investments rated by S&amp;P or Moody's, they may be rated as low as "C" in the rating categories established by S&amp;P and Moody's. Such securities are commonly referred to as "junk bonds" and are considered, on balance, as predominantly speculative.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Restricted Securities and Valuation Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Some of the Fund's investments are subject to restrictions on resale and generally have no established trading market or are otherwise illiquid with little or no trading activity. The valuation process requires an analysis of various factors. The Fund's fair value methodology includes the examination of, among other things, (i) the existence of any contractual restrictions on the disposition of the securities; (ii) information obtained from the issuer which may include an analysis of the company's financial statements, the company's products or intended markets, or the company's technologies; and (iii) the price of a security sold at arm's length in an issuer's subsequent completed round of financing. As there is typically no readily available market value for some of the Restricted Securities in the Fund's portfolio, such Restricted Securities in the Fund's portfolio are valued at fair value as determined in good faith by or under the direction of the Board pursuant to the Fund's valuation policy and a consistently applied valuation process. Because of the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund's investments determined in good faith by the Board may differ significantly from the values that would have been used had a ready market existed for the investments, and the differences could be material. There is no single standard </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>39</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=41,FOLIO='39',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment, while employing a consistently applied valuation process for the types of investments the Fund makes.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Foreign Securities Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may invest up to 20% of its net assets in Foreign Securities. Foreign Securities involve special risks that are not typically associated with U.S. dollar denominated or quoted securities of U.S. issuers. Foreign Securities may be affected by changes in currency rates, changes in foreign or U.S. laws or restrictions applicable to such investments and changes in exchange control regulations (e.g., currency blockage). A decline in the exchange rate of the currency (i.e., weakening of the currency against the U.S. dollar) in which a portfolio security is quoted or denominated relative to the U.S. dollar would reduce the value of the portfolio security. In addition, if the currency in which the Fund receives dividends, interest or other payments declines in value against the U.S. dollar before such income is distributed as dividends to Shareholders or converted to U.S. dollars, the Fund may have to sell portfolio securities to obtain sufficient cash to pay such dividends.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Brokerage commissions, custodial services and other costs relating to investment in international securities markets generally are more expensive than in the United States. In addition, clearance and settlement procedures may be different in foreign countries and, in certain markets, such procedures have been unable to keep pace with the volume of securities transactions, thus making it difficult to conduct such transactions.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Foreign issuers are not generally subject to uniform accounting, auditing and financial reporting standards comparable to those applicable to U.S. issuers. There may be less publicly available information about a foreign issuer than about a U.S. issuer. In addition, there is generally less government regulation of foreign markets, companies and securities dealers than in the United States, and the legal remedies for investors may be more limited than the remedies available in the United States. Foreign securities markets may have substantially less volume than U.S. securities markets and securities of many foreign issuers are less liquid and more volatile than securities of comparable domestic issuers. Furthermore, with respect to certain foreign countries, there is a possibility of nationalization, expropriation or confiscatory taxation, imposition of withholding or other taxes on dividend or interest payments (or, in some cases, capital gains distributions), limitations on the removal of funds or other assets from such countries, and risks of political or social instability or diplomatic developments which could adversely affect investments in those countries.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Key Personnel Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> There may be only a limited number of securities professionals who have comparable experience to that of the Fund's existing portfolio management team in the area of Healthcare Companies. If one or more of the team members dies, resigns, retires or is otherwise unable to act on behalf of the Investment Adviser, there can be no assurance that a suitable replacement could be found immediately.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Concentration of Investments.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may from time to time concentrate its investments in a few issuers and take large positions in those issuers. As a result, the Fund may be subject to a greater risk of loss than an investment company that diversifies its investments more broadly. Taking larger positions is also likely to increase the volatility of the Fund's NAV reflecting fluctuation in the value of its large holdings. The Fund may make investments in any company with the objective of controlling or influencing the management and policies of that company. Investing for the purpose of controlling or influencing the management and policies of a company could potentially make the Fund less diversified and more susceptible to declines in the value of the company's stock. The Investment Adviser may seek a control </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>40</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=42,FOLIO='40',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>INVESTMENT OBJECTIVE, POLICIES AND <BR>RISK FACTORS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">position in private venture capital investments where the Investment Adviser believes its knowledge and experience will be of significant benefit to the invested company and, therefore, to the Fund's investment. The Investment Adviser expects to seek control in public companies only occasionally and most often in companies with a small capitalization.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Anti-Takeover Provisions Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund's Declaration of Trust ("Declaration of Trust"), dated February 20, 1992, as amended, has provisions that could have the effect of limiting the ability of other entities or persons to (1) acquire control of the Fund, (2) cause it to engage in certain transactions, or (3) modify its structure. The By-Laws also contain provisions regarding qualifications for nominees for Trustee positions, advance notice of Shareholder proposals, and requirements for the call of special Shareholder meetings. These provisions may be considered "anti-takeover" provisions.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Related Party Transactions Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The majority of the Board is unaffiliated with the Investment Adviser; nevertheless, the Fund may be subject to certain potential conflicts of interest. Although the Fund has no obligation to do so, it may place brokerage orders with brokers who provide supplemental investment research and market and statistical information about Life Sciences Companies and the life sciences industries. In addition, other investment companies advised by the Investment Adviser may concurrently invest with the Fund in Restricted Securities under certain conditions. The Fund also may invest, subject to applicable law, in companies in which the principals of the Investment Adviser or Trustees of the Fund have invested, or for which they serve as directors or executive officers. The Investment Company Act prohibits the Fund from engaging in certain transactions involving its "affiliates," including, among others, the Fund's Trustees, officers and employees, the Investment Adviser and any "affiliates" of such affiliates except pursuant to an exemptive order or the provisions of certain rules under the Investment Company Act. In the view of the staff of the Commission, other investment companies advised by the Investment Adviser may, in some instances, be viewed to be affiliates of the Fund. Such legal restrictions and delays and costs involved in obtaining necessary regulatory approvals may preclude or discourage the Fund from making certain investments and no assurance can be given that any exemptive order sought by the Fund will be granted.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Investment Adviser's investment team is responsible for managing the Fund as well as three other closed-end investment companies. In the future, the investment team may manage other funds and accounts, including proprietary accounts, separate accounts and other pooled investment vehicles, such as unregistered hedge funds. In the future, a portfolio manager may manage a separate account or other pooled investment vehicle which may have materially higher fee arrangements than the Fund and may also have a performance-based fee. The side-by-side management of these funds or accounts may raise potential conflicts of interest relating to cross trading, the allocation of investment opportunities and the aggregation and allocation of trades.</font></p>
<p style="margin:8pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Special Purpose Acquisition Company Risk.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund may invest in SPACs. SPACs are collective investment structures that pool funds in order to seek potential acquisition opportunities. Unless and until an acquisition is completed, a SPAC generally invests its assets (less an amount to cover expenses) in U.S. Government securities, money market fund securities and cash. SPACs and similar entities may be blank check companies with no operating history or ongoing business other than to seek a potential acquisition. Certain SPACs may seek acquisitions only in limited industries or regions. If an acquisition that meets the requirements for the SPAC is not completed within a predetermined period of time, the invested funds are returned to the entity's shareholders. Investments in SPACs may be illiquid and/or be subject to restrictions on resale.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>41</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=43,FOLIO='41',FILE='20-30671-2.ga.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>

<!-- Document name: 20-30671-2.za-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:16pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">New York Stock Exchange Symbol: HQL<BR>NAV Symbol: XHQLX</font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">100 Federal Street, 19th Floor<BR>Boston, Massachusetts 02110<BR>(617) 772-8500<BR>www.teklacap.com</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Officers</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D., President<BR>Laura Woodward, CPA, Chief Compliance Officer,<BR>Secretary and Treasurer</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Trustees</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Jeffrey A. Bailey<BR>Rakesh K. Jain, Ph.D.<BR>Thomas M. Kent, CPA<BR>Daniel R. Omstead, Ph.D.<BR>Oleg M. Pohotsky, M.B.A., J.D.<BR>William S. Reardon, M.B.A.<BR>Lucinda H. Stebbins, M.B.A., CPA</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Adviser</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tekla Capital Management LLC</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Administrator &amp; Custodian</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">State Street Bank and Trust Company</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Transfer Agent</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Computershare, Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Legal Counsel</b></font></p>
<p style="margin:0pt 0pt 11pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dechert LLP</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders with questions regarding share transfers may call</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>1-800-426-5523</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daily net asset value may be obtained from</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">our website (</font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>www.teklacap.com</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) or by calling</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>617-772-8500</b></font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=44,FOLIO='',FILE='20-30671-2.za.qxp',USER='Unknown',CD='Nov 24 12:22 2020' -->
<br clear="all"><Div style="page-break-before:always;"></Div>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2. CODE OF ETHICS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>As of the end of the period covered by this report, the Registrant has adopted a code of ethics that applies to the Registrant&#8217;s
principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar
functions, regardless of whether these individuals are employed by the Registrant or a third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>No disclosures are required by this Item.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD>During the period covered by this report, the Registrant did not make any substantive amendment to the code of ethics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>During the period covered by this report, the Registrant did not grant any waiver, including any implicit waiver, from any
provision of the code of ethics.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD>Not applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD>A copy of the Registrant&#8217;s code is filed as Exhibit&nbsp;1 to this Form&nbsp;N-CSR. Copies of the Code will also be made
available, free of charge, upon request, by writing or calling Tekla Capital Management LLC at 100 Federal Street, 19th Floor,
Boston, MA 02110, 617-772-8500.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant&#8217;s Board of Trustees has determined that
the Registrant has at least one audit committee financial expert serving on its audit committee. The audit committee financial
expert is William S. Reardon. He is &#8220;independent&#8221; for the purposes of Item 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>Audit Fees. The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal
accountant for the audit of the Registrant&#8217;s annual financial statements or services that are normally provided by the accountant
in connection with statutory and regulatory filings or engagements for those fiscal years were $102,696 for the fiscal year ended
September&nbsp;30, 2020 and $99,704 for the fiscal year ended September&nbsp;30, 2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>Audit Related Fees. The Registrant was not billed any fees in each of the last two fiscal years ended September&nbsp;30 for
assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the Registrant&#8217;s
financial statements and not otherwise included above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD>Tax Fees. The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal
accountant for tax compliance, tax advice, and tax planning were $5,830 for the fiscal year ended September&nbsp;30, 2020 and $5,660
for the fiscal year ended September&nbsp;30, 2019. The nature of the services comprising the fees disclosed under this category
was tax compliance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>All Other Fees. The Registrant was not billed any fees in each of the last two fiscal years ended September&nbsp;30 for products
and services provided by the principal accountant, other than the services reported in paragraphs (a)&nbsp;through (c)&nbsp;of
this Item.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD>(1)&nbsp; Pre-approval Policies and Procedures.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Pursuant to the Registrant&#8217;s Audit
Committee Charter (&#8220;Charter&#8221;), the Audit Committee is responsible for approving in advance the firm to be
employed as the Registrant&#8217;s independent auditor. In addition, the Charter provides that the Audit Committee is
responsible for approving any and all proposals by the Registrant, its investment adviser or their affiliated persons or any
entity controlling, controlled by, or under common control with the adviser that provides services to the Registrant to
employ the independent auditor to render permissible non-audit services related directly to the operations and financial
reporting of the Registrant. In determining whether to pre-approve non-audit services, the Audit Committee considers whether
such services are consistent with the independent auditor&#8217;s independence. The Charter further permits the Audit
Committee to delegate to one or more of its members authority to pre-approve permissible non-audit services to the
registrant, provided that any pre-approval determination of a delegate is for services with an estimated budget of less than
$15,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the services described in each of paragraphs (b)&nbsp;through (d)&nbsp;of this Item were approved by the Audit Committee pursuant
to paragraph (c)(7)(i)(C)&nbsp;of Rule&nbsp;2-01 of Regulation S-X. All services described in paragraphs (b)&nbsp;though (d)&nbsp;of
the NCSR were approved in advance by the Audit Committee of each Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD>Not applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD>None.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD>Not applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant has a separately-designated standing Audit Committee
established in accordance with Section&nbsp;3(a)(58)(A)&nbsp;of the Securities Exchange Act (15 U.S.C. 78c(a)(58)(A)). The members
of the Audit Committee are Lucinda H. Stebbins, Thomas M. Kent, and William S. Reardon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 6. INVESTMENTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant&#8217;s Schedule of Investments is included as
part of the Report to Shareholders filed under Item 1 of this form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES
FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant has adopted the following proxy voting policies
and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY VOTING POLICIES AND PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Policy</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following are the policies and procedures adopted and implemented
by Tekla Capital Management LLC (&#8220;TCM&#8221;) for voting proxies with respect to portfolio securities held by Tekla Healthcare
Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#8220;Fund&#8221;
and collectively the &#8220;Funds&#8221;). The policies and procedures are reasonably designed to ensure that proxies are voted
in the best interest of the Funds and the Funds&#8217; shareholders, in accordance with TCM&#8217;s fiduciary duties and Rule&nbsp;206(4)-6
under the Investment Advisers Act of 1940 (the &#8220;Investment Advisers Act&#8221;). TCM considers the &#8220;best interests&#8221;
of the Funds and their shareholders to mean their best long-term economic interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM shall vote proxies for the exclusive benefit, and in the
best economic interest, of the Funds and their shareholders. Such exercise of voting rights shall be subject to the same standard
of care as is generally applicable to TCM&#8217;s performance of its duties, as set forth in the advisory agreements with the Funds.
The policies and procedures contained herein are designed to be guidelines, however each vote is ultimately cast on a case-by-case
basis, taking into consideration the relevant facts and circumstances at the time of the vote. Any material conflicts that may
arise will be resolved in the best interests of the Funds and their shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A proxy committee has been designated and is responsible for
administering and overseeing the proxy voting process. The committee consists of the President of TCM, TCM&#8217;s Chief Compliance
Officer (&#8220;CCO&#8221;), and the analyst responsible for oversight of the company that is the subject of the proxy. The committee
considers proxy questions and determines the vote on behalf of the Funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: a2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Procedures</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Logistics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#8217;s CCO shall be responsible for maintaining the proxy
log, monitoring corporate actions and confirming the timely voting of proxies. The proxy log shall contain the following information,
in accordance with Form&nbsp;N-PX:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the name of the issuer;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the exchange ticker symbol, if available;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the CUSIP number, if available;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>the shareholder meeting date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>a brief identification of the matter voted on;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>whether the matter was proposed by the issuer or a security holder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>whether TCM cast its vote on the matter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>how TCM cast its vote on the matter (for, against, abstain; for or withhold regarding the election of directors); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>whether TCM cast its vote for or against management;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#8217;s CCO shall also record whether any conflicts of interest
have been identified and, if so, what action was taken to resolve the conflict with respect to each vote cast and each abstention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Substantive Voting Decisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#8217;s substantive voting decisions turn on the particular
facts and circumstances of each proxy vote. The following is a list of common proxy vote issues and TCM&#8217;s standard considerations
when determining how to vote such proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Routine
Matters/Corporate Administrative Items</I></FONT>. After an initial review, TCM generally votes with management on routine matters
related to the operation of the issuer that are not expected to have a significant economic impact on the issuer and/or its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Potential
for Major Economic Impact</I></FONT>. TCM may review and analyze on a case-by-case basis, non-routine proposals that are more likely
to affect the structure and operation of the issuer and to have a greater impact on the value of the investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
Governance</I></FONT>. TCM may review and consider corporate governance issues related to proxy matters and generally supports
proposals that foster good corporate governance practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Special
Interest Issues</I></FONT>. TCM may consider: (i)&nbsp;the long-term benefit to shareholders of promoting corporate accountability
and responsibility on social issues; (ii)&nbsp;management&#8217;s responsibility with respect to special interest issues; (iii)&nbsp;any
economic costs and restrictions on management; and (iv)&nbsp;the responsibility of TCM to vote proxies for the greatest long-term
shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Limitations
on Director Tenure and Retirement</I></FONT>. TCM may consider: (i)&nbsp;a reasonable retirement age for directors, <I>e.g.</I>
70 or 72; (ii)&nbsp;the introduction of new perspectives on the board; and (iii)&nbsp;the arbitrary nature of such limitations
and the possibility of detracting from the board&#8217;s stability and continuity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors&#8217;
Minimum Stock Ownership</I></FONT>. TCM may consider: (i)&nbsp;the benefits of additional vested interest; (ii)&nbsp;the ability
of a director to serve a company well regardless of the extent of his or her share ownership; and (iii)&nbsp;the impact of limiting
the number of persons qualified to be directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>D&amp;O
Indemnification and Liability Protection</I></FONT>. TCM may consider: (i)&nbsp;indemnifying directors for acts conducted in the
normal course of business; (ii)&nbsp;limiting liability for monetary damages for violating the duty of care; (iii)&nbsp;expanding
coverage beyond legal expenses to acts that represent more serious violations of fiduciary obligation than carelessness (<I>e.g.</I>
negligence);and (iv)&nbsp;providing expanded coverage in cases when a director&#8217;s legal defense was unsuccessful if the director
was found to have acted in good faith and in a manner that he or she reasonably believed was in the best interests of the issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Director
Nominations in Contested Elections</I></FONT>. TCM may consider: (i)&nbsp;long-term financial performance of the issuer relative
to its industry; (ii)&nbsp;management&#8217;s track record; (iii)&nbsp;background to proxy contest; (iv)&nbsp;qualifications of
both slates of nominees; (v)&nbsp;evaluations of what each side is offering shareholders as well as the likelihood that the proposed
objectives and goals can be met; and (vi)&nbsp;stock ownership positions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cumulative
Voting</I></FONT>. TCM may consider: (i)&nbsp;the ability of significant stockholders to elect a director of their choosing; (ii)&nbsp;the
ability of minority shareholders to concentrate their support in favor of a director or directors of their choosing; and (iii)&nbsp;the
potential to limit the ability of directors to work for all shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classified
Boards</I></FONT>. TCM may consider: (i)&nbsp;providing continuity; (ii)&nbsp;promoting long-term planning; and (iii)&nbsp;guarding
against unwanted takeovers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Poison
Pills</I></FONT>. TCM may consider: (i)&nbsp;TCM&#8217;s position on supporting proposals to require a shareholder vote on other
shareholder rights plans; (ii)&nbsp;ratifying or redeeming a poison pill in the interest of protecting the value of the issuer;
and (iii)&nbsp;other alternatives to prevent a takeover at a price demonstrably below the true value of the issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Price Provisions</I></FONT>. TCM may consider: (i)&nbsp;the vote required to approve the proposed acquisition; (ii)&nbsp;the vote
required to repeal the fair price provision; (iii)&nbsp;the mechanism for determining fair price; and (iv)&nbsp;whether these provisions
are bundled with other anti-takeover measures (<I>e.g.</I>, supermajority voting requirements) that may entrench management and
discourage attractive tender offers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Equal
Access</I></FONT>. TCM may consider: (i)&nbsp;the opportunity for significant shareholders of the issuer to evaluate and propose
voting recommendations on proxy proposals and director nominees, and to nominate candidates to the board; and (ii)&nbsp;the added
complexity and burden.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Charitable
Contributions</I></FONT>. TCM may consider: (i)&nbsp;the potential benefits to shareholders; (ii)&nbsp;the potential to detract
the issuer&#8217;s resources from more direct uses of increasing shareholder value; and (iii)&nbsp;the responsibility of shareholders
to make individual contributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Authorizations</I></FONT>: TCM may consider: (i)&nbsp;the need for the increase; (ii)&nbsp;the percentage increase with respect
to the existing authorization; (iii)&nbsp;voting rights of the stock; and (iv)&nbsp;overall capitalization structures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Preferred
Stock</I></FONT>. TCM may consider: (i)&nbsp;whether the new class of preferred stock has unspecified voting, conversion, dividend
distribution, and other rights; (ii)&nbsp;whether the issuer expressly states that the stock will not be used as a takeover defense
or carry superior voting rights; (iii)&nbsp;whether the issuer specifies the voting, dividend, conversion, and other rights of
such stock and the terms of the preferred stock appear reasonable; and (iv)&nbsp;whether the stated purpose is to raise capital
or make acquisitions in the normal course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Director
Compensation</I></FONT>. TCM may consider: (i)&nbsp;whether director shares are at the same market risk as those of the shareholders;
and (ii)&nbsp;how option programs for outside directors compare with the standards of internal programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Golden
and Tin Parachutes</I></FONT>. TCM may consider: (i)&nbsp;whether they will be submitted for shareholder approval; and (ii)&nbsp;the
employees covered by the plan and the quality of management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation.
</I></FONT>TCM may consider: (i)&nbsp;Whether the company has an independent compensation committee; (ii)&nbsp;whether the compensation
committee engaged independent consultants; (iii)&nbsp;whether the compensation committee has lapsed or waived equity vesting restrictions;
and (iv)&nbsp;whether the company has adopted or extended a Golden Parachute without shareholder approval. TCM will generally support
annual advisory votes on executive compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Limitations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM may abstain from voting a proxy if it concludes that the
effect on shareholders&#8217; economic interests or the value of the portfolio holding is indeterminable or insignificant. TCM
may abstain from voting a proxy if it concludes that the cost of voting is disproportionate to the economic impact the vote would
have on the portfolio holdings. With respect to certain privately held companies, TCM may not have the opportunity to vote or may
have a limitation on its ability to vote. For example, in certain cases a company may be permitted by its charter or other governing
documents to take action without a shareholder meeting and with written consent of fewer than all shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conflicts of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Proxy Committee identifies any potential conflicts of interest.
Each potential conflict must be addressed in a manner which will be in the best interest of the Funds and their shareholders. If
any potential conflict is identified the Proxy Committee consults with the Funds&#8217; counsel. Where conflicts of interest arise
between clients and TCM, TCM may convene an ad-hoc committee to debate the conflict and to give a ruling on a preferred course
of action. If the ad-hoc committee determines that TCM has a conflict of interest in any instance, TCM&#8217;s CCO shall disclose
the conflict to the Board and seek voting instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM may cause the proxies to be voted in accordance with the
recommendations of an independent third party service provider that TCM may use to assist in voting proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Disclosure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following disclosure shall be provided in connection with
these policies and procedures:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>TCM shall provide a description or a copy of these policies and procedures to the Boards of Trustees of the Funds annually
and upon request.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>TCM shall make available to the Funds its proxy voting records, for inclusion on the Funds&#8217; Form&nbsp;N-PX.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>TCM shall include its proxy voting policies and procedures in its annual filing on Form&nbsp;N-CSR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>TCM shall cause the Funds&#8217; shareholder reports to include a statement that a copy of these policies and procedures is
available upon request (i)&nbsp;by calling a toll-free number; (ii)&nbsp;on the Funds&#8217; website, (if the Funds choose); and
(iii)&nbsp;on the SEC&#8217;s website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>TCM shall cause the Funds&#8217; annual and semi-annual reports to include a statement that information is available regarding
how the Funds voted proxies during the most recent twelve-month period (i)&nbsp;without charge, upon request, either by calling
a toll-free number or on or through the Funds&#8217; website, or both; and (ii)&nbsp;on the SEC&#8217;s website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recordkeeping</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM shall maintain records of proxies voted in accordance with
Section&nbsp;204-2 of the Advisers Act, including proxy statements, a record of each vote cast, and a copy of any document created
by the Adviser that was material to making a decision of how to vote the proxy, or that memorializes the basis for the Adviser&#8217;s
decision on how to vote the proxy. TCM shall also maintain a copy of its policies and procedures and each written request from
a client for proxy voting records and the Adviser&#8217;s written response to any client request, either written or oral, for such
records. Proxy statements that are filed on EDGAR shall be considered maintained by TCM. All such records shall be maintained for
a period of five years in an easily accessible place, the first two years in the offices of TCM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT
COMPANIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;(1)&#9;As
of December&nbsp;4, 2020, Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A.,</FONT> Timothy Gasperoni, M.B.A., Ph.D., Henry Skinner,
Ph.D., Ashton L. Wilson, Christopher Abbott, Robert Benson, Richard Goss, Jack Liu, M.B.A., Ph.D. and Loretta Tse, Ph.D. are members
of a team that analyzes investments on behalf of the Registrant. Dr.&nbsp;Omstead exercises ultimate decision making authority
with respect to investments. Dr.&nbsp;Omstead also performs other duties including management of the investment adviser and makes
investments on behalf of Tekla Healthcare Investors (&#8220;HQH&#8221;), Tekla Healthcare Opportunities Fund (&#8220;THQ&#8221;)
and Tekla World Healthcare Fund (&#8220;THW&#8221;). The date each team member joined the portfolio management team and each team
member&#8217;s business experience for at least the last five years is included below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel R. Omstead, Ph.D. is President and Chief Executive Officer
of the investment adviser and has been employed by the investment adviser of the Registrant since 2000. He is also President of
the Registrant, HQH, THQ and THW.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jason C. Akus, M.D./M.B.A. is Senior Vice President, Research
of the investment adviser and is responsible for investment research and due diligence in the biotechnology, medical device, and
diagnostic areas. Dr.&nbsp;Akus joined the investment adviser of the Registrant in 2001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timothy Gasperoni, M.B.A., Ph.D. is Senior Vice President, Research
of the investment adviser. He&nbsp;was previously a Senior Analyst and Founding Member of Sabby Capital.&nbsp; He joined TCM in
2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Henry Skinner, Ph.D. is Senior Vice President, Venture of the
investment adviser. He was previously Vice President and Deputy Head and Managing Director of the Novartis Venture Fund. He joined
TCM in October&nbsp;2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ashton L. Wilson is Senior Vice President of the investment
adviser. He was previously a Vice President in equity derivative trading at Goldman Sachs and Co. and was an equity derivative
trader at Bank of America Merrill Lynch. He joined TCM in 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
Abbott is </FONT>Vice President, Research of the investment adviser. Previously, Mr.&nbsp;Abbott was at Leerink Partners where
he was a Vice President on the Equity Research Team. He joined TCM in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert Benson is Senior Analyst, Research of the investment
adviser.&nbsp;Previously, Mr.&nbsp;Benson was at State Street Global Advisors (SSgA) where he performed quantitative research for
asset allocation, equities, and alternatives teams. He joined TCM in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Goss is Senior Analyst of </FONT>the investment adviser. Previously, Mr.&nbsp;Goss was at Leerink Partners where he was a Vice
President on the Large Pharma and Biotech Equity Research Teams and a Healthcare Analyst at Datamonitor. He joined TCM in 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jack Liu, M.B.A., Ph.D. is Senior Analyst of the investment
adviser. He was previously a Research Analyst at Weatherbie Capital. He joined TCM in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loretta
Tse, Ph.D. is Senior Analyst, Venture of </FONT>the investment adviser. She previously ran a biotech consulting business and worked
at various venture funds and start-up companies and was Managing Director at Fred Hutchinson Cancer Research Center. She joined
TCM in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;(a)&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table lists the number and types of other accounts and assets under management in those accounts advised by the Registrant&#8217;s
portfolio management team as of the end of the Registrant&#8217;s fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTERED</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTMENT</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PORTFOLIO</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSETS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POOLED</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSETS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSETS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGER</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGED</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGED</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCOUNTS</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANAGED</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; width: 24%; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel R. Omstead</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason C. Akus</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy Gasperoni</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Henry Skinner</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ashton L. Wilson</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Abbott</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Benson</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Goss</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Liu</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loretta Tse</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665 million</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None of the funds or other accounts are subject to a performance-based
advisory fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each member of the portfolio management team may perform investment
management services for other accounts similar to those provided to the Registrant and the investment action for each account may
differ. The portfolio management team may discover an investment opportunity that may be suitable for more than one account. However,
the investment opportunity may be limited so that all accounts may not be able to fully participate or an investment opportunity
or&nbsp;investment allocation&nbsp;may be allocated to just one account or may be allocated between accounts at different levels
based on an investment decision made by the investment team.&nbsp; The investment team may subsequently make investment decisions
that result in&nbsp;investment levels that make the accounts&nbsp;more differentiated or, conversely, more closely&nbsp;or completely
aligned.&nbsp;&nbsp;Such investment decisions may occur within a day or two.&nbsp;&nbsp;In addition, the investment adviser may
receive different compensation from each account. In that case, the portfolio management team may have an incentive to direct investments
to an account that could result in higher fees for the investment adviser. The registrant has adopted procedures designed to allocate
investments fairly across multiple accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, a portfolio manager may be perceived to have a
conflict of interest if he has other executive management responsibilities. In addition to managing the Registrant, HQH, THQ and
THW, Dr.&nbsp;Omstead is the President of the investment adviser of the Registrant. Dr.&nbsp;Omstead periodically discusses the
amount of time he allocates to each of his responsibilities with the Registrant&#8217;s Board of Trustees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The portfolio management team&#8217;s management of personal
accounts may also present certain conflicts of interest. The Registrant has adopted a code of ethics designed to address these
potential conflicts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;(3) &nbsp;&nbsp;&nbsp;As of September&nbsp;30,
2020, portfolio manager compensation is comprised of a base salary and discretionary compensation as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Base
Salary Compensation</I></FONT>. The team members receive a base salary compensation linked to individual experience and responsibilities.
The amount of base salary is reviewed annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Discretionary
Compensation</I></FONT>. Discretionary Compensation is in the form of a cash bonus, paid annually, which may be up to 50% of the
team member&#8217;s base salary. Several factors affect discretionary compensation, which can vary by team member and circumstances.
The discretionary compensation component is determined based on factors including investment performance of accounts managed by
the team predominantly relative to the S&amp;P 500 Index and a blended consideration of appropriate healthcare indicies and related
performance metrics during the Fund&#8217;s fiscal year, performance of specific investments proposed by the individual, financial
performance of the investment adviser and a qualitative assessment of the individual overall contribution to the investment team
and to the investment adviser. Discretionary compensation is evaluated annually after the completion of the Registrant&#8217;s
fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;(4) &nbsp;&nbsp;&nbsp;As of September&nbsp;30,
2020, the dollar range of Registrant&#8217;s shares beneficially owned by the portfolio managers are as follows as of the end of
the Registrant&#8217;s fiscal year:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; width: 21%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PORTFOLIO&nbsp;MANAGER</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 77%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOLLAR&nbsp;RANGE&nbsp;OF&nbsp;SHARES&nbsp;BENEFICIALLY&nbsp;OWNED</B></FONT></TD>
    </TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel R. Omstead</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">over $1,000,000</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason C. Akus</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy Gasperoni</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Henry Skinner</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ashton L. Wilson</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Abbott</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Benson</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Goss</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Liu</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loretta Tse</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">(b)&nbsp;N/A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT
INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Period</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;Total&nbsp;No.<BR>
of&nbsp;Shares<BR>
Purchased&nbsp;(1)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;Average<BR>
Price&nbsp;Paid&nbsp;per<BR>
Share</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;Total&nbsp;No.<BR>
of&nbsp;Shares<BR>
Purchased&nbsp;as<BR>
Part&nbsp;of<BR>
Publicly<BR>
Announced&nbsp;Plans<BR>
or&nbsp;Programs</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)&nbsp;Maximum&nbsp;No.<BR>
of&nbsp;Shares&nbsp;that<BR>
May&nbsp;Yet&nbsp;Be<BR>
Purchased&nbsp;Under<BR>
the&nbsp;Plans&nbsp;or<BR>
Programs</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #1 (Oct.&nbsp;1, 2019 &mdash; Oct.&nbsp;31, 2019)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,781,589</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #2 (Nov.&nbsp;1, 2019 &mdash; Nov.&nbsp;30, 2019)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>91,683</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.71</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>91,683</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,689,906</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #3 (Dec.&nbsp;1, 2019 &mdash; Dec.&nbsp;31, 2019)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,689,906</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #4 (Jan.&nbsp;1, 2020 &mdash; Jan.&nbsp;31, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,689,906</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #5 (Feb.&nbsp;1, 2020 &mdash; Feb.&nbsp;29, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20,294</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.73</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20,294</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,669,612</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #6 (Mar.&nbsp;1, 2020 &mdash; Mar.&nbsp;31, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>33,023</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.55</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24,723</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,644,889</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #7 (Apr.&nbsp;1, 2020 &mdash; Apr.&nbsp;30, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,644,889</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #8 (May&nbsp;1, 2020 &mdash; May&nbsp;31, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5,950</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.74</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,644,889</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #9 (June&nbsp;1, 2020 &mdash; June&nbsp;30, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,644,889</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #10 (Jul.&nbsp;1, 2020 &mdash; Jul.&nbsp;31, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,839,946</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #11 (Aug.&nbsp;1, 2020 &mdash; Aug.&nbsp;31, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,839,946</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Month #12 (Sep.&nbsp;1, 2020 &mdash; Sep.&nbsp;30, 2020)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,839,946</B></FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>150,950</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.93</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>136,700</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></P>





<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD>On June&nbsp;30, 2011, the share repurchase program was announced, which has been subsequently reviewed and approved by the
Board of Trustees.&nbsp; On March&nbsp;21, 2019, the Trustees approved the renewal of the share repurchase program, allowing the
Registrant to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July&nbsp;14, 2020.
On March&nbsp;19, 2020, the Trustees approved the renewal of the share repurchase program allowing the Registrant to repurchase
up to 12% of its outstanding shares in the open market for a one year period ending July&nbsp;14, 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD>8,300 shares were purchased in Month #6 and 5,950 shares were purchased in Month #8 by Daniel R. Omstead in the open market.&nbsp;
Dr.&nbsp;Omstead is a director of the Registrant and a controlling person of the Registrant&#8217;s investment adviser.&nbsp; Accordingly,
Dr.&nbsp;Omstead may be deemed an &#8220;affiliated purchaser&#8221; of the Registrant&#8217;s shares as such term is defined by
Rule&nbsp;10b-18(a)(3)&nbsp;under the Exchange Act of 1934.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There have been no material changes to the procedures by which
the shareholders may recommend nominees to the registrant&#8217;s Board of Trustees, where those changes were implemented after
the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv)&nbsp;of Regulation S-K (17 CFR229.407)
(as required by Item 22(b)(15) of Schedule 14A (17 CFR240.14a-101)), or this Item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 11. CONTROLS AND PROCEDURES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>In the opinion of the principal executive officer and principal financial officer, based on their evaluation which took place
within 90 days of this filing, the Registrant&#8217;s disclosure controls and procedures are adequately designed and are operating
effectively to ensure (i)&nbsp;that material information relating to the Registrant, including its consolidated subsidiaries, is
made known to them by others within those entities, particularly during the period in which this report is being prepared; and
(ii)&nbsp;that information required to be disclosed by the registrant on Form&nbsp;N-CSR is recorded, processed, summarized and
reported within the time period specified in the Securities and Exchange Commission&#8217;s rules&nbsp;and forms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>There were no changes in the Registrant&#8217;s internal control over financial reporting that occurred during the Registrant&#8217;s
most recent fiscal half-year that have materially affected or that are reasonably likely to materially affect the Registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Item 12. Disclosure
of Securities Lending Activities for Closed-End Management Investment Companies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 13. EXHIBITS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><A HREF="tm2030671d1_ex99codeeth.htm" STYLE="-sec-extract: exhibit">(a)&nbsp;(1)&nbsp;The Code of Ethics that is the subject of the disclosure required by Item 2 is attached hereto (Exhibit&nbsp;1).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><A HREF="tm2030671d1_ex99cert.htm" STYLE="-sec-extract: exhibit">(a)&nbsp;(2)&nbsp;Separate certifications of the Principal Executive and Financial Officers as required by Rule&nbsp;30a-2(a)&nbsp;under the 1940 Act and Section&nbsp;302 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;2 and 3).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><A HREF="tm2030671d1_ex99section19a.htm" STYLE="-sec-extract: exhibit">(a)&nbsp;(3)&nbsp;Notice to Fund&#8217;s shareholders in accordance with Investment Company Act Section&nbsp;19(a)&nbsp;and Rule&nbsp;19a-1 (Exhibit&nbsp;4).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><A HREF="tm2030671d1_ex99-906cert.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certifications pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;5).</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf
by the undersigned, there unto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TEKLA LIFE SCIENCES INVESTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By (Signature and Title)*</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Daniel R. Omstead</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daniel R. Omstead, President</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/4/20</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By (Signature and Title)*</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Laura Woodward, Treasurer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/4/20</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 0pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Print the name and title of each signing officer under his
or her signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CODEETH
<SEQUENCE>2
<FILENAME>tm2030671d1_ex99codeeth.htm
<DESCRIPTION>EXHIBIT 99.CODEETH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&nbsp;99.CODEETH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Exhibit&nbsp;1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Sarbanes-Oxley Code of Ethics</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Introduction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Trustees of Tekla Life Sciences Investors, Tekla
Healthcare Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#8220;Fund&#8221;) has established
this Code of Ethics (&#8220;Code&#8221;) in accordance with the Sarbanes-Oxley Act of 2002 and the rules&nbsp;promulgated thereunder.
This Code does not supersede or otherwise affect the separate code of ethics that the Fund and its investment adviser have adopted
pursuant to Rule&nbsp;17j-1 under the Investment Company Act of 1940, as amended (&#8220;1940 Act&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Code is designed to deter wrongdoing and promote: (i)&nbsp;honest
and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional
relationships; (ii)&nbsp;full, fair, accurate, timely, and understandable disclosure in reports and documents that the Fund files
with, or submits to, the Securities and Exchange Commission (&#8220;SEC&#8221;) and in other public communications made by the
Fund; (iii)&nbsp;compliance with applicable governmental laws, rules, and regulations; (iv)&nbsp;the prompt internal reporting
of violations of the Code to an appropriate person or persons; and (v)&nbsp;accountability for adherence to the Code. The Code
applies to the Funds&#8217; President, Treasurer, Secretary and Assistant Treasurer (collectively, &#8220;Covered Officers,&#8221;
each of whom is set forth in Exhibit&nbsp;A).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD><TD STYLE="text-align: justify"><B>Principles of Honest and Ethical Conduct</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">1<I>. </I>General Objectives</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The Fund expects all Covered Officers to adhere to
the highest possible standards of honest and ethical conduct. All Covered Officers are expected to handle actual or apparent conflicts
of interest between personal and professional relationships in a manner that is above reproach, and to place the interests of the
Fund above their own personal interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2. Conflicts of Interest</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">All Covered Officers should be scrupulous in avoiding
a conflict of interest with regard to the Fund&#8217;s interests. A conflict of interest occurs when an individual&#8217;s private
interest interferes in any way with the interests of the Fund. This includes any specific situation or transaction that the Trustees
of the Fund who are not interested persons as defined in the 1940 Act, would consider to create the appearance of a conflict of
interest. A conflict situation can arise when a Covered Officer takes actions or has interests that may make it difficult to perform
his or her work for the Fund objectively and effectively. Conflicts of interest also arise when a Covered Officer, or a member
of his or her family, receives improper benefits as a result of his or her position with the Fund, whether such benefits are received
from the Fund or a third party. Any conflict of interest that arises in a specific situation or transaction must be disclosed by
the Covered Officer and resolved before taking any action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Conflicts of interest may not always be evident,
and Covered Officers should consult with the Funds&#8217; Chief Compliance Officer or the Funds&#8217; legal counsel if they are
uncertain about any situation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Examples of possible conflicts of interest include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD><TD><I>Outside Employment or Activities</I>. Covered Officers may not engage in any outside employment or activity that interferes
with their performance or responsibilities to the Fund or is otherwise in conflict with or prejudicial
to the Fund. A Covered Officer must disclose to the Funds&#8217; Chief Compliance Officer any outside employment or activity that
may constitute a conflict of interest and obtain the Funds&#8217; Chief Compliance Officer&#8217;s approval before engaging in
any such employment or activity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</FONT></TD><TD><I>Gifts.</I>Covered Officers may not accept gifts or other items of more than small value, consistent with industry standards
from any person or entity that does business with or on behalf of the Fund.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii)</FONT></TD><TD><I>Other Situations.</I> Because other conflicts of interest may arise, it would be impractical to attempt to list all possible
situations in this Code. If a proposed transaction or situation raises questions or doubts, a Covered Officer should consult with
the Funds&#8217; Chief Compliance Officer before engaging in the transaction or activity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Corporate
Opportunities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Covered Officers may not exploit for their own personal
gain, or for the personal gain or their family members or relatives, opportunities that are discovered through the use of Fund
property, information, or position, unless the opportunity is first disclosed fully in writing to the Board of Trustees and the
Board of Trustees declines to pursue such opportunity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.</B></FONT></TD><TD><B>Full, Fair, Accurate, Timely, and Understandable Disclosure in Fund Disclosure and Reporting Documents</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As registered investment companies, it is of critical importance
that the Funds&#8217; public communications, reports, and filings contain full, fair, accurate, timely, and understandable disclosure.
Accordingly, Covered Officers are expected to consider it central to their roles as officers of the Funds to promote full, fair,
accurate, timely, and understandable disclosure in the Funds&#8217; public communications and reports, and in the documents that
the Funds file with, or submits to, the Securities and Exchange Commission (the &#8220;SEC&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depending on his or her position with the Funds, a Covered Officer
may be called upon to provide necessary information to make the Funds&#8217; public reports, communications, and SEC filings and
submissions complete, fair, and understandable. The Funds expect Covered Officers to take this responsibility very seriously and
to provide prompt and accurate answers to inquiries related to the Funds&#8217; public disclosure requirements. Covered Officers
may be asked to certify the accuracy of all responses and information provided for inclusion in the Funds&#8217; public reports,
communications, and SEC filings and submissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD><TD STYLE="text-align: justify"><B>Compliance with Applicable Governmental Rules&nbsp;and
Regulations</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As registered investment companies, the Funds are subject to
regulation by the SEC and must comply with Federal securities laws and regulations, as well as other applicable laws. The Funds
insist on strict compliance with the spirit and the letter of these laws and regulations. Each Covered Officer shall cooperate
with Fund counsel, the Funds&#8217; independent accountants, and the Funds&#8217; other service providers with the goal of maintaining
the Funds&#8217; material compliance with applicable governmental rules&nbsp;and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Funds expect their Covered Officers to comply with all
laws, rules, and regulations applicable to the Funds&#8217; operations and business. Covered Officers should seek guidance
whenever they are in doubt as to the applicability of any law, rule, or regulation, or regarding any contemplated course of
action. Covered Officers should also make use of the various guidelines which the Funds and their service providers have
prepared on specific laws and regulations. If in doubt on a course of action, a good guideline is &#8220;always ask first,
act later&#8221; &#8212; if you are unsure of what to do in any situation, seek guidance before you act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Covered Officers are encouraged to attend courses and seminars
for the purpose of keeping themselves apprised of developments relating to those governmental statutes, rules, and regulations
applicable to the Funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon obtaining knowledge of any material violation of any applicable
law, rule, or regulation by the Funds or a person acting with or on behalf of the Fund, a Covered Officer shall report such violation
to the Funds&#8217; Chief Compliance Officer, Fund counsel, or both. (See Section&nbsp;VI of the Code for a discussion of reporting
Code violations.) Each Covered Officer shall cooperate or take such steps as may be necessary or appropriate to remedy any such
material violation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.</B></FONT></TD><TD STYLE="text-align: justify"><B>Confidentiality</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Covered Officers must maintain the confidentiality of information
entrusted to them by the Funds, except when disclosure is authorized by Fund counsel or required by laws or regulations. Whenever
possible, Covered Officers should consult with Fund counsel if they believe they have a legal obligation to disclose confidential
information. Confidential information includes all non-public information that might be of use to competitors, or harmful to the
Funds or their shareholders, if disclosed. The obligation to preserve confidential information continues even after employment
as a Covered Officer ends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.</B></FONT></TD><TD><B>Prompt Internal Reporting of Violations of the Code; Evaluation of Possible Violations; Determination of Sanctions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD>Reporting to the Funds&#8217; Chief Compliance Officer</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A Covered Officer shall promptly report knowledge
of, or information concerning, any material violation of this Code to the Funds&#8217; Chief Compliance Officer. Any such report
shall preferably be in writing, and shall describe in reasonable detail the conduct that such Covered Officer believes to have
violated this Code. The Funds&#8217; Chief Compliance Officer shall also have the authority to draft a report of a suspected material
violation of the Code, if no written report is made by a Covered Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Evaluation of Reports</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Funds&#8217; Chief Compliance Officer shall then
consult with Fund counsel to the extent necessary to determine whether the reported conduct actually violates the Code. If it is
determined that there has been a violation of the Code, the Funds&#8217; Chief Compliance Officer will determine (in consultation
with Fund counsel) whether the violation has had or may have, in the reasonable judgment of the Funds&#8217; Chief Compliance Officer,
a material adverse impact upon the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</FONT></TD><TD><I>No Material Adverse Impact on the Funds.</I> If the Funds&#8217; Chief Compliance Officer determines that the violation
has not caused a material adverse impact upon the Fund, the Funds&#8217; Chief Compliance Officer shall determine what sanctions,
if any, may be appropriate for the violation. (See G of this Code for a discussion of possible sanctions.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD><TD><I>Material Adverse Impact on the Funds</I>. If the Funds&#8217; Chief Compliance Officer determines that the violation has
caused a material adverse impact upon the Fund, the Funds&#8217; Chief Compliance Officer shall promptly notify the Board of such
violation. The Board shall be entitled to consult with independent legal counsel to determine whether the violation actually has
had a material adverse impact upon the Fund; to formulate sanctions, if any, appropriate for the violation; or for any other purpose
that the Board, in its business judgment, determines to be necessary or advisable. (See G of this Code for a discussion of possible
sanctions.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD>Periodic Reports by the Funds&#8217; Chief Compliance Officer to Board of Trustees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Funds&#8217; Chief Compliance Officer shall report
to the Board at each regularly scheduled Board meeting all violations of this Code (whether or not they caused a material adverse
impact upon the Fund) and all sanctions imposed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.</B></FONT></TD><TD STYLE="text-align: justify"><B>Waivers of Provisions of the Code</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD>Waivers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A Covered Officer may request a waiver of a provision
of this Code if there is a reasonable likelihood that a contemplated action would be a material departure from a provision of the
Code. Waivers will not be granted except under extraordinary or special circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The process of requesting a waiver shall consist of
the following steps:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.65pt"></TD><TD STYLE="width: 18.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD><TD>The Covered Officer shall set forth a request for waiver in writing and submit such request to the Funds&#8217; Chief Compliance
Officer. The request shall describe the conduct, activity, or transaction for which the Covered Officer seeks a waiver, and shall
briefly explain the reason for engaging in the conduct, activity, or transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.65pt"></TD><TD STYLE="width: 18.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD><TD>The determination with respect to the waiver shall be made in a timely fashion by the Funds&#8217; Chief Compliance Officer,
in consultation with Fund counsel, and submitted to the Board for ratification.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.65pt"></TD><TD STYLE="width: 18.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD><TD>The decision with respect to the waiver request shall be documented and kept in the Fund&#8217;s records for the appropriate
period mandated by applicable law or regulation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Disclosure of Waivers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">To the extent required by applicable law, waivers
(including &#8220;implicit waivers&#8221;) shall be publicly disclosed on a timely basis. An &#8220;implicit waiver&#8221; is defined
as the Fund&#8217;s failure to take action within a reasonable period of time regarding a material departure from a provision of
the Code that has been made known to an &#8220;executive officer&#8221; of the Fund. For this purpose, an &#8220;executive officer&#8221;
is a Fund&#8217;s President or Chief Executive Officer, Vice President (who is in charge of a principal policymaking function),
or any other person who performs similar policymaking functions for the Fund. For the purpose of determining whether an &#8220;implicit
waiver&#8221; has occurred, if a material departure from a provision of the Code is known only by the Covered Officer who has caused
the material departure, the material departure will not be considered to have been made known to an executive officer of the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.</B></FONT></TD><TD STYLE="text-align: justify"><B>Accountability for Adherence to the Code</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The matters covered in this Code are of the utmost importance
to the Fund and its shareholders, and are essential to the Fund&#8217;s ability to conduct its business in accordance with its
stated values. Covered Officers are expected to adhere to these rules&nbsp;in carrying out their duties for the Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund will, if appropriate, take action against any Covered
Officer whose actions are found to violate this Code. Sanctions for violations of the Code may include, among other things, a requirement
that the violator undergo training related to the violation, a letter of sanction, the imposition of a monetary penalty, and/or
suspension or termination of the employment of the violator. Where the Fund has suffered a loss because of violations of this Code
or applicable laws, regulations, or rules, it may pursue its remedies against the individuals or entities responsible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.</B></FONT></TD><TD STYLE="text-align: justify"><B>Recordkeeping</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD>General.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Fund requires accurate recording and reporting
of information in order to make responsible business decisions. All of the Fund&#8217;s books, records, accounts and financial
statements must be maintained in reasonable detail, must appropriately reflect the Fund&#8217;s transactions and must conform both
to applicable legal requirements and to the Fund&#8217;s system of internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD>Code of Ethics Records.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A copy of this Code, any amendments hereto, and any
reports or other records created in relation to waivers of or amendments to provisions of this Code shall be kept as records of
the Fund for six years from the end of the fiscal year in which such document was created. Such records shall be furnished to the
SEC or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.</B></FONT></TD><TD STYLE="text-align: justify"><B>Amendments to the Code</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Covered Officers and the Funds&#8217; Chief Compliance Officer
are encouraged to recommend improvements to this Code to the Board, and the Board may amend the Code in its discretion. In connection
with any amendment to the Code, the Funds&#8217; Chief Compliance Officer shall prepare a brief description of the amendment, in
order that this description may be disclosed in accordance with applicable law and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Exhibit&nbsp;A: Covered Officers</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel R. Omstead, President</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Laura Woodward, Treasurer and Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>3
<FILENAME>tm2030671d1_ex99cert.htm
<DESCRIPTION>EXHIBIT 99.CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&nbsp;99.CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;2: CERTIFICATION OF PRINCIPAL
EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I,&nbsp;&nbsp;&nbsp;Daniel R. Omstead, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>I
have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial
reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this
report based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during
the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially
affect, the registrant&#8217;s internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#8217;s auditors and the audit
committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize, and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/4/20</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel R. Omstead</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Daniel R. Omstead</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;3: CERTIFICATION OF PRINCIPAL
FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I,&nbsp;&nbsp;&nbsp;Laura Woodward, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>I
have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements
are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial
reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this
report based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during
the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially
affect, the registrant&#8217;s internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD>The registrant&#8217;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#8217;s auditors and the audit
committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize, and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.5pt"></TD><TD STYLE="width: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/4/20</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Treasurer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.SECTION 19(A)
<SEQUENCE>4
<FILENAME>tm2030671d1_ex99section19a.htm
<DESCRIPTION>EXHIBIT 99.SECTION19(A)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.Section 19(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT 4: SECTION&nbsp;19(a) NOTICE
TO FUND&#8217;S SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><FONT STYLE="font-size: 18pt">T</FONT><FONT STYLE="font-size: 14pt">EKLA
</FONT><FONT STYLE="font-size: 18pt">L</FONT><FONT STYLE="font-size: 14pt">IFE </FONT><FONT STYLE="font-size: 18pt">S</FONT><FONT STYLE="font-size: 14pt">CIENCES
</FONT><FONT STYLE="font-size: 18pt">I</FONT><FONT STYLE="font-size: 14pt">NVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>Notification of Sources of Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Distribution Paid Date: June 30, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Distribution Amount Per Common Share: $0.34</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The following table sets forth the estimated amounts
of the current distribution, paid June 30, 2020, and the cumulative distributions paid this fiscal year-to-date from the following
sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital
or other capital source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current<BR> Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage<BR> Breakdown<BR> of Current<BR> Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Cumulative<BR> Distributions for the<BR> Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<BR> Breakdown of the<BR> Total Cumulative<BR> Distributions for the<BR> Fiscal Year to Date<SUP>1</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left">Net Investment Income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized ST Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.2118</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.2118</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized LT Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.1282</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.8482</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">Return of Capital or Other Capital Source</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">TOTAL (per common share):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.3400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.0600</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">The table below includes information relating to the
Fund&rsquo;s performance based on its NAV for certain periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">Average annual total return at NAV for the period from April 30, 2015 through April 30, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">3.40</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Annualized current distribution rate expressed as a percentage of NAV as of April 30, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.02</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through April 30, 2020<SUP>2</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">23.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of April 30, 2020<SUP>1</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5.47</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">You should not draw any conclusions about the Fund&rsquo;s
investment performance from the amount of this distribution or from the terms of the Fund&rsquo;s managed distribution policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt">The composition of this and subsequent distribution may vary
from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate
of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $163,698,946, of which
$144,824,655 represents net unrealized appreciation of portfolio securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 1pt">The amounts and sources of distributions reported
in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of
the amounts for tax reporting purposes will depend upon the Fund&rsquo;s investment experience during the remainder of its fiscal
year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that
will tell you how to report these distributions for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-size: 10pt"><SUP>1</SUP> The Fund&rsquo;s
current fiscal year began on October 1, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 5pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><SUP>2
</SUP>Cumulative total return at NAV is the percentage change in the Fund&rsquo;s NAV and includes all distributions and assumes
the reinvestment of those distributions for the period of September 30, 2019 through April 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Tekla Life Sciences Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 87911K100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">www.teklacap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Tekla Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">100 Federal Street, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 470pt 0pt 1pt">617-772-8500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 470pt 0pt 1pt">Fax: 617-772-8577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><FONT STYLE="font-size: 18pt">T</FONT><FONT STYLE="font-size: 14pt">EKLA
</FONT><FONT STYLE="font-size: 18pt">L</FONT><FONT STYLE="font-size: 14pt">IFE </FONT><FONT STYLE="font-size: 18pt">S</FONT><FONT STYLE="font-size: 14pt">CIENCES
</FONT><FONT STYLE="font-size: 18pt">I</FONT><FONT STYLE="font-size: 14pt">NVESTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B>Notification of Sources of Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Distribution Paid Date: September 30, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Distribution Amount Per Common Share: $0.41</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The following table sets forth the estimated amounts
of the current distribution, paid September 30, 2020, and the cumulative distributions paid this fiscal year-to-date from the following
sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital
or other capital source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom"><TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current<BR> Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage<BR> Breakdown<BR> of Current<BR> Distribution</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total
    Cumulative<BR> Distributions for the<BR> Fiscal Year to Date<SUP>1</SUP></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage<BR>
    Breakdown of the<BR> Total Cumulative<BR> Distributions for the<BR> Fiscal Year to Date<SUP>1</SUP></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left">Net Investment Income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized ST Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.2118</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized LT Cap Gains</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.4100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2582</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">86</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Return of Capital or Other Capital Source</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">TOTAL (per common share):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.4700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">The table below includes information relating to the
Fund&rsquo;s performance based on its NAV for certain periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">Average annual total return at NAV for the period from July 31, 2015 through July 31, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">2.16</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Annualized current distribution rate expressed as a percentage of NAV as of July 31, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8.01</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through July 31, 2020<SUP>2</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">32.41</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of July 31, 2020<SUP>1</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.18</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">You should not draw any conclusions about the Fund&rsquo;s
investment performance from the amount of this distribution or from the terms of the Fund&rsquo;s managed distribution policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt">The composition of this and subsequent distribution may vary
from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate
of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $152,963,475, of which
$119,328,491 represents net unrealized appreciation of portfolio securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 1pt">The amounts and sources of distributions reported
in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of
the amounts for tax reporting purposes will depend upon the Fund&rsquo;s investment experience during the remainder of its fiscal
year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that
will tell you how to report these distributions for federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-size: 10pt"><SUP>1</SUP> The Fund&rsquo;s
current fiscal year began on October 1, 2019.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt; text-indent: -3.95pt"><FONT STYLE="font-size: 10pt"><SUP>2
</SUP>Cumulative total return at NAV is the percentage change in the Fund&rsquo;s NAV and includes all distributions and assumes
the reinvestment of those distributions for the period of September 30, 2019 through July 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Tekla Life Sciences Investors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP: 87911K100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">www.teklacap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Tekla Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">100 Federal Street, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt">Boston, Massachusetts 02110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 470pt 0pt 1pt">617-772-8500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 470pt 0pt 1pt">Fax: 617-772-8577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>5
<FILENAME>tm2030671d1_ex99-906cert.htm
<DESCRIPTION>EXHIBIT 99.906 CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&nbsp;99.906CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;5: CERTIFICATION PURSUANT
TO SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26pt">Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002, each of the undersigned officers of TEKLA LIFE SCIENCES INVESTORS, do hereby certify, to such officer&#8217;s knowledge,
that the report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS for the period ended September&nbsp;30, 2020 fully complies
with the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934, as applicable, and information
contained in the Form&nbsp;N-CSR fairly presents, in all material respects, the financial condition and results of operations of
TEKLA LIFE SCIENCES INVESTORS for the stated period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/4/20</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Daniel R. Omstead</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Daniel R. Omstead</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Laura Woodward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: President</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Treasurer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section&nbsp;906
has been provided to TEKLA LIFE SCIENCES INVESTORS and will be retained by TEKLA LIFE SCIENCES INVESTORS and furnished to the SEC
or its staff upon request. This statement accompanies this report on Form&nbsp;N-CSR pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j20306712_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_aa001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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M4M(*P*:(0C'8*9C*9 A-@";-9K_H+J:HT)N)D_&-GACI_2,,[4KPX ]5]?S
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M&R\@KI_A%3;KK.A(<V95_<K*7OFJH?C'44:/J.B@FBC9/*(F#:S[OG\5/SZ
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IJM]2?I*?O6N?'U?45_YO=_\ O..K5/=>AAU[W[KW7O?NO=>]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j20306712_aa002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_aa002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 8P!E P$1  (1 0,1 ?_$ :(    & @,!
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MKU$LT6-PE=%)D59/N:NKH:UJ=M4I\ST=P[S:712*Z>&QV4J=$7B".9B#2CH
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M3-9W*S1QRR18O!86AJ*NH*(\ABA*HKN54Z)H*GI=MFWW&ZWT>WVH!FD:@KP
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M/15HJ:^.685<K-,R03.T,6@<9_R=&FY[?.;^=+"-OIQ,X5BMX6PQ#$D:U)U
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D?JO'^LX^7C=M?])CC\^MC/VWU*'7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j20306712_aa003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_aa003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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MD3#/D:54_:& (^8ZTL/YGG_=//\ \9>_$S_Y?_;R^?V]0/S;_P LS_I46_\
MS_U5[[MT$>C&]9?)?<W7N$IMJY[874G=6T,4E9_=G;/=NRO[XTNS9J^:HJJN
M3:&7H,G@-U8"BJJ^I>IGQT.0&)J:IC--2R2DL=$5Z-+3=9;:,0R1PW$ KI65
M-6FO'200P%<E0VDG)!/1Z_Y:O:\G</R;[;Z'[:K\?'M#YS]8;TZIW#3TU#0X
MC;N W;08&MS75>3P.$HDIL;B3LV7%/B\!2T\8AH_NXHHD4*FFK"@J/+H1<JW
MAOMVFVZ](\#<(6C; "A@"8R ,#332@&!4 =;'G^S/;^_X:S_ -+?DJ/]//\
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M<DS4X1!35OD:G#/'H<BM\T6S?326UO(HEEEFF,DG@)4LQ% (ZTQVKJQY-7I
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ML*E"CTTT=+M_*]8Y/R12+<.F7@T?72QM;=1Z]%-ML6\1S!I["[,8_P"$2G_
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..^ZWU[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j20306712_ba004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ PP&) P$1  (1 0,1 ?_$ :(    & @,!
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MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
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MYC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\
MJ_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z
M]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U
M,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_
M\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[Y
MC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^
MKUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]
M_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\
M<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[
MYC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\
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M #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\
M.G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z
M=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IV
MG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?
M_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__
M &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\
M91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E
M'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>
M_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]
M0>O7NI/\4KO^><S/_4_;W_U^]^IUKKGF\!@MS8Z;#[DPN)W!B*EHGJ,7F\=1
MY7'3O3RI/ TU#7PSTTK0SQJZ%E)5U!%B/>NM]8\?MS!8JOR&5Q^)H:7*Y9:>
M/)9-($.1K8*/R?8TE17.&JI*''K,RTT!?PTZ,5C55-O?NO=%:_E[?]D"_![_
M ,5 ^-/_ +YC97OW7NC?^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND;1]B]?9'
M?&8ZQQ^^]FUW9.W<+0;DW!U[1[GPE5OC!;=RLO@QF>S&TX*Y\]C,+DICH@JI
MZ=()FX1B??NO=%R_E[?]D"_![_Q4#XT_^^8V5[]U[HW_ +]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z+_MKK'(X3O7<78>#K-\8':N>VWN"CWIMG.[YR>Y=J[WW
MQ7979<NU-[[8VMD=P;CHMBR;4V]@<ICYOL(\*,E'E(EJ::H%%224_NO=%I^&
M6].NNN?@-\$ZSL;N+"=<T^;^)'QU&)_OAO7:>TZ2NDINF-C2U5-BFW!]G]W]
MDE3'K5&D:-775]038 G@*]);F\L[, W<L<0;AK<+6G&FHBM/ET/7^S%?&;_O
M++J?_P!'3U=_]</>]#_PG]AZ2_OK9O\ E+MO^<J?]!=.^![JZ$W5F,?M[;'R
M7Z^W'G\M4"DQ6#P/:_768S&3JF5F6FQ^,Q]345M94,JDA(T9B >/?BK#)!I]
MG3D6Z[5/((H;FW>5C0!9$))^0#5/0C[@J,#M*@&4W5V)-MG&-41TBY'<&?P.
M&H&JIED>*F%9D:6FIS42I$Q5-6I@I('!]U%3P'2N6:&!=<[JB5I5B *_:3TB
M?]*737_>0>S_ /T96Q/^OOO>EO3I-^\=N_Y2(?\ G(O^?K+!V7U#53PTU-W[
MM6HJ:B6."GIX.QMC33SSS.(XH88HW:26661@JJH)8FPY]^HWIUL;AM[&@GA)
M/]-?\_0F_P  F_YZ/<7_ )TT'_UM]ZKTLIU[^ 3?\]'N+_SIH/\ ZV^_5Z]3
MKW\ F_YZ/<7_ )TT'_UM]^KUZG3)N5\7L_;F?W;N3>6>Q6W=K83*[CS^3EFI
MY8L=A<)0SY/*5\L5-B)ZF6.CH:621EC1W8+95)L/?ADT STW-+';PO/,=,2*
M68YP *DX] .J_?\ AU+^7?\ ]Y@0_P#H/[X_^UU[=\&3^'_5^WH+?UZY2_Y3
M4_WF3_H#KW_#J7\N_P#[S A_]!_?'_VNO?O!D_A_U?MZ]_7KE+_E-3_>9/\
MH#H[_5V\=D=T["V[V?UAV+F=V[#W;35-9MW<5'_D=-DZ:CR%7BZF6*FRF"H:
M^(15]#+&1)$A)0D @@EL@J:$9Z$EE>6NXVJ7MD_B6T@JK"HK0D>=#Q!\NJ =
MZ_S_ /:>S=Y;MVA+\?NR*^3:NYL]MN2NC[>VW3I6O@\K58QZM(&ZTE:!*EJ7
M6$+,5!M<VO[4"WJ*U'[/]GJ+;CW6M[>XDMS9.2CLM?%&=)(K\'RZ3/\ T$1[
M0_[QS[+_ /1R;:_^UA[W]-\Q^S_9Z9_UW+;_ )09/^<H_P"@.KD/@?\ *>C^
M<G2-7W1BL-O#KJEI=\Y[9)V_D-T8C<D[RX+'X/(/D!D*;;&'C6.I&;"B/PW4
MQDZC>P8D3PVT\>I Y9W].9-M.XI$8E$K)I+:OA -:T'KZ=$"^1G\Z[J_XY]X
M=E='YKJWN3<>5ZUW)/MNNSF+W9LRDQ^3G@IZ>H-324U7B34PQ,*@ !S>X]N+
M 64-49Z"^[>Y-CM.Y3;;);3.\+Z20R@'[*] I_T$,=.?\^2[S_\ 0UV)_P#6
MCW;Z8^HZ+O\ 7:V[_E$G_P![7JR_X!?.O:GS\Q'9N7VAM_LCK^/K/);7QM=#
MN3/;;R;Y-]STN;JH)*1L9BE6%*5<(P</RQ<6^A]M21^'2M#7H8<K\U6_-$<T
MEO$\0A*@ZB#74"<4]*=#_P!E_)WXR=-;HEV3VO\ )_9O7N[H**CR,VV]V[ZV
MQA<Q%09!&DH:MZ&MIHIUIZI$)C:UF X]U"L14"HZ-+S?=EV^;Z:^NH8IP =+
M. :'@:$^?2 _V?+X-_\ >:_4_P#Z-'9O_7KWO0_\)_9TE_K7RS_RG6W_ #D7
M_/T*75'R#^/7>N9R.WNF_D=MGLW.XC&'-93$[+WIMO/5]!B154]"<C54U!2R
MR0T@K*N*+60%UR*/J?=2K+EA3I;8[SM.YR&+;[F*:55J0C!B!6E33RJ>AY_@
M$W_/1[B_\Z:#_P"MOO5>C.G7OX!-_P ]'N+_ ,Z:#_ZV^_5Z]3KW\ F_YZ/<
M7_G30?\ UM]^KUZG7OX!-_ST>XO_ #IH/_K;[]7KU.O?P";_ )Z/<7_G30?_
M %M]^KUZG7OX!-_ST>XO_.F@_P#K;[]7KU.@O[B[(ZWZ V%E.S^X.S\OLG8>
M%J<91Y/<5<LM=34E3F<A3XO&1/38;;^2KW-57U4<8*Q, 6NQ N?>U!8T49Z1
M[AN%EM=JU[?R".V4@%C4TJ:#@"<D^G1,O^'4OY=__>8$/_H/[X_^UU[<\&3^
M'_5^WH/?UZY2_P"4U/\ >9/^@.O?\.I?R[_^\P(?_0?WQ_\ :Z]^\&3^'_5^
MWKW]>N4O^4U/]YD_Z ZL=_@$W_/1[B_\Z:#_ .MOMJO0MIU[^ 3?\]'N+_SI
MH/\ ZV^_5Z]3KW\ F_YZ/<7_ )TT'_UM]^KUZG6*?#_:P35-3NG.T]-3Q23U
M%1/6XV&"""%#)+--+)CECBBBC4LS,0% N??J]>)"C4QH!T6'_9POAC_WG%\?
M_P#THGIC_P"O?NVA_P"$_L/1+_6/EW_E/LO^<\?_ $%U[_9POAC_ -YQ?'__
M -*)Z8_^O?OVA_X3^P]>_K'R[_RGV7_.>/\ Z"Z'78^X-E=G;<I-X=;=LT?8
M6TLA+5P4&Z=C[MVONS;E;/05,E'70TF;P,5?C*F6BK(7BE5)6,<B%6LP(]U-
M0:$4/1G;75K>0BXLY$E@-:,C!E-,&A4D8.#GI!97O7X]8+*9+!YSY0=;8;-8
M:OK,5E\1E>W>ML=E,5E,=424F0QN2Q]75PU=#7T-7"\4T,J+)%(I5@""/=M+
M'(4_LZ3/N^TQ.8Y+JW6120094!!&"""U00<$'J!_LQ7QF_[RRZG_ /1T]7?_
M %P]^T/_  G]AZI^^MF_Y2[;_G*G_070D;+W+L7LB@JLKUWV[0;]Q=#5G'UV
M2V7O#:NZ:"CKQ#%4FBJJS!QUU/3U8IYTD\3L'T.K6L0?>B".(ITLM[JUNU+V
MDL<J T)1@P!]"03GI9?P";_GH]Q?^=-!_P#6WWJO3].O?P";_GH]Q?\ G30?
M_6WWZO7J=>_@$W_/1[B_\Z:#_P"MOOU>O4Z]_ )O^>CW%_YTT'_UM]^KUZG7
MOX!-_P ]'N+_ ,Z:#_ZV^_5Z]3KW\ F_YZ/<7_G30?\ UM]^KUZG4G^$2_\
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M'01WCVT@W?<YMR:[=&F?5I$8-/E76*_LZ W_ *!S_F+_ ,_\^-'_ )P=I?\
MUB]V^I/IT6?ZT=O_ ,IS_P#.(?\ 0?5H?\O#X!?.+^7]ANTL/A]P?%+LY>SL
MGM7)3SY+</;NUVQ#;7I<[2QQ0QTNPLV*P5@S9)+&/1XP #?AJ20R4Q2G0TY4
MY4CY6CGCCG,WC,IRH6FD$>3&M:]%Z^</\H/YK?-7OC(=Y93L;XM]?U=?MG;F
MVVV[05W;.X:>)-NTTU.E6,E4;0Q,C/5"6Y3P@);ZGW:.8HNFE>BKF3D"'F+<
MSN3W31,45=(0-\/G74./V=%!_P"@<_YB_P#/_/C1_P"<':7_ -8O=_J3Z=$'
M^M';_P#*<_\ SB'_ $'T??\ E]_RN?FW\".R]Z=CXC>OQ8[+GWCL9MDRXK)9
M;MO;,5!$V?P^=_B$=72[*S3U$@?$"/QF-!9RVKBQ;DF,@I2G0HY5Y(BY8O)+
MM+AIC)%HH4"T[@U:ZCZ=.?\ ,)_EE_-SY^;RZ\W?E]X?%;K.78&V<IMN&AQN
M9[;W.F33)Y5<HU7)/5;(PK4KPLN@(%<$<W'T]^CE,8(I7J_-?)<7-%Q%<27#
M0F)"M @:M36OQ"G5>O\ T#G_ #%_Y_Y\:/\ S@[2_P#K%[<^I/IT%/\ 6CM_
M^4Y_^<0_Z#Z,Q\//Y+_S2^(WR-ZZ^0V.[1^+V^*SK[^]WAVO6U':^"I<I_>O
M8NY]D2>7*P;3R<M+]E%N5JA;0/K:$(=(;4*/.74K3CT<[![=0[#N\6ZI=M*T
M6KM,86NI&3CK-*:J\/+JS3Y.=4?S3>[MI8#;_5/;/QQ^-F9Q.XAF,CNK96[>
MV-P5^=Q@QE?1';]539'K?&Q0T9JJJ.IUJ[-K@46L20TC!34BO0QWG;KW<H$B
ML;N2SD5ZED4,6%"-)!(Q4U_+HDW^R'_SQ?\ O9+UU_M^P/\ [$/;GB)_ .@Y
M_5;F'_H^77_.-?\ H+I7; ^%_P#.LVEOS9.ZMQ_/KJO?FWML[NVWN#/;'RM5
MV+18O>6&PV9HLCE-J9*L@V7//24&XJ&F>CFE1':..8L%)%O>C(A% HKTHM>6
M]]@NHYYMXN)8DD5F0QJ X!!*DZL!A@GY]&5^:7QN^=GS'^/NZN@\F/B7L.CW
M1D]K9*3<M#O+N+/U-&VV=PX[<$<28RHZWQ44PK'QXB),RZ VJQM8U1M#:NCC
MF+95Y@VI]K>0Q*[*=0&JFE@W"HXTIQZI)_Z!S_F+_P _\^-'_G!VE_\ 6+V_
M]2?3J./]:.W_ .4Y_P#G$/\ H/KW_0.?\Q?^?^?&C_S@[2_^L7OWU)].O?ZT
M=O\ \IS_ /.(?]!];$7:N!_F+]@=;;XV1MF7XL=:[AW5MG+8+#=@;=[([JDS
MNSLCD:22GI=PXA$ZRH&>OQDKB6,">(ZE'J'U]I@:&ISU+%];RW5G);0R-#*Z
M%0Z_$A(PPR,CCQ'55'_#<'\Z_P#[V88+_P!#GO7_ .M_M[Q4_@'0(_J?OO\
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MO_00W9_]9/?J'KW7O[T8W_E6W%_Z"&[/_K)[]0]>Z]_>C&_\JVXO_00W9_\
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M[^]&-_Y5MQ?^@ANS_P"LGOU#U[K3A_FJ_#SY5]R?/;OCLCJ[X[=R;WV+N/\
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MRO\ \>3K=6]HNLB.O>_=>Z][]U[HH'\O;_L@7X/?^*@?&G_WS&RO?NO=&_\
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MW\*S?_/4UG_GKP__ -2>_=>SU[^%9O\ YZFL_P#/7A__ *D]^Z]GKW\*S?\
MSU-9_P">O#__ %)[]U[/7OX5F_\ GJ:S_P ]>'_^I/?NO9Z]_"LW_P ]36?^
M>O#_ /U)[]U[/7OX5F_^>IK/_/7A_P#ZD]^Z]GKW\*S?_/4UG_GKP_\ ]2>_
M=>SU[^%9O_GJ:S_SUX?_ .I/?NO9Z]_"LW_SU-9_YZ\/_P#4GOW7L]>_A6;_
M .>IK/\ SUX?_P"I/?NO9Z]_"LW_ ,]36?\ GKP__P!2>_=>SU[^%9O_ )ZF
ML_\ /7A__J3W[KV>O?PK-_\ /4UG_GKP_P#]2>_=>SU[^%9O_GJ:S_SUX?\
M^I/?NO9Z]_"LW_SU-9_YZ\/_ /4GOW7L]>_A6;_YZFL_\]>'_P#J3W[KV>O?
MPK-_\]36?^>O#_\ U)[]U[/7OX5F_P#GJ:S_ ,]>'_\ J3W[KV>O?PK-_P#/
M4UG_ )Z\/_\ 4GOW7L]>_A6;_P">IK/_ #UX?_ZD]^Z]GKW\*S?_ #U-9_YZ
M\/\ _4GOW7L]>_A6;_YZFL_\]>'_ /J3W[KV>O?PK-_\]36?^>O#_P#U)[]U
M[/7OX5F_^>IK/_/7A_\ ZD]^Z]GKW\*S?_/4UG_GKP__ -2>_=>SU[^%9O\
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MVW\]L-0U&3S'RO\ A/BL;2*KU60R7P<[FH:&F1Y$B1JBKJOYCD4$*M*ZJ"S
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M2IHZZAK*;^8Y+3U='5T\JR12QLR2(P9200??NO9ZT]_^@G;^9/\ \^^^#O\
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MS*;GEJZVDW%+6Q54]9%%4UD DFU"HF=I'/NO=!M\:?\ F<_\PG_Q;_97_P
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M>]^Z]U[W[KW0<8O_ )F[OC_F7'_,N.J_^+7_ ,S=_P"/G[C_ ./X_P"_<?\
M/*_]7/\ O#[]U[H1_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0;T'_,WMV?\
M,M_^9;]>_P# #_F;W_'S]G?\?9_W[?\ YY[_ *N?\:]^Z]TH-Y?\>[6?\>O_
M ,",5_Q^7_'N_P#%WH?^!G_31_RJ_P#37XO?NO=*CW[KW7O?NO=>]^Z]U[W[
5KW7O?NO=>]^Z]U[W[KW7O?NO=?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>j20306712_ba005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ PP&) P$1  (1 0,1 ?_$ :(    & @,!
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MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
M/W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_
M8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;
MB/\ S]UG_P!C_OV.O=>\V>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V
M/^_8Z]U[S9[_ )UN(_\ /W6?_8_[]CKW7O-GO^=;B/\ S]UG_P!C_OV.O=>\
MV>_YUN(_\_=9_P#8_P"_8Z]U[S9[_G6XC_S]UG_V/^_8Z]U[S9[_ )UN(_\
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MF.Y6..M2- 6/ 4 #Z 6][KUJ@Z-W_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\
M'"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_
M #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J
M_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KU
MZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=
M3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*
MS_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^
M8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^K
MUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#
MKW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\
M'"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_
M #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J
M_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KU
MZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=
M3"?\<*S_ ,^^8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*
MS_S[YC_ZO]^KUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^
M8_\ J_WZO7J#KW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^K
MUZ@Z]_=3"?\ '"L_\^^8_P#J_P!^KUZ@Z]_=3"?\<*S_ ,^^8_\ J_WZO7J#
MKW]U,)_QPK/_ #[YC_ZO]^KUZ@Z]_=3"?\<*S_S[YC_ZO]^KUZ@Z]_=3"?\
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MVLZ@KJY;^0__ -O =N_^(N[+_P#=91^V;C^S_/J0?;+_ )6E/^:,G^ =;O\
M[0=9']>]^Z]TC:/L7K[([XS'6./WWLVN[)V[A:#<FX.O:/<^$JM\8+;N5E\&
M,SV8VG!7/GL9A<E,=$%5/3I!,W",3[]U[HN7\O;_ +(%^#W_ (J!\:?_ 'S&
MRO?NO=&_]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]UKB_\ "C?_ )DK\</_ !*.Z_\ WDXO:FVXG[.HD]VO^2=:?\UF
M_P".]:DGM9U!75RW\A__ +> [=_\1=V7_P"ZRC]LW']G^?4@^V7_ "M*?\T9
M/\ ZW?\ V@ZR/Z][]U[HO^VNL<CA.]=Q=AX.LWQ@=JY[;>X*/>FV<[OG)[EV
MKO??%=E=ER[4WOMC:V1W!N.BV+)M3;V!RF/F^PCPHR4>4B6IIJ@45))3^Z]T
M67X9[YZUZX^!?P0E['[FP'7 W!\1/CS)A8=X[XVCM*')"@Z:V"V0CPZ[A-&U
M='C/XA )1&9#")H]9&M;V )X"O26YO;*SI]7-%%JK36ZK6E*TU$5I45IPJ.A
M^_V8KXS?]Y9=3_\ HZ>KO_KA[WH?^$_L/27]];-_REVW_.5/^@NE=LSLKJ+L
M?*3X/KSOW:N_,U2T$N5JL1LSL78^Z,I38N"HI:2;)3X_!O75<-!#5UT$33,@
MC629%)NZ@Z(89(IT_;[AM]VYCM)X99 *D(ZL:8%: DTJ0*_,=/VY-P;)V=/3
M4V[^V:/:M36Q//1T^Y-V[7P<]7!&_CDFIHLG%2R3Q))Z2R@@'CWH G@.G9KJ
MUMR%GD1">&I@*_M(Z3?^E+IK_O(/9_\ Z,K8G_7WWO2WITS^\=N_Y2(?^<B_
MY^E)MO<&R=XSU--M#MFCW54T423UE/MO=NU\Y/202/XXYJF+&154D$3R>D,P
M )X]Z((XCIZ&ZM;@E8)$<CCI8&G[">E=_ )O^>CW%_YTT'_UM]^KT_3KW\ F
M_P">CW%_YTT'_P!;??J]>IU[^ 3?\]'N+_SIH/\ ZV^_5Z]3HG?=/S?^(WQW
MWQ4=;=S_ "/FV+O>EQN.R\^ K\9N*OJ(\=E8WEQ]4:C"[*R="4J8T) $I86Y
M ]W6-V%5&.B#<>:-@VFY-GN%RL5R #I(<X/ X4C^?03?\.I?R[_^\P(?_0?W
MQ_\ :Z]V\&3^'_5^WI#_ %ZY2_Y34_WF3_H#HT'0?R"Z+^4.(S^>Z&[HR'8N
M(VMDJ;$9^MQM-D,:F.R-92FLIJ61,_M?$S2O+3*7!C5U ^I!X]T963XA3HZV
MO>=KWJ-I=LF$L:&C$!A0D5IW =59?,/^<EMWXC?(WL7X\Y'I_L'?%9U]_='S
M;HHNS=OX*FRG]Z]B[8WO'XL5/U_E):7[*+<JT[7G?6T)<:0VD.I#K4-7CT"M
M_P#<2#8=VEVI[5Y&BT]PD"@ZD5^&DTIJIQ\NBS_]!$>T/^\<^R__ $<FVO\
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M\?\ VNO;O@R?P_ZOV]!3^O7*7_*:G^\R?] =>_X=2_EW_P#>8$/_ *#^^/\
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M.-HSI#30SII;\^GVS/\ V?Y]2#[9_P#*TI_S1D_P#K=P_A$O_.ZS/_4^D_\
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M%'4U6*P="\@QN$HZV;&TK57VL,4M<]) ]4\SPQLONO=%D_E[?]D"_![_ ,5
M^-/_ +YC97OW7NC?^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>ZH7_P"%$/\ V17UA_XM'LK_ -]/W9[46WQG[/\ -U&/NO\ \J[#_P ]J?\
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M\]>'_P#J3W[KV>O?PK-_\]36?^>O#_\ U)[]U[/7OX5F_P#GJ:S_ ,]>'_\
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M-9_YZ\/_ /4GOW7L]>_A6;_YZFL_\]>'_P#J3W[KV>O?PK-_\]36?^>O#_\
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M ,]1MW_S]XW_ .J??J'T/7NO?WOVG_SU&W?_ #]XW_ZI]^H?0]>Z]_>_:?\
MSU&W?_/WC?\ ZI]^H?0]>Z]_>_:?_/4;=_\ /WC?_JGWZA]#U[KW][]I_P#/
M4;=_\_>-_P#JGWZA]#U[KW][]I_\]1MW_P _>-_^J??J'T/7NO?WOVG_ ,]1
MMW_S]XW_ .J??J'T/7NO?WOVG_SU&W?_ #]XW_ZI]^H?0]>Z]_>_:?\ SU&W
M?_/WC?\ ZI]^H?0]>Z]_>_:?_/4;=_\ /WC?_JGWZA]#U[KW][]I_P#/4;=_
M\_>-_P#JGWZA]#U[KW][]I_\]1MW_P _>-_^J??J'T/7NO?WOVG_ ,]1MW_S
M]XW_ .J??J'T/7NO?WOVG_SU&W?_ #]XW_ZI]^H?0]>Z]_>_:?\ SU&W?_/W
MC?\ ZI]^H?0]>Z]_>_:?_/4;=_\ /WC?_JGWZA]#U[KW][]I_P#/4;=_\_>-
M_P#JGWZA]#U[KW][]I_\]1MW_P _>-_^J??J'T/7NO?WOVG_ ,]1MW_S]XW_
M .J??J'T/7NO?WOVG_SU&W?_ #]XW_ZI]^H?0]>Z]_>_:?\ SU&W?_/WC?\
MZI]^H?0]>Z]_>_:?_/4;=_\ /WC?_JGWZA]#U[KW][]I_P#/4;=_\_>-_P#J
MGWZA]#U[KW][]I_\]1MW_P _>-_^J??J'T/7NJ)/^%"6=P>4^&'65/C<SBLC
M.GR>V7,\-#D:2KF6%>J>Z4:5HZ>:1UC5Y%!8BP+ ?D>W[<$.:^G^;J,?=?\
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M7O?NO=4+_P#"B'_LBOK#_P 6CV5_[Z?NSVHMOC/V?YNHQ]U_^5=A_P">U/\
MJU-UII>UO6/O5HO\E[_MY9\;?_*Q?^^#[3]M3_V1_+_#T-/;W_E<+/\ YN_]
M6).M]#V7]9.=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10/Y>W_9 OP>_P#%0/C3
M_P"^8V5[]U[HW_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ
M[/YF?PJW1\[>A]I=1;2WM@-AY';G;F!['GR^XL?D<E15-%B-F[]VS)C8H,8R
MSI533[OCE5SZ D+ \D>W8G$;5/IT$^<>79N9MLCL()%B=)UDJP)% CK3'GWU
M_+JC;_H'([K_ .\C^K?_ $%=V?\ 7SV_]2OH>HV_UI=Q_P"4N#_>6Z-O\%/Y
M*W:'Q)^5/5OR#W%W7L+=V&Z__OO]YM["[?W#0Y/(?WKZYW?LFG^VJJYS2Q?:
M56Y$G?5^J.)@.2/=))U="H!ST>\M>W=[L6]P;K+<Q21Q:ZJ%8$ZHV3B<8+5Z
MV)?:;J6.O>_=>Z][]U[KWOW7NBG_ "3S>^:S8>^-J8?=&W^C\GEI*?!=9=E[
M@W-F)ZS=.<EVOG]PY3%[5VML7*8?=DF[*>@P56N/A6:M=9$%><9E8J67%57N
MO=,/4\'9<_R(S6[=RY%<IBM^=2Q9'<6T:/>G8U33?'K=N%JMAQ8OJS)[7_TE
M;HZ1W!FMQPYK,5#Y_%[?VWF@^$E$S5U+6PBB]U[HOWQ(ZR^<N"^*7QDPFSOD
MI\4,?M##?'OI?%;5H-S?"OM_<>Y*+;>.ZWVW28.DW!N'%_/C:6,SV;IL9#$E
M76TV*QD%5.KRQTE.C"%/=>ST,>$IOFYN:HR%)MOYC_!/<%5B5I7RE-A/A9VW
ME:C&I7/61439"&@_F15$E&M9)CZA8C(%$C02!;E&M[K6>H>?I/GYC=BYS?.)
M^4/PKSE!C=JY7=&-DIO@WW8:',4M!BJC*4CTM?#_ #%IXY*'(QPJ8JB,21O&
MX=-2D$^ZWGIIZB/\PWL_J?K#LN;Y&_#'#3=A]>;*WS+B(O@WW?6QXJ3=NV\9
MGWQL=:W\Q*E:K2A;(&(2F*,R!=6E;V'NO9Z<J2N^8]?A\SN&A^;7P#K<!MRE
M:NW#G*3X<=I5.'P5$M*U<U9F<E#_ #)GHL72K1(TQDG=$$0+WTB_OW6L](SY
M%YW^8?T3\?.]N[Z;Y"?##<M1TWTWV?VK3[<G^$'>&+AS\W7FR<YNZ+"S9./^
M8=728Z+*R8@0-.L$QA$FL(]M)]UO/0OU&T/Y@%'3SU=7\IOA?2TM+#+45-34
M?!;NJ"GIZ>!&EFGGFE_F-+'###&I9F8A54$DV]^ZUGI(C(?,0X7(;D'S<^ )
MV[B:PX[*Y\?#KM$X7&9 4E/7FAR&5_X<G^QHZP4-9%-XI)%?Q2H]M+ GW7L]
M(KO_ ''_ #"NEND.P>X<?\B?A9NK^Y6V7W%28D_"/NZ@I<P@EIDCC&3@_F'U
M_AAE2HU"18I 1:P-_?NMYZ%^NVK\^\915F2R7RK^%>/QV/I:BNKZ^N^#/=%)
M14-%21/45596551_,;C@IJ6F@C9Y)'941%)) 'OW6L])G[OYE#"/N4_-?X"_
MW<CK),=)G_\ 9-^U/X(F0A5GFH7RO_#DWV*UD2H2T1DUJ ;CCW[KV>D5WMG?
MYA_3>R<'NZG^0GPPS\F7[D^.G534,WP@[PQR00][?(/K#I"IS0J$_F'5ADEV
MU3]AOD4@T 53THA+Q"0RI[K>>A7R6V_GMAJ&HR>8^5_PGQ6-I%5ZK(9+X.=S
M4-#3(\B1(U15U7\QR*"%6E=5!9@"Q ^I]^ZUGIMI*/YP5^&@W%C_ )A?!G(X
M"JK%QU+FL?\ ";N"NQ=7D7R_]WH\=25U)_,?FIJK(2Y__($@C9I6K?V IE]'
MOW7L]!UW5GOYA_4N-Z^KX/D)\,,X=[]R]5]4R12_"#O"@&.@['W91;:ES:.G
M\PZK^YEQ*5?F6 A!,5TETOJ]^ZWGH4\O@/GCM_'SY;/?+3X1X3%4S4Z5.3R_
MP?[DQN/IWJZF&CI5GK*S^8]#31-4U=1'%&&8%Y'51=B ?=:SU!IJ3YO5L. J
M*/YB_!6KI]UU$])M:>F^%7;D\.Y:JFH,AE:FFP$L7\R%TS%13XS$U52Z4YD9
M(*:60@)&Y'NO9Z#KL_._S#^O-[?'3:,7R$^&&5C[V[DSG55372?"#O"D?;4.
M(^/G>W=ZYJ"G7^8=4#*2SU'3<>.,#/ %3(--K)A$4GNMYZ$_,X;YV;<HQD-P
M_+GX/X&@:9*<5V9^$7<6+HS42*[1P"IKOYC\$)FD6-BJZM1"FPX/OW6L]-H_
MV=1I-N0K\SO@:TV\:>"KVC$/ACVP9-TTM52M74U3MQ!_,DU9NGJ*%#,CTPE5
MX@7!*B_OW7L](+?V>_F'[*[0Z'Z[C^0GPPR$7<VXM]8*HRK_  @[PII-OKL[
MKG<&^XZF&C7^8=,N1:ODP8IBK20^-9"X+%=)]UO/0DY_'?.3:E''D=T_,#X,
M[:Q\U1]I#79_X3]O8>CEJC3U%6*:.IR/\R"FA>H-+22RZ Q;QQ.UK*2/=:SU
MQ^Q^</\ $,3B?]G"^"_\5S]+]]@L9_LE/;O\0S5$*:>L-9B:/_AR'[G)4OVE
M+++Y(5=/'&S7TJ2/=>ST'&<SO\P_$?(/K#I!?D)\,)Z?L/IOO;M67<9^$'>$
M<V*FZ;WM\=-HT^%CQ@_F'/'5Q9^/O:2=YS/&:8XU4"2><M%[K>>A#W%3?-S:
M%/'5[L^8_P $]KTLJU#Q5.XOA9VWA*>5*1%EJFCFR7\R*FC=::-PTA!(12";
M#W[K6>G:3:_SZAKJ3&2?*KX6IDJZGK*RCH#\%NZ_O*BCQST<>0K(J8?S&O,U
M'0S9"GCFEMXXY*B)&(:6,-[KV>@FJ<]_,/I_D)A>CQ\A/A@U-ENFMT=K-N/_
M &2#O 3P3[=WOM#:*X08S_APXQR154>Z#.9_."AA":#JU+[K>>A#SM-\W-KR
M4$.YOF/\$]NRY1I4QD6=^%G;>(DR+P2TD$RT"9#^9%3M6-#-7P(PC#%6FC!Y
M=;^ZUGIRBV[\\ZC)UV$@^67PEFS.,H\=D<EB(O@]W+)D\?C\Q+D8,375U G\
MQTU5)1Y2;#U:4TLB*D[4LP0L8WT^Z]GH*L'G?YA^7^0?9_2#?(3X804_7G3?
M1/:L6XQ\(.\))LK-W)O;Y%[1J,+)C#_,.2.DBP$?1,<Z3B>0U)R3(4C\ :7W
M6\]"'E:;YN8+(8_$YOYC_!/#97+34=/BL9E?A9VWC\ADZC(UJ8W'P8^BJ_YD
M4-36S5V1D6GA6-6:69@B@L0/?NM9ZS46.^<F2R^2V_COF!\&<AGL+'#-F,)1
M?"?MZJR^)BJ'EBIY<EC8/YD$E901SR0.J-*B!F1@+D'W[KV>@VVEGOYA^YNZ
MNY.I7^0GPPHX.J]N]3YV'.+\(.\)I<TW9=/O:::FEH#_ ##HDH5Q!VBH5A++
MYO.;A-'J]UO/0AUU-\W,7FJ';>3^8_P3QVXLFM.^-P-=\+.VZ3-9!*N6JAI6
MH<74?S(HZZK6IFH9DC,<;!VA<"Y1K>ZUGJ5C\1\Z<M797%XKY=_!W)Y+!20P
MYO'8_P"$G<-;78>6H>IC@BRM)3?S'Y*C'R3R44RHLRH6,3@7*M;W7L]!EUAG
M?YA_8>]OD7M&7Y"?##%1]$]R8/JJFKH_A!WA5ON6'+_'SHGN]LU/3M_,.IQB
MY8*CN23'"!7G#)CUFU@S&*/W6\]"'+3?-R#/T^U)OF/\$X=T5C,E)MN7X6=M
MQY^J=:"?*LM/AW_F1#(SLN,I9:DA8R1!&TGZ%)'NM9Z=J?:_SZK*BOI*3Y5?
M"VIJ,5414>3A@^"W=<KX^LGHZ;(Q4=8(_P"8TWVU8^/K8*CQ/:003Q2$:)$+
M>Z]GH)NHL]_,/[.R7<]!-\A/AAAQU1W+G.J8)8OA!WA6G-P8?:>RMRKFY4;^
M8=3?82SONUH3 #*%$ ;6=>E?=;ST(:4WS<DW!)M)/F/\$WW5"I>7;*?"SMMM
MP1(M)!7LTF&'\R(Y%%%!513DF,#PR*_Z6!/NM9Z<L9MWYYYNE:NPWRR^$N7H
MEK,ECFK,9\'NY:^E7(8;(U6'R]"U12_S'98168K+4$]+4Q7UP5,+Q.%=&4>Z
M]GH*NB<[_,/[DV3G-W5'R$^&& DQ'<GR+ZJ6AA^$'>&12>'HGY!]G](4V:-0
M_P#,.HS'+N6GZ\3(O!H(I7JC"'E$8E?W6\]+^!/FO4Y:NP--\S/@?49W%TM=
M79/"P?"_MF7+8ZBQDU-3Y*LKL='_ #(VK*2EQ]16PQSR2(J1/*BN064'W6L]
M3L'B/G3N>@&5VU\N_@[N'&&HJ:09'!_"3N'+4!JJ*9Z>LIA64'\Q^HI_N*2H
MC:.5-6J-P58 BWOW7L]!ET#GOYA_=?5^*[$J/D)\,-O2Y+<78>".*A^$'>&2
MCA78W8V[-B1U(K'_ )AU$SMDH]M"I9?&/$TQ0%@NIO=;STO:#_9U,K/FJ;%_
M,[X&Y*IVU&\VXZ>@^&/;%9/@(HYJVGDES45/_,DDDQ4<=1C*E&:<1@/3R*>8
MV ]UK/3MB,!\\=P8^#+8'Y:?"/-XJI:H2FR>(^#_ ')DL?4/25,U'5+!64?\
MQZ:FE:FJZ>2*0*Q*2(RFS @>Z]GK3]_Z"=OYD_\ S[[X._\ HF.^O_NL/?NM
M];[WOW7NO>_=>Z*'U!LNI[(^!75_7='N;,;*K-^_$/9.RZ7>6WG,>?VE4[IZ
M9QF#@W-@Y!+ 4S&!EKA54QUI::)?4/K[]U[H-<'L7LO??:VW:7-[6QO2-;T'
MU#NSJ#&_W:VUNC-=<=J8KL27H#<]37[+W%24^W\5MKJW$4O6M7@OX'/7KNB/
M(.9@M'2T%)59KW7NAJVWM7?.Q/A[0;'[,R.#S&_]F_'N3:N[,MMNKS&0PF4S
M6WM@RXBKR-!7Y^GH\U71US4?E::IABEED9F*+?2/=>Z0.R.MJWN3^75L/J;&
MY]=K9#LGX<[+V30[AEHI<G2XBKW+TYBL33UF1Q=/78NIRN)CEJA]Y2Q5=)+4
MTIDB2>%W$J>Z]T'>\>NNS_D)D^]9*_8U#U-O&/XT]N?&G"[4S1W/4;)W[F-Z
MY3&Y#;?8V8[2Q^R&V_G-D[,_A<<^T8J*CJ,UCHMQYO[VBH:QY*.+W7NAC^=M
M#FLU\"_F3C(,7)5[BRWQ$^0U##A<']WFI:G-5_36[Z>/%XC10TE=EI)JZ414
M]J:*6<E;1*S:![KW0K]_=:Y7MSJK/[&PF6H\1E*O*;,SU'_%H:FHV[G7V1OC
M;>^'V3O&FHW2KJMA]@Q;<;!9^*+5)+ALC5(JN2$/NO=%$K<3\D-][J[I[4Z[
MZYVWLCM#.;?Z\Z(_N)V;O'?/7-#CMM=7[\[NJ\YV_MSNG;_2G:."W%G-X[>[
M)5=GQ8W#U28:CJ&J\M,:R6; T7NO="#\L]I5V-^!?9>R,1MBAH*[$],XG;M%
MM#99R6;Q6,DQ--A:%<%MB2>@H\MD\3C5IO#222TL,\D$:L\:,2H]U[H=._.M
M\[VCL3'8/;62QM#FMO\ 974'95#29QJR/;VXWZH[2VCV1)M/.U&/AJJ['4.Y
MH=L-1I71059QM5+#6-25R0-15'NO=$RR?66].^L3WMN#-;"[3Z\S/>N+V7LB
MHZVPF6_N%!UWG>M=J=CT5%V#VANG+5.,V_VG_>C<&XZ7#YR+;M-NW;^:VO@,
M+0UE-F,2U933^Z]T/7S%Q6:K>D=A4$<=5G\K2_*G^7_69";'8Z3R5$.$^<OQ
MOR>=S!Q]+]R:.AI*"AGK)S=HZ6GC=V8(C,/=>Z$OO'KO<F^J?K+,;5J<;/EN
MJNUL'V@NT-P3U-+M?L"'%[>W7MIMMYZKI8*R2AFQ,FZTW!A:DT]1'2;EPF-G
MDC*1L5]U[HHV ZJ[I[/P>[>V-K31]4;P[,^1'2O=N8Z<[)P.^-NQ[)I^O:'X
MZ;=W+MS-[DQL5&NZM\3;:ZAS$%368NGK=K9$Y>*B@GJ(*5,Y5>Z]T-?S)_X]
MSH/_ ,7 ^+__ +]3#>_=>Z7/?VR]XYBHZG[*V/CH]V9OHC?&X^REZSFKH,2_
M94%=U#V7UT=O8+.5LL>)P&]*:;?*5>*J<B&QLTD$E'4/1K5C)T'NO= =UEU/
MO7,939':U#08O%_Q3Y6;T^0.YMD;EQ^^-@R=<;8WA\?MR].U.U-E8G<6QDR>
M7W!ELUE:?=.?:>'%8_([DR&6FCF.N-F]U[H1?D;C\A6]P_ >IHZ&LJZ?$?+/
M>.0RU134TT\.,Q\OP5^:>)CKLA+$CI14<F4R=-3++(50U%1%&#KD0'W7NGGO
MC;.]\;NC8G?>Q]O3=EU_2VT>W89>F(ZRGQ^0WJ=Z8C;=33YK85=D)(\)2=M8
M4[,?$8@U[04<^+W)E:9ZFF\XD]^Z]T W7W5'=D/^C*@QFV.K\_U!ENY.R.^^
MRI-S[J[4ZLWGM_<>\^]-V]P;.VIMKJ_/]#UU7O#;_5LVY!6Q/ELOM6;+[IBB
MR0IL;30MCJGW7NA?[OQV0JOD?\*:VEH:RIH\7OSNB;)U<%---2XZ*JZ#WU24
MTM=41HT5)'45<J1(TA4/(P47) ]^Z]U/[MPF^-I]C;-^1>SMLU79L77W6O8G
M7.;ZOQTTM-N6>@[(WEU%G)=];+E2GKXLC7;5INNY?XGAQ325^6H)@V.D:LHX
M\;EO=>Z![J;H#<>)K/CY4I+O6EFZISV]=[SYF2IEV[U%3X3M.N[FR.:ZGV;T
MWN6N_O30MUR=\8_ ;;R>3P>+R.'VK2)!09".GJ<OB\E[KW0I[QQ^0E^=7QRR
MT=#628NB^)GS3Q]9DDIIGQ])D,GW#\!ZG&T-36*AIX*S(4^(JY((G8/*E+*R
M B-RONO=<.V\5OWK?M#)?(3:FSYNX,;E.M=E=19;KZ"7()N#9-/3=DY3(UV_
MMG0X_#[DJ\G@<M1;V^XWK045!4YBKQ^T\8^.ILA54Z4,WNO=([H#X]]H]3Y?
MXY&+?^#W9UUUO\;*_I_<T&3P>\-F;CERT6-Z6BVO4[;VC75F1Q]'M^CR&P<S
M+'#DW3*XFERBTAFKA^[#[KW2GR7_ &7WLW_Q3_LO_P!_1U-[]U[IF[IVOOS9
M6_NR^R<#L3&]Q;8[RZQZYZ0S>V\IC<SFX>NGVO5]S5*;BW/M;!8S.YK?W4.Z
M)>SH:7+X[$TG\6Q\T;S,M50UD\^%]U[I9]$]-[JZNW-!4UF;AWAM>/XT_'#J
M2'>VX*_,0]H;MW5TU)V<F7W7O?;U=MV&FIJK=&.WU2RR3-E)ZQ:J"6.6!1I;
MW[KW4+9V/R$7SJ^1N6DH:R/%UOQ,^%F/H\D]-,F/J\AC.X?GQ4Y*AIJQD%//
M68^GR]))/$C%XDJHF< 2(6]U[H(_D-UCV%14_P DMO8G ?WYVM\T,?'UW6;V
M_@^X=U97X]"MZ.K^MDGS^RMMT5?N'>O3^/R.!7*T%%B7IJF'=.Z*[[N2AQ]5
M49>A]U[H<>MMH=Q1=T[NW7V+M;K6GV-A]LU&SNG-RX'L_=FZ-^R[=K\G@\KG
M:K>6Q\KTQL+ [5W-OS+8E,CG*BDSN925Z/'4J1(:2:LK/=>Z:>K\=D(/E[\L
M<E/0UD./R&P_C##05\M--'15TM!1=P"NBHZIT$%3)1FIC$JHS&/R+JMJ%_=>
MZ!CNGJKL*G_T^=8TV)K,SM#Y?;\CW+3=T8;$;AW%G^@,CC^MNH]BQ_?;7VYC
M,OFJK=FW6Z[FS^Q-PTQI<5CLM#34^2^SEHZ>JS'NO=&+ZKZZS.&[>[<[0GI-
MZ;?QO86/V]B*K;N^MS8C=M949G9^Y^P&IL]M1L9F=R0['V'5[=S]*U%@Z:M@
MHS43U%9+C*+*5&4J\K[KW2<^.6/R%%W#\^*FLH:RDI\O\L]G9#$U%33300Y/
M'Q?!7X68F2NQ\LJ(E;1QY3&5-,TL99!44\L9.N-P/=>Z!?>/5786*JVZ.J<3
M693:':'R8B^1\'R"QN(W#N;*[9?:WR!ZY[QI^N=YX/"8ROKJ#>"4-#+MC9^>
MGJ(=O8W;6"IFK9!4T5-BLK[KW1F>C>N^R^OLQW0=^[EV[NC$;R[&Q&[MD5^)
M.?BRR8[_ $7=>[4W$-R8S+SUF/PM=D=W[5KJ]*;&U$U$!6-(OB,AIX?=>Z0/
MQ/\ ^/C^8?\ XN!O7_WU?3?OW7N@D7JKL+"Y?8O0>6Q-8NW,5\D,K\G,)\A\
M+B-PYRJKZ;(_(#>7<55US/3X?&5_]PNP*^CW''M3<64RE93X7-;2RN1FH6$M
M34XG&>Z]T;?HO9&Y.O=EYG;FYZ;;=+43=J=V;NQ,>ULK7Y7'+MOL;M_>W8NW
MH9VR&W=M/0Y2AQ>ZXZ:JIHX9J>*: ^*>5""/=>Z##X68_(8SI[>--DJ&LQ]1
M+\L_GQD(Z>NIIJ2:3'Y?YU?(W+8FN2*H2-WH\GBZV&IIY0-$U/*DB%D92?=>
MZ '!=4]J;;JOCWT16[6I<F/C)-D.R]L=O5L6Z9=N?(G)UO6G>O5<6W-X;CPV
MT]TQ]5[^W16;UILYV#E<M%D(JULE-_"*3*25E3)A_=>Z-K\=ML=H;<V;FJON
MC =?X/M+=N\,INO>4O6^_-R=B[?S60JL;AL539),_NGK?JO*4\='B\/3XVAQ
MYQ;C&X>@HZ9JNMECDJ9/=>Z"?XE[1R>3^(W]S*ZIW!LW(Y_.?)#$#)T22XK<
MF 7<7=?:\=%G,4:J(/2Y"FIJ^.KHY60J3XW%U(O[KW0:;5V3V3'N?KO;&Y>O
M,IMVJ^*72>Y^ML%4=5X^II,?WY2[UZWZ[Q5+)UEN_<1Q>Q.O=D45;MB=*C;F
MX,NF8@W-A:"5C_#*2AR6:]U[HV?Q]ZXKNJ>MXMFU=7F*BE@W9V!G,)3;CS+[
MIW/BL!NO?&?W1B<7NK>51/6Y3>NZ*>GR^K(9?(5>1R==5O))6Y#)U7ER-5[K
MW7R<_?NO=?7X]^Z]U[W[KW1(>J]X[KV;\2OB%4[2&W:RORW5/Q]PIP6;HZ^>
MIS5-5[3V3)G?L<A29?&4^W:7!;+@RV4K<E/%7I1047D^TJ+>&3W7NN4/R=W?
M7;&W)NVBV[@X)J?K/HSN'#4F3ILG V,VUW5O+?F AV=N""'*2M6[TVO0[("5
M\D4E'3Q5M8P$3K3Z:CW7NG#<_<M9NM.V=OUN,S&"VY/M/OO:^Q7%'B9:;<64
MZH@?;F^JS=50U?/GL'D)\T:A\!1Q4<-%486E-?-6SRY"GH:#W7NA,^)O_9+'
MQH_\5_Z:_P#?=;<]^Z]T8#W[KW7O?NO=>]^Z]TVYF>HI<3DJFEJL;0U%/0U4
MT5?F=?\ ":%XX7?[W)+'/2.]#2 >251-"712/)'?6ONO=$]V_P#)'?$[P_QW
M;F'6+&9SJZ'(/0XK*4;;MVMWY\FNP^@^K]P86*LS]74;*J,1MO:%%N;+45?'
MDJB9,B:$KCYH7D]^Z]UBW!O_ .36\>M*+=_4V[NC=D;FH.UNZ.LLEM[?G378
M':V/W;7[5[TW#U)U^N%R.V^_.H*W9M+!2;:DJ\_734N>U0S/504M.E(U//[K
MW1V??NO=>]^Z]U[W[KW7O?NO=$_^9/\ Q[G0?_BX'Q?_ /?J8;W[KW1P/?NO
M=>]^Z]U[W[KW7O?NO=!#WCO'=>P^N<_N79(V[4[JH:&N_NWA-Q4=?70;LW-)
MCJM=L[1I$H,O@VH9L]GOMXI:^6H^VQU():B=1"DDL7NO= #O3Y.[OP.U>TMQ
MXC;N#FFP/6_R[WMLZBRM-DXJ?'U7Q'[!Q_6N6I]T5U+E"VX:?L.NR:Y2A2EA
MQ+4%-"U,\E2S_=1^Z]TI)/D=FH?DG!TI4;5K*;;]5OP; Q^[1M_*9/!9/+KT
M#5=XU./.[\-DZ^DVYO"DI*<@XC,8R@II\6%JJ?)2U$L5"WNO=&X]^Z]U[W[K
MW7O?NO=>]^Z]T3_)?]E][-_\4_[+_P#?T=3>_=>Z.![]U[KWOW7NO>_=>Z][
M]U[HL_?7<^Z.GIH,SB<5@]UX/$[3[%WMN[:L<5=3;JAVML'J_L#>#9JDW <C
M_":#^+;RPF%PE/2/CZRHF6NJ:F/5'2S^#W7NHM/W/O*#?^UNOZ^@V[6RK\@L
MGTGN_<%/CLKB(<I3GXL93Y'XC-[6PDV:S+8AH9FI<54BJKJ]9/MIY4"&=%IO
M=>ZS?'_O#<?:62S.WMW[<DVQN?"]9]/=AYW!U>W-P[3RVT,KVF=_TV0ZZS>(
MW)/4UE?E-G5>P'9LK"8:3(Q5R&&!%B\DWNO=&<]^Z]U[W[KW7O?NO=>]^Z]T
M3_XG_P#'Q_,/_P 7 WK_ .^KZ;]^Z]T<#W[KW7O?NO=!?W'NC<NS>O\ .;AV
MB^'.X:&GE7#4&8PU?N#^/9NKIYZ3;>VL7A\=G]L3UN8W'N>>BHH%:N@C'F8L
MPM<>Z]T"N#^0NX,YDY(:N#:NTL56X'O3,PY')PY/-TVTXOCUV1U]USNRKS=7
M1Y/%C<E#NU]VU64PGV\..:3&0TLCEFJ66+W7NH_77R#WWN+.;$P>[MI8W 9#
M+;VQ'4^[<5'2UD.3H=Z5/QXSO?\ D=R4VO,Y"#%;=IX,9'@GQLGWU139E:V
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M@VWN+!96FDH\GA<[@\M3U>,R^)R-),\4]-4120S1L5=2I(]^Z]TD]F=,]/\
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:U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>j20306712_ba006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
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MIJ.(S31XO%93.9!T! (I<3A:/(96OEN?\W!#(Y'-N#[KT9NXC0NU:#T!)_(
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MG>/7G0VS-J?(O)9?;V1PW2^P^N1O^J[#Q]%LRHK5W5E>SLGN#?-3/A*58/X
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ML=MTN+IQ92@_CM8W)!/%SH>%YZOY?['2F8\UH^FW7;I(Z?$S31DG_2!90/\
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&WKI7U__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>j20306712_ba007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@!T P$1  (1 0,1 ?_$ :(    & @,!
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M[J;%0$FRH3;\VO\ \5]^Z]U,6@<'E2#_ +'_ (W8^]=>Z<(\6Y4G3_AS^?\
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M-]GEJ4-P6L!JX(]TD'=^75XSCJC<038]G0JVF)PR2@']R._%C:X8%N03]?\
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M>]@.6+ &Y!_UC^/?NO=)*7_<;E-14BASLL<+L>%ILV D-'.;*=,>4B1:=O\
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K_F]_3_:O?AU[JSO_ +IN_P#=N=_V6G_Y:G_S(S_W_P#_ /*[[W^+KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>j20306712_ba008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba008.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0#A P$1  (1 0,1 ?_$ :(    & @,!
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M<L9:Y@S.RLK3(%*E2J/M[=6"E%B=0)9O4.;BX-O#7Y]!"/GW?4-6$#CYH?\
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MFGJSC/=>Z-1[]U[KWOW7NO>_=>Z][]U[KWOW7NNB0H+,0JJ"68D   7))/
M'OW7NJ5OF1_-ZV1U7493K[XY08;L[?5*TM'DM]54CU?7.W*@!TD3$O0U$,F]
M<G3M_:@ECQL;$'S5!5X0ZL9.6X= #?>>+>S)MMJTS7(P7XHOV4^,_8=/S.1T
M!_\ +/\ G1V'VYV/O;JCO;>E?N[<N\7JMZ;#S66DIH?%78ZCB3<>SL904D%/
M0T%!)BJ5<A1TM+%!3P?;5;:2TWNY4 8Z+N4^8KJ^NY++<9"\LE70GU [E &
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M6;3W)D-Y[6ZTZ_VUO#+_ ,<_BVZ\!LW;F&W)D_[SU^+RNY/XAG<=C:;*5O\
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MF4AE>)V5@RD@^(J*=*+2YDL[J.[B_M(W##\C6GV'@?EUOJ;/W1B=\;2VOO7
MS&HP>[]NX3=&%G( ,^)W!C*;+8Z8A2R@R4=6C<$CGVDX=9(03)<0)<19CD0,
M/L85'\CTHO?NG>H.3H1E,;D,:U774 R-#5T)KL94O19*C%73R4YJ\?61@O25
MU.)-<4J\QR ,/I[]U[JECJWL;Y/;9W;OO:O=N5[JR%'UAL'.9C)[]JL)O7 [
M-R&Z?C71X"D[FS:3X''UDM=L'NK;F(V%N;:M'3#(Y2IE[2WA2T;U+[5%+CO=
M>Z,&?E[V_DMF[\W1AJ;K&AJNO.K?D5O^HPNX-L[D%?NW(=7=I]D===>XO&IC
MNQ9:?"T.\:/ X;(?<PS9R/(?=M%1-HJ8*B+W7NE)E/ECV!B-W[DV(O\ <'+Y
M';55T]MZJW.^TMV[:VU)G,[WKU_U/VEDTI<GO&NR24.+VSO:/<--0RM'_#*2
MHHY?O\QC:FGR=1[KW2&F^7/?&(C["J9<=U_O/(;4P<&-QFV]K;6R>*K=SYS:
MW=/RKV)N_=>SJ?</8M/A*F3<.T.H-M5E!M_-;FP]''59NGITSTU368^#(>Z]
MU8[5;CR4.7VMCZ/9.ZLKC=Q0ULV1W-2R[3H\1LP4U''54D>Z:#.;JQ&['FRT
MC^"!<5C,F8YE/W/@2SGW7N@-K>U=P8CY&4&SMQX;(83957U7V/N"AR-3E,+4
M4BR[1W=U+B*'*OC<)GZW(M4;QEWG71TT=;1&:"GPZM3M&]1D84]U[HN</;>]
M.R=R=DU_Q^[ACW-A^M>Q.O=L9G9F87[W+Y?<:9C>>%SV2QV:H<(V+IL/O3*+
M18Z/ ,^.Q\--A&RSU>,IZQY:GW7NC2?'+L7<786T<I/NS'9"CW'BLP!F9:N0
M&&GR.?Q])NBJVG]G_"\4^ RG7SYC^"5F*85TN/>B6.?(5]5YZAO=>Z,)[]U[
MKWOW7NO>_=>ZT_?YM>])MV_-WL3'M)Y*/8> V+LO'-:1;0IM>@W17QZ954KX
MLYNBK7@:6MJ!(-RHC^'J#N=;@S\P2K^&-40?[R&/\V/5:ON_03Z][]U[JVO^
M3CTM3=D?)^J[!R])'587I7:\^Y:99HQ-"=X[@D? [7$D;H8]5)2/D:Z%R=4=
M311,HN+JW(:+3UZ&O(M@+O>#<N*QVZ:O]LV%_9W$?,#K;!]L=31U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]T7#Y<],4GR ^.7;'5TM**G)9S:E=6[6(0-+
M3[SP &=VE-"VEI(P^=Q\$4VBSR4\DD=[.0=J:&O15O=@-SVJ:S(J[(2O^F7*
M_P P ?E4=:,7M5UCOU[W[KW7O?NO=;E?\KW?,V^OA'TU-63--7[6I=P[&JF9
MM6B':NY<KC\)"IO<+#ML42@&UK6'%O:=Q1CU._*%R;GE^ MED#(?]JQ _P",
MTZ6'R7^=74GQ7W7@=G]A;=[&S&3W%MX;EHI]FXC;.0H8J$Y*NQ8BJI<WN[;U
M0E7]QCW.E(G305.JY(&@I/#I1NO,-EL\RP7*RL[+J&D*12I'FRYQU(^-'S?Z
MJ^5.:W3@>N]N=B8JNVEAZ7-9 [PQ6V<=!54U95M10PT$F'W=GVDJ?,O(E6%
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MCL;CJ&!ZFLKJZLJ7CIZ2CI*>-GDD=E1$4DD >_=5=TC0R2$+&HJ2<  <23Y
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MV#N');5W?MJM3(83.XJ80UE%4JK1N+.LD%335,$C13P3))!40NT<J/&S*?$
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6O=&$]^Z]U[W[KW7O?NO=>]^Z]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>j20306712_ba009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ FP#A P$1  (1 0,1 ?_$ :(    & @,!
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M]U[HPW^D_9/_ #T6W_\ T*MH?_9![]U[H0/?NO==$A068A54$DD@  "Y))X
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M_P MM/ X3)=Q;PR.;H\IFIMS9RE^0/:VRHMRQ)U5V_M/"Y'%0;"VQM_-[/\
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M6EIJ&EIJ*C@BI:2C@AI:6F@18H*>FIXUB@@AC0!(XH8D"JH   L/:7K(M0%
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MLK9F_P JW%N[<F+VG7Q24B10_:KDUKH_O1%4U?NO='2]^Z]U[W[KW7O?NO=
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M?P_[[T?W;T:?[G?;_P"3_=Z[>K7[]U[H5-F_\!L__P >?_Q^&Z/^/-_X#?\
G%UF_XO\ _P!GA_SM/^FK5[]U[I8>_=>Z][]U[KWOW7NO>_=>Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>j20306712_ba010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba010.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0%* P$1  (1 0,1 ?_$ :(    & @,!
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MK/\ SZ8?_P"J_?NO9Z]_%<W_ ,\M6?\ GTP__P!5^_=>SU[^*YO_ )Y:L_\
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M[6KF8^Z]T72O^'794V^MK=E)E>N<UFY>N>S/C[V=M'>#39GK_=_Q\W3UKMO
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MV:PVX-OS1TE1AUW%#CZRESF*QU7C]T2;>=<@,+.D>8^Q85'VWA(?W[KW6/\
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M=O;F[8ZOPFY1C\)C::MA[3K>G=QY%L9_%J*LK<-LZOBT>"J\\>Z=>Z+'W/\
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M7I7S!$MQL\]FI59)(R%!]>(%!]F.JS/^$_G3NV-O?!+<.^:^"EW1N'Y)=O\
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MY-$2KIV=\:Q"KD%59"6H6)L)1^V3^??NM]1?[PX#_G>8?_BS_P!X?^+G1?\
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MLX*2Y&3'X#8N3BVOV#NZ+(0014S9&-:#'4ZUPJ()ZQH'IS[21QZN=PN[]/\
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MNYN;GWJA]#T^J(@H@ 'RQU._O?M/_GJ-N_\ G[QO_P!4^_4/H>K=>_O?M/\
MYZC;O_G[QO\ ]4^_4/H>O=>_O?M/_GJ-N_\ G[QO_P!4^_4/H>O=>_O?M/\
MYZC;O_G[QO\ ]4^_4/H>O=>_O?M/_GJ-N_\ G[QO_P!4^_4/H>O=>_O?M/\
MYZC;O_G[QO\ ]4^_4/H>O=>_O?M/_GJ-N_\ G[QO_P!4^_4/H>O=>_O?M/\
MYZC;O_G[QO\ ]4^_4/H>O=>_O?M/_GJ-N_\ G[QO_P!4^_4/H>O=>_O?M/\
MYZC;O_G[QO\ ]4^_4/H>O=>_O?M/_GJ-N_\ G[QO_P!4^_4/H>O=>_O?M/\
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MFW?_ $*,E_\ 8A[]CY]>Z]]SNS_G2;=_]"C)?_8A[]CY]>Z]]SNS_G2;=_\
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M&#"_'KM>DZVV)M2LR^TZ+-UWRGS/>W<-5MK>6]L"LNTI>P-Y=F[=VCM?/8;
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M]C_N_P!^Z]T9R;^%_P"S!=1?Q?\ TD?WT_T#]J?PC[O_ $<_W1_@7]ZNE?\
M2#_>K^$_[G/[\?QS^[?C_AO^X?1YO#QY/?NO=&(]^Z]U7A\H?[O_ .G;:/\
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%=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>j20306712_ba011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j20306712_ba011.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0'+ P$1  (1 0,1 ?_$ :(    & @,!
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M)ZTV/V_LS+=>]CX&'<^S<ZV/;+X*IJ\C14]><5DZ/,X\338NLH:S3393'PS
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M5:5FI9G\T\-'$K&]K(/;J*",]11SIO>Z[?O @LIWCA\%304I4EJGA\NJUO\
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M#&_^(;V5_P"[S>/O4?P]'7N#_P EX?\ /.G^%NJD?=^@/UM-?R0?^R4>P?\
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M;X3]G1IL?_);L_\ GJB_ZN+T>G^=)_V6!C?_ !#>RO\ W>;Q]UC^'H2>X/\
MR7A_SSI_A;JI'W?H#];37\D'_LE'L'_Q87=?_OM^IO;,GQ?EU,WMU_R1)?\
MGJ;_ *MQ=7(>V^A]U[W[KW5&7SW_ .RA,E_X:VV/_<6;W8<.H[YD_P"2F?\
M2+T2_P![Z(.KA?AU_P!DI;N_\.[<G_N#MSW4\>AQLG_)$D_T[?X%ZF^]],]+
M+K[_ (_3;G_:QC_Z$D]ZZ4V?^Y2?;UKM?S</^RY.R?\ PW>N/_>%P?MZ/X>H
MQYY_Y6.;_21_\<'5:?N_01ZOTZC_ .W)/<W_ (<.<_\ ?D;+]M'^TZDVQ_Z=
MW<?Z9O\ JXG5!?MWJ,NCT_RT?^RY/C]_X<6X?_>%W5[J_P )Z$G*/_*QVO\
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MOJO;]109'/SX&*BBH>H]LUQG$D.)RWW7GUZ"C*H YN?I[9"ZF/4TW7,#\O\
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MDI;N_P##NW)_[@[<]U/'H<;)_P D23_3M_@7J;[WTSTLNOO^/TVY_P!K&/\
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M&71A?B-_V5=\8O\ Q87I;_WY&VO>F^$_9T:;'_R6[/\ YZHO^KB]'I_G2?\
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M[U_\3)V=_P"]MF_:@<!U!.Z_\E2Y_P">B3_CYZ!OWOI!U>E_,8_[=]?R[?\
MQ'G77_OD]K>VT^,]21S7_P JMM7_ #2C_P"K*]46^W.HWZNR_D<?]E!=M_\
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M_P#FJ?\  .B;^[=$'5^G;G_;DGIG_P .'!_^_(WI[:']IU)M]_T[NW_TR_\
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M?]N^OY=O_B/.NO\ WR>UO;:?&>I(YK_Y5;:O^:4?_5E>J+?;G4;]79?R./\
MLH+MO_Q#<G_O;;5]MR<.I#]N?^2I/_SS_P#/Z]5']N?\S7[._P#$A;T_]Z3)
M>[CAT!K_ /W.F_YJO_QX]![[WTEZVG/_ +SC[9_Z"ZF?_O0=$/W9O"KS@W#B
M=M=4_)7=[[1^2W\P'"9K*;)^)WR=WMM;^)3?S"?E'ETBQ&\]J=1YC:.Y(5HL
MC%KGQM;5P1RZH7=9HY$2@/1CS!ME]>W*26J:D$=#E1FI/F1TB/NMY_\ >/\
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MU-1U,FPVL]EL]O:W*Z9TC 85!H<^8)!_(]&6_P!GAZ8_YXKY?_\ IO;Y]?\
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M)]I[UR5/34M/MSLWN3#01T]-5HFB'<V7*E2'E60/%'[KW1C/?NO=5Z=/?!'
M=4]K;)[7BHNIY-P;-R&5Q>-K=L=98G9=1C=BR;*WGMQFC7%+(<SV9O?<.ZH\
MAELY42Q08O%4HPF*HH:>>NJJWW7NK"_?NO=>]^Z]U[W[KW0>]J[=W)NS8&XM
MO[/SV%VMNO(PT2[<W)N*@W/E<+@\U3Y2AJ\=E,AB-F;WZUW-F8:*JIUD%%2Y
M[%-5L!"U0D;O[]U[H#>C.H_]$G8.XJ7<'9FY.U.P-S;3ILCG]U;[_P!)-3G:
MO%XW*QTF)I-KR9_>.?ZRP.V\6]3,M;BMM4&,9:F>GJZY):BI-1-[KW1M/?NO
M=5'?,;J"LWMWF,IMWJ'=78&7.!PLDF?ROQX^/><ZWP-5]I/BI0W=^_\ H+Y$
M=N4-=%A&:;[+!;.W+1^6]-(:0U4LL7NO=6;]7T%/B^L^N\92??&EQVQ=HT%,
M<GC$PN2-/1X#'T\/\0PT6,PD>)KO'&/+3+14BP2700Q!="^Z]UD['VI5[XV-
MN7:=!6X7&5^<QKT=#D]P[6I-[8C&5ODCFI,E5;4R%;C\?G6Q]1$LT4%1+]NT
MR(94DC#1O[KW01]&_'JFZ5R.8RD&8P.>RFYZ%%W=N1=GS8;=>Z<O324IQ]=6
MUL>Z,AMW 86@7[QHL%@<3A\)3SUTDE/2P>I7]U[HR7OW7NJQOE1FLEMCY HV
M-VEL7.2;VZIV/M=:_=FV>O=X5JU%!FN[,VU'0P;]^;_QU?:D--CJ>>6.MHMO
M%IIY"IRD\BI2T?NO='CZ(HJG&]']-8ZL,+5E!U3UY15;4_V'V[5-+M'#P3F#
M^%Y_=>,\)EC.G[;*9*#3;QU50EIG]U[I6;ZVM!OG9&\=E54T-/3;PVKN':U1
M45&.H\Q3P0;@Q%9B9II\3D4DQ^4ABCJRS4\ZM#.H*."K'W[KW12/CK\.L1T3
MV15=G4V,ZMI-Q[CV;N3;FZ9]A;#I=ET='35V8V'/M#:6T<=3&9J';NV<3LZ9
M\ODJRIJ\MNS,UPK*HTU/14%#2^Z]T>'W[KW7O?NO=>]^Z]U[W[KW1">O^@=R
M; [/ZDWKVKW55=D;@?-;GPFP]M4U#WC1];[0IZOK[>,IHMD8.N[HWYMU=Q+M
M7&!)<_O0YNNFACR$6*EQ@R7V:^Z]T?;W[KW57WSJZNFWYV#LFLP_5.[NSL_2
M[51*=(>@.@>P.O\ #S4.;R4V'?<G:O<'5_;&Z-@S551D*GR#;6W]RU5-!&)Y
M,:S/")_=>Z.O\=<$NV>E>O\  K3U5*V+Q-12STM9A*7;DM/5KE*]JR!,)0]?
M=3T6/I8JMG6!8=K[=B, 1DQM$I%/'[KW2T['VI5[XV-N7:=!6X7&5^<QKT=#
MD]P[6I-[8C&5ODCFI,E5;4R%;C\?G6Q]1$LT4%1+]NTR(94DC#1O[KW01]&_
M'JFZ5R.8RD&8P.>RFYZ%%W=N1=GS8;=>Z<O324IQ]=6UL>Z,AMW 86@7[QHL
M%@<3A\)3SUTDE/2P>I7]U[HR7OW7NJ</EA6YNF["^1VS<)M3K^JJ>P]MU.13
M,[BVSU?N7,*,5U'UYMVHK*;.[]^?W2>1V;)1RY*E1*>EVSB(9D3[@_>%I:F7
MW7NKC_?NO= ;\@NH!W5L6FVND.Q:JKQFXL;N7&TG96RH>P-DSY+&TV0I:-MP
M;7>NQ-3E*&BER'W+4\%;125@@^U>>.">5O?NO=)?XS?'# _&S!;CVQMJGP,.
M)RU=B*P5.,P]!C,MG,E28>"GSFYMP_PG'X;"455G\R\\\&(QM%38G"TY6FHE
M2GT0P^Z]T9KW[KW7O?NO=>]^Z]T'O:NW=R;LV!N+;^S\]A=K;KR,-$NW-R;B
MH-SY7"X/-4^4H:O'93(8C9F]^M=S9F&BJJ=9!14N>Q35; 0M4)&[^_=>Z WH
MSJ/_ $2=@[BI=P=F;D[4[ W-M.FR.?W5OO\ TDU.=J\7C<K'28FDVO)G]XY_
MK+ [;Q;U,RUN*VU08QEJ9Z>KKDEJ*DU$WNO=&T]^Z]U2I\S.D9-[]R]HYG$=
M0[XW5/DL!1T&=WS6?&7X[Y;:V"Q-1L3;-+N'^YW;.Y/C=\DN[M[YRDPV'I)Z
M?%4VUZW%5F8A7'')47V[_;>Z]U=7[]U[H+^Y>O\ )=H]=9O9&(SV'VOD<M6;
M:J:;<.<V/@NQJ/$'!;JPFX9*VFVCN=QMVNSD4.*;^&3UL=338_(^"L>FJE@-
M-+[KW27Z-Z/Q_25+N*AQ<^WZF'<=1C<GD:S';>S&/SV6S]/'64^1S.X\[G=Y
M;NK,M]U1M2PT='#]G08J&F,5+"D+K'%[KW0\>_=>ZIO[!K<W3]B[ZZ^Q^U.O
MX8]R=F;[W=!F:O;/5^9W$8\=O['RY&I_OQN3Y_8;=>)CGJ,G3E\<=E14JB6:
M-<%5Q"6FG]U[JY#W[KW0 _(SI9N\MD8K;4*[!>OPFZJ'=&+3LW8-'V5LU:^#
M$9S QUF4VG55V*;)MB(=P/7101U=)]Y+3+2331TU1.??NO=-_P 9?CUM_P"-
M6SMR["VI1X6CVYD-Y'<F,_AE!2T>3KC)LS9FW<GF]VST&/Q&.KMS;@S6VZFO
M=*.DI,?C*2II\910QT=#3J/=>Z,=[]U[H/\ MF"EJ>J^RZ:NI*.OHJCK_>4%
M90Y'#9'<>/K:67;F2CJ*2NV]A\1G\MGJ.HA8I+14M!6U-4A,45/,[+&WNO=5
M*?#':..R/<\U?U7USW9T348ZGSW]]]Q?(CXK=1[/K]^;:PF]-B-N_:/2F^>C
MMA=8XK:^'S>YL)0PY.EW'5M4)!1R+2;6BG^XR./]U[JZOW[KW5?'S,[I[(ZD
MW#M:/:/<WQTZIP^>P\,-3%\GNU=N]);1S5;_ !J:CJ%V1NO*]8=GU6\-R1TM
M9$N0Q?AHXJ-&H6$CFN?Q>Z]T//Q6RV?R746*IL[M[<6&BPE=48G Y?<4^'=M
M[X1J2@RR;NV_38BLJOLMFRY3*56/PXJ%I9ZK'8^*K%-!#40Q+[KW1CO?NO=>
M]^Z]U[W[KW1,?EALZFW-D=A55=3;^J\;387=^(ST>R>MX-Z,NU<AN_J/<&[$
M7<TN:P<_6VXLUM[9]1AZ'+4LC5U+2Y2NJJ3QU5)#/%[KW0T= T>#H>K\)#M7
M%[JP.TFKMPR[7P>]J$T>Y\7AY,_DBB9"=Z[(U&9I:^L$U909">:6JK<;4T\M
M1)-.TD\ONO=#-[]U[KWOW7NO>_=>Z][]U[KWOW7N@+^2]'19#HSL.BK\-)N&
MFJ<711?P2GVB=^5V2J#FL9]G2XG:3;,[$H\SG)*P1_8)68',8Z.L\4E923TJ
M31M[KW5?GP.VO03;^K,_UML?MSH[:F+DW#%O#;7R+^-?6?7O:G8OV4N9P:XW
M;6^>CMO;(V!0[(VQNG()65-%E*C=>:^]BCIX:?;\$,W\1]U[JW?W[KW59GRZ
M[M[+Z\['AV;A^[?C!L#:V[,/3I)MGY*=N;7Z>R.=IJW'5E)D:+K/'Y'J?L:J
M[/CE:BD^\26IQ_VTM08AJ4#W[KW1T>@\EG<GU+LLY_:^]MIU&-PN/P%'1=E?
MPV'L'*8_;U%386#<V[\7B<KGZ/!9;<\E"]<*,U]74Q4\T1J3#4M-30>Z]T,7
MOW7NO>_=>Z][]U[H@OR6V5MS+=I4F=WEBNSLQLMMJ[%&\:'9>P)'IJW$[7R'
M<,F+PM#W%0;HVUG]CS9#<^\J+(9:#'N*BII\-14TDJTE=4Q3^Z]T<#K"G6DZ
MYV-314V:H::+:N#6@QVY<12X#<N*Q?\ #H#BL/N3#4)^QQ^XL1C3%35\<*QP
MBKBDT1QJ1&ONO=+KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0IT9LO"9CO?
M$X[JKJ[N#J#L*CRF2Q\/='9/P]ZTHNA<<:KKS<[Y+_0AEMF=6=6]Q[0W15]?
MYBHBQ=5O'(;9CD@R$4N03<528:*M]U[J^OW[KW5?'S,[I[(ZDW#M:/:/<WQT
MZIP^>P\,-3%\GNU=N]);1S5;_&IJ.H79&Z\KUAV?5;PW)'2UD2Y#%^&CBHT:
MA82.:Y_%[KW0\_%;+9_)=18JFSNWMQ8:+"5U1B<#E]Q3X=VWOA&I*#+)N[;]
M-B*RJ^RV;+E,I58_#BH6EGJL=CXJL4T$-1#$ONO=&.]^Z]U[W[KW7O?NO=5K
M]_;(V>_9.]LSV!M7NC>NS:G*1[CFP6P.L5@K<WO&IZ^Z\V?M/ 8;LNFW/B,A
MNG;=#'@*J1-L-324.4W!F72K:H2F2E/NO=6.8Z&KIL?0T]?6_P 2KH*.FAK<
MC]M%1_?U<4*)4UOVD):&E^ZF5I/&A*IJTC@>_=>ZF>_=>Z][]U[KWOW7NO>_
M=>Z][]U[H"_DO1T60Z,[#HJ_#2;AIJG%T47\$I]HG?E=DJ@YK&?9TN)VDVS.
MQ*/,YR2L$?V"5F!S&.CK/%)64D]*DT;>Z]U7Y\#MKT$V_JS/];;'[<Z.VIBY
M-PQ;PVU\B_C7UGU[VIV+]E+F<&N-VUOGH[;VR-@4.R-L;IR"5E3192HW7FOO
M8HZ>&GV_!#-_$?=>ZMW]^Z]U4Q\P^W>T,=V)O+I_']Z_'S9.T][8,XFDV)V9
MVGMKK[OK)4^3V12?=3_'WK6?J_<^4[AJ*O*&;^%5#9[#3/N%*JAC:$44<S^Z
M]U9SL3<68W9M7&;BSNSLUL&ORC9"==J;CJ,549_&XY,G6P86;,C"UN1QU%DL
MKAHJ>LFI$GF>A>H-/(YDB<^_=>Z5WOW7NO>_=>Z][]U[JLO?&PMM4G9>4DW)
M@NZ,P<7NC?\ 5[%J]O=4PT$>0[ WWN*;L.FS&8W(FZ:.D[JQ>R*1YJ#"8BLH
M/X3'BHY8ZR"LJ(?N(O=>ZLT]^Z]U[W[KW7O?NO=>]^Z]TE][_P #_N7N_P#O
M/_&/[M_W7S_]X?[O?WE_C_\  _X35_Q;^!_W+_W^/\8^P\GVW\)_W)^;3]K^
M_H]^Z]T6?H7_ $"_WVJ/]&'^S(?Q[^[^\]?^EC_9SO[F_:?WOP']]/M/]F _
MXQY_?#^]OV_F\'^YS5]WH_:^^]^Z]T<#W[KW5>?S!Q65R.\, V&WYVIM"HCQ
M>R14P=7=3?.7L>KK*/\ O]5/.^:JOBYW3U7LS&XLT@GCG7(PU>6%$:F2-B@@
MC;W7NC<=)0^#JW:$)R%9E7BHZQ)<ED</V5M_)UTZY6O%14Y3"=PYS<O9V*RD
MTVHU,&:R%971SZP\SBS'W7NA4]^Z]U[W[KW7O?NO=$P^67^RZ_Q?J[_9@?XA
M_!_]_'][X/X5_=G_ $?_ -XNMO[W_P"EGR?[G_\ 0A_>_P#NK_>G[?\ W#?8
MZ?[Q_P"_=_B?OW7NAOZ'_NW_ *+\+_=+^,?P3^,;W\7\=_NC_$/XA_?O<O\
M'+?W"_WYG\/_ ([]S]G_  S_ "/[/Q>/T^_=>Z&#W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=!_P!I?W6_N)G?[Z?WP_NY_N,^^_N!_I%_OEYOXQC_ .&?W>_T2_\
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MVW_I;_BG]ZO[I[=^PU_W(_N#_'_O>S/]!_\ ?[^]7^XC^.?WH_O+_<C^]?\
MOR_[V_;W_P!S_P# _?NO=&WZL_@O^C'KC^[?\4_N[_</:'\ _CGVG\:_@O\
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7?NO=68>_=>Z][]U[KWOW7NO>_=>Z_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
